Medizinische Klinik
Innere Medizin VII
Institut für Tropenmedizin, Reisemedizin, Humanparasitologie

811

Adresse: Wilhelmstraße 27
72074 Tübingen


Publikationen

2023

  • · Groger M, Lutete GT, Assi SB, Bigoga JD, Ntamabyaliro NY, Arbe-Barnes S, Shin J, Adegnika AA, Ntoumi F, Kremsner PG, Ramharter M, Duparc S, Borghini-Fuhrer I, Mombo-Ngoma G:

    · Community health workers in clinical research at the example of a phase IIIb/ IV antimalarial drug trial conducted in five African countries

    · Int J Infect Dis (2023)

  • · Mouzinga FH, Heinzel C, Lissom A, Kreidenweiss A, Batchi-Bouyou AL, Mbama Ntabi JD, Djontu JC, Ngumbi E, Kremsner PG, Fendel R, Ntoumi F:

    · Mucosal response of inactivated and recombinant COVID-19 vaccines in Congolese individuals.Immun

    · Inflamm Dis (2023)

  • · Huttner A, Agnandji ST, Engler O, Hooper JW, Kwilas S, Ricks K, Clements TL, Jonsdottir HR, Nakka SS, Rothenberger S, Kremsner P, Züst R, Medaglini D, Ottenhoff T, Harandi AM, Siegrist CA, VEBCON , VSV-EBOVAC , VSV-EBOPLUS Consortia:

    · Antibody responses to recombinant vesicular stomatitis virus-Zaire Ebolavirus vaccination for Ebola virus disease across doses and continents: 5-year durability

    · Clin Microbiol Infect (2023)

  • · Boussougou-Sambe ST, Ngossanga B, Doumba-Ndalembouly AG, Boussougou LN, Woldearegai TG, Mougeni F, Mba TN, Edoa JR, Dejon-Agobé JC, Awono-Ambene P, Kremsner PG, Kenguele HM, Borrmann S, Mordmüller B, Adegnika AA:

    · Anopheles gambiae s.s. resistance to pyrethroids and DDT in semi-urban and rural areas of the Moyen-Ogooué Province, Gabon

    · Malar J (2023)

  • · Yao L, Chemaitelly H, Goldman E, Gudina EK, Khalil A, Ahmed R, James AB, Roca A, Fallah MP, Macnab A, Cho WC, Eikelboom J, Qamar FN, Kremsner P, Oliu-Barton M, Sisa I, Tadesse BT, Marks F, Wang L, Kim JH, Meng X, Wang Y, Fly AD, Wang CY, Day SW, Howard SC, Graff JC, Maida M, Ray K, Franco-Paredes C, Mashe T, Ngongo N, Kaseya J, Ndembi N, Hu Y, Bottazzi ME, Hotez PJ, Ishii KJ, Wang G, Sun D, Aleya L, Gu W:

    · Time to establish an international vaccine candidate pool for potential highly infectious respiratory disease: a community's view

    · EClinicalMedicine (2023)

  • · Richie TL, Church LWP, Murshedkar T, Billingsley PF, James ER, Chen MC, Abebe Y, Natasha Kc , Chakravarty S, Dolberg D, Healy SA, Diawara H, Sissoko MS, Sagara I, Cook DM, Epstein JE, Mordmüller B, Kapulu M, Kreidenweiss A, Franke-Fayard B, Agnandji ST, López Mikue MA, McCall MBB, Steinhardt L, Oneko M, Olotu A, Vaughan AM, Kublin JG, Murphy SC, Jongo S, Tanner M, Sirima SB, Laurens MB, Daubenberger C, Silva JC, Lyke KE, Janse CJ, Roestenberg M, Sauerwein RW, Abdulla S, Dicko A, Kappe SHI, Sim BKL, Duffy PE, Kremsner PG, Hoffman SL:

    · Sporozoite immunization: innovative translational science to support the fight against malaria

    · Expert Rev Vaccines (2023)

  • · Ekoka Mbassi D, Mombo-Ngoma G, Held J, Okwu DG, Ndzebe-Ndoumba W, Kalkman LC, Ekoka Mbassi FA, Pessanha de Carvalho L, Inoue J, Akinosho MA, Dimessa Mbadinga LB, Yovo EK, Mordmüller B, Kremsner PG, Adegnika AA, Ramharter M, Zoleko-Manego R:

    · Efficacy and safety of ivermectin for the treatment of Plasmodium falciparum infections in asymptomatic male and female Gabonese adults - a pilot randomized, double-blind, placebo-controlled single-center phase Ib/IIa clinical trial

    · EBioMedicine (2023)

  • · Ayran J, Köhler C, Linh LTK, Schneider G, Pallerla SR, Battke F, Federle L, Martus P, Kremsner PG, Velavan TP:

    · Tübingen model study: large-scale introduction of rapid antigen testing in the population and the viral dynamics of SARS-CoV-2

    · Front Public Health (2023)

  • · Ndanga MED, Abdul JBPAA, Edoa JR, Ibinda GARM, Adegbite BR, Mevyann RC, Biyogho CM, Mahoumbou J, Manguinga S, Roguet NM, Lell B, Kremsner PG, Alabi AS, Grobusch MP, Adegnika AA:

    · Species identification and drug susceptibility testing of non-tuberculous mycobacteria by Line Probe Assay in Lambaréné, Gabon-a cross-sectional study

    · BMC Infect Dis (2023)

  • · Mitjà O, Reis G, Boulware DR, Spivak AM, Sarwar A, Johnston C, Webb B, Hill MD, Smith D, Kremsner P, Curran M, Carter D, Alexander J, Corbacho M, Lee TC, Hullsiek KH, McDonald EG, Hess R, Hughes M, Baeten JM, Schwartz I, Metz L, Richer L, Chew KW, Daar E, Wohl D, Dunne M:

    · Hydroxychloroquine for treatment of non-hospitalized adults with COVID-19: A meta-analysis of individual participant data of randomized trials

    · Clin Transl Sci (2023)

  • · Oludada OE, Costa G, Burn Aschner C, Obraztsova AS, Prieto K, Canetta C, Hoffman SL, Kremsner PG, Mordmüller B, Murugan R, Julien JP, Levashina EA, Wardemann H:

    · Molecular and functional properties of human Plasmodium falciparum CSP C-terminus antibodies

    · EMBO Mol Med (2023)

  • · Augustin Y, Staines HM, Velavan TP, Kamarulzaman A, Kremsner PG, Krishna S:

    · Drug repurposing for COVID-19: current evidence from randomized controlled adaptive platform trials and living systematic reviews

    · Br Med Bull (2023)

  • · Heinzel C, Pinilla YT, Binder A, Kremsner PG, Held J, Fendel R, Kreidenweiss A:

    ·· Saliva and Plasma Antibody Levels in Children and Adolescents After Primary Infection With Omicron Variants of SARS-CoV-2 Infection in Germany

    · JAMA Pediatr. (2023)

  • · Velavan TP, Ntoumi F, Kremsner PG, Lee SS, Meyer CG:

    · Emergence and geographic dominance of Omicron subvariants XBB/XBB.1.5 and BF.7 - the public health challenges

    · Int J Infect Dis (2023)

  • · Wichers-Misterek JS, Krumkamp R, Held J, von Thien H, Wittmann I, Höppner YD, Ruge JM, Moser K, Dara A, Strauss J, Esen M, Fendel R, Sulyok Z, Jeninga MD, Kremsner PG, Sim BKL, Hoffman SL, Duffy MF, Otto TD, Gilberger TW, Silva JC, Mordmüller B, Petter M, Bachmann A:

    · The exception that proves the rule: Virulence gene expression at the onset of Plasmodium falciparum blood stage infections

    · PLoS Pathog (2023)

  • · Smit MJ, Sander AF, Ariaans MBPA, Fougeroux C, Heinzel C, Fendel R, Esen M, Kremsner PG, Ter Heine R, Wertheim HF, Idorn M, Paludan SR, Underwood AP, Binderup A, Ramirez S, Bukh J, Soegaard M, Erdogan SM, Gustavsson T, Clemmensen S, Theander TG, Salanti A, Hamborg M, de Jongh WA, McCall MBB, Nielsen MA, Mordmüller BG, COUGH-1 trial study group:

    · First-in-human use of a modular capsid virus-like vaccine platform: an open-label, non-randomised, phase 1 clinical trial of the SARS-CoV-2 vaccine ABNCoV2

    · Lancet Microbe (2023)

  • · Badr HS, Colston JM, Nguyen NH, Chen YT, Burnett E, Ali SA, Rayamajhi A, Satter SM, Van Trang N, Eibach D, Krumkamp R, May J, Adegnika AA, Manouana GP, Kremsner PG, Chilengi R, Hatyoka L, Debes AK, Ateudjieu J, Faruque ASG, Hossain MJ, Kanungo S, Kotloff KL, Mandomando I, Nisar MI, Omore R, Sow SO, Zaidi AKM, Lambrecht N, Adu B, Page N, Platts-Mills JA, Mavacala Freitas C, Pelkonen T, Ashorn P, Maleta K, Ahmed T, Bessong P, Bhutta ZA, Mason C, Mduma E, Olortegui MP, Peñataro Yori P, Lima AAM, Kang G, Humphrey J, Ntozini R, Prendergast AJ, Okada K, Wongboot W, Langeland N, Moyo SJ, Gaensbauer J, Melgar M, Freeman M, Chard AN, Thongpaseuth V, Houpt E, Zaitchik BF, Kosek MN:

    · Spatiotemporal variation in risk of Shigella infection in childhood: a global risk mapping and prediction model using individual participant data

    · Lancet Glob Health (2023)

  • · Agnandji ST, Recker M, Mordmüller B, Glöckner S, Adegnika AA, Lell B, Otieno L, Otieno W, Owusu-Agyei S, Asante KP, Agbenyega T, Ansong D, Macete E, Aide P, Sorgho H, Tinto H, Mturi N, Lusingu JPA, Gesase S, Hoffman I, Masoud NS, Newton CR, Bojang K, Krause G, Kremsner PG:

    · Prostration and the prognosis of death in African children with severe malaria

    · Int J Infect Dis (2023)

  • · Inoue J, Weber D, Fernandes JF, Adegnika AA, Agnandji ST, Lell B, Kremsner PG, Grobusch MP, Mordmüller B, Held J:

    · HHV-6 infections in hospitalized young children of Gabon.

    ·· Infection (2023)

  • · Krueger T, Ikegbunam M, Lissom A, Sandri TL, Ntabi JDM, Djontu JC, Baina MT, Lontchi RAL, Maloum M, Ella GZ, Agonhossou R, Akoton R, Djogbenou L, Borrmann S, Held J, Ntoumi F, Adegnika AA, Kremsner PG, Kreidenweiss A:

    · Low Prevalence of Plasmodium falciparum Histidine-Rich Protein 2 and 3 Gene Deletions-A Multiregional Study in Central and West Africa

    · Pathogens (2023)

  • · Manouana GP, Nguema-Moure PA, Tomazatos A, Maloum MN, Bock CT, Kremsner PG, Velavan TP, Adegnika AA, Niendorf S:

    · RT-PCR-based assessment of the SD Bioline Rota/Adeno Antigen-based test in infants with and without diarrhea

    · Virol J (2023)

  • · Abdul JBPAA, Adegbite BR, Ndanga MED, Edoa JR, Mevyann RC, Mfoumbi GRAI, de Dieu TJ, Mahoumbou J, Biyogho CM, Jeyaraj S, Niemann S, Lell B, Kremsner PG, Alabi AS, Adegnika AA, Grobusch MP:

    · Resistance patterns among drug-resistant tuberculosis patients and trends-over-time analysis of national surveillance data in Gabon, Central Africa

    · Infection (2023)

  • · Ayran J, Köhler C, Linh LTK, Schneider G, Pallerla SR, Battke F, Federle L, Martus P, Kremsner PG, Velavan TP:

    · Large-scale introduction of rapid antigen testing in the population and the viral dynamics of SARS-CoV-2

    · Front Public Health (2023)

2022

  • · Zumla A, Traore T, Amao L, Ntoumi F, Sharma A, Azhar EI, Abbara A:

    · Reducing the threat of epidemic-prone infections at mass gathering religious events.

    · Lancet (2022)

  • · Ntoumi F, Zumla A:

    · Advancing accurate metrics for future pandemic preparedness

    · Lancet (2022)

  • · Lazarus JV, Romero D, Kopka CJ, Karim SA, Abu-Raddad LJ, Almeida G, Baptista-Leite R, Barocas JA, Barreto ML, Bar-Yam Y, Bassat Q, Batista C, Bazilian M, Chiou ST, Del Rio C, Dore GJ, Gao GF, Gostin LO, Hellard M, Jimenez JL, Kang G, Lee N, Matičič M, McKee M, Nsanzimana S, Oliu-Barton M, Pradelski B, Pyzik O, Rabin K, Raina S, Rashid SF, Rathe M, Saenz R, Singh S, Trock-Hempler M, Villapol S, Yap P, Binagwaho A, Kamarulzaman A, El-Mohandes A, COVID-19 Consensus Statement Panel:

    · A multinational Delphi consensus to end the COVID-19 public health threat.

    · Nature (2022)

  • · Suzuki TA, Fitzstevens JL, Schmidt VT, Enav H, Huus KE, Mbong Ngwese M, Grießhammer A, Pfleiderer A, Adegbite BR, Zinsou JF, Esen M, Velavan TP, Adegnika AA, Song LH, Spector TD, Muehlbauer AL, Marchi N, Kang H, Maier L, Blekhman R, Ségurel L, Ko G, Youngblut ND, Kremsner P, Ley RE:

    · Codiversification of gut microbiota with humans

    ·· Science (2022)

  • · Tegally H, San JE, Cotten M, Moir M, Tegomoh B, Mboowa G, Martin DP, Baxter C, Lambisia AW, Diallo A, Amoako DG, Diagne MM, Sisay A, Zekri AN, Gueye AS, Sangare AK, Ouedraogo AS, Sow A, Musa AO, Sesay AK, Abias AG, Elzagheid AI, Lagare A, Kemi AS, Abar AE, Johnson AA, Fowotade A, Oluwapelumi AO, Amuri AA, Juru A, Kandeil A, Mostafa A, Rebai A, Sayed A, Kazeem A, Balde A, Christoffels A, Trotter AJ, Campbell A, Keita AK, Kone A, Bouzid A, Souissi A, Agweyu A, Naguib A, Gutierrez AV, Nkeshimana A, Page AJ, Yadouleton A, Vinze A, Happi AN, Chouikha A, Iranzadeh A, Maharaj A, Batchi-Bouyou AL, Ismail A, Sylverken AA, Goba A, Femi A, Sijuwola AE, Marycelin B, Salako BL, Oderinde BS, Bolajoko B, Diarra B, Herring BL, Tsofa B, Lekana-Douki B, Mvula B, Njanpop-Lafourcade BM, Marondera BT, Khaireh BA, Kouriba B, Adu B, Pool B, McInnis B, Brook C, Williamson C, Nduwimana C, Anscombe C, Pratt CB, Scheepers C, Akoua-Koffi CG, Agoti CN, Mapanguy CM, Loucoubar C, Onwuamah CK, Ihekweazu C, Malaka CN, Peyrefitte C, Grace C, Omoruyi CE, Rafaï CD, Morang'a CM, Erameh C, Lule DB, Bridges DJ, Mukadi-Bamuleka D, Park D, Rasmussen DA, Baker D, Nokes DJ, Ssemwanga D, Tshiabuila D, Amuzu DSY, Goedhals D, Grant DS, Omuoyo DO, Maruapula D, Wanjohi DW, Foster-Nyarko E, Lusamaki EK, Simulundu E, Ong'era EM, Ngabana EN, Abworo EO, Otieno E, Shumba E, Barasa E, Ahmed EB, Ahmed EA, Lokilo E, Mukantwari E, Philomena E, Belarbi E, Simon-Loriere E, Anoh EA, Manuel E, Leendertz F, Taweh FM, Wasfi F, Abdelmoula F, Takawira FT, Derrar F, Ajogbasile FV, Treurnicht F, Onikepe F, Ntoumi F, Muyembe FM, Ragomzingba FEZ, Dratibi FA, Iyanu FA, Mbunsu GK, Thilliez G, Kay GL, Akpede GO, van Zyl GU, Awandare GA, Kpeli GS, Schubert G, Maphalala GP, Ranaivoson HC, Omunakwe HE, Onywera H, Abe H, Karray H, Nansumba H, Triki H, Kadjo HAA, Elgahzaly H, Gumbo H, Mathieu H, Kavunga-Membo H, Smeti I, Olawoye IB, Adetifa IMO, Odia I, Ben Boubaker IB, Muhammad IA, Ssewanyana I, Wurie I, Konstantinus IS, Halatoko JWA, Ayei J, Sonoo J, Makangara JC, Tamfum JM, Heraud JM, Shaffer JG, Giandhari J, Musyoki J, Nkurunziza J, Uwanibe JN, Bhiman JN, Yasuda J, Morais J, Kiconco J, Sandi JD, Huddleston J, Odoom JK, Morobe JM, Gyapong JO, Kayiwa JT, Okolie JC, Xavier JS, Gyamfi J, Wamala JF, Bonney JHK, Nyandwi J, Everatt J, Nakaseegu J, Ngoi JM, Namulondo J, Oguzie JU, Andeko JC, Lutwama JJ, Mogga JJH, O'Grady J, Siddle KJ, Victoir K, Adeyemi KT, Tumedi KA, Carvalho KS, Mohammed KS, Dellagi K, Musonda KG, Duedu KO, Fki-Berrajah L, Singh L, Kepler LM, Biscornet L, de Oliveira Martins L, Chabuka L, Olubayo L, Ojok LD, Deng LL, Ochola-Oyier LI, Tyers L, Mine M, Ramuth M, Mastouri M, ElHefnawi M, Mbanne M, Matsheka MI, Kebabonye M, Diop M, Momoh M, Lima Mendonça MDL, Venter M, Paye MF, Faye M, Nyaga MM, Mareka M, Damaris MM, Mburu MW, Mpina MG, Owusu M, Wiley MR, Tatfeng MY, Ayekaba MO, Abouelhoda M, Beloufa MA, Seadawy MG, Khalifa MK, Matobo MM, Kane M, Salou M, Mbulawa MB, Mwenda M, Allam M, Phan MVT, Abid N, Rujeni N, Abuzaid N, Ismael N, Elguindy N, Top NM, Dia N, Mabunda N, Hsiao NY, Silochi NB, Francisco NM, Saasa N, Bbosa N, Murunga N, Gumede N, Wolter N, Sitharam N, Ndodo N, Ajayi NA, Tordo N, Mbhele N, Razanajatovo NH, Iguosadolo N, Mba N, Kingsley OC, Sylvanus O, Femi O, Adewumi OM, Testimony O, Ogunsanya OA, Fakayode O, Ogah OE, Oludayo OE, Faye O, Smith-Lawrence P, Ondoa P, Combe P, Nabisubi P, Semanda P, Oluniyi PE, Arnaldo P, Quashie PK, Okokhere PO, Bejon P, Dussart P, Bester PA, Mbala PK, Kaleebu P, Abechi P, El-Shesheny R, Joseph R, Aziz RK, Essomba RG, Ayivor-Djanie R, Njouom R, Phillips RO, Gorman R, Kingsley RA, Neto Rodrigues RMDESA, Audu RA, Carr RAA, Gargouri S, Masmoudi S, Bootsma S, Sankhe S, Mohamed SI, Femi S, Mhalla S, Hosch S, Kassim SK, Metha S, Trabelsi S, Agwa SH, Mwangi SW, Doumbia S, Makiala-Mandanda S, Aryeetey S, Ahmed SS, Ahmed SM, Elhamoumi S, Moyo S, Lutucuta S, Gaseitsiwe S, Jalloh S, Andriamandimby SF, Oguntope S, Grayo S, Lekana-Douki S, Prosolek S, Ouangraoua S, van Wyk S, Schaffner SF, Kanyerezi S, Ahuka-Mundeke S, Rudder S, Pillay S, Nabadda S, Behillil S, Budiaki SL, van der Werf S, Mashe T, Mohale T, Le-Viet T, Velavan TP, Schindler T, Maponga TG, Bedford T, Anyaneji UJ, Chinedu U, Ramphal U, George UE, Enouf V, Nene V, Gorova V, Roshdy WH, Karim WA, Ampofo WK, Preiser W, Choga WT, Ahmed YA, Ramphal Y, Bediako Y, Naidoo Y, Butera Y, de Laurent ZR, Africa Pathogen Genomics Initiative (Africa PGI)‡ , Ouma AEO, von Gottberg A, Githinji G, Moeti M, Tomori O, Sabeti PC, Sall AA, Oyola SO, Tebeje YK, Tessema SK, de Oliveira T, Happi C, Lessells R, Nkengasong J, Wilkinson E:

    · The evolving SARS-CoV-2 epidemic in Africa: Insights from rapidly expanding genomic surveillance

    · Science (2022)

  • · Kremsner PG, Ahuad Guerrero RA, Arana-Arri E, Aroca Martinez GJ, Bonten M, Chandler R, Corral G, De Block EJL, Ecker L, Gabor JJ, Garcia Lopez CA, Gonzales L, Granados González MA, Gorini N, Grobusch MP, Hrabar AD, Junker H, Kimura A, Lanata CF, Lehmann C, Leroux-Roels I, Mann P, Martinez-Reséndez MF, Ochoa TJ, Poy CA, Reyes Fentanes MJ, Rivera Mejia LM, Ruiz Herrera VV, Sáez-Llorens X, Schönborn-Kellenberger O, Schunk M, Sierra Garcia A, Vergara I, Verstraeten T, Vico M, Oostvogels L, HERALD Study Group:

    · Efficacy and safety of the CVnCoV SARS-CoV-2 mRNA vaccine candidate in ten countries in Europe and Latin America (HERALD): a randomised, observer-blinded, placebo-controlled, phase 2b/3 trial

    · Lancet Infect Dis (2022)

  • · Grobusch MP, Schlagenhauf P:

    · Primaquine and the power of adherence in radical cure

    · Lancet Infect Dis (2022)

  • · Agnandji ST, Loembe MM:

    · Ebola vaccines for mass immunisation in affected regions

    · Lancet Infect Dis (2022)

  • · Kalkman LC, Hänscheid T, Krishna S, Grobusch MP:

    · Fluid therapy for severe malaria.

    · Lancet Infect Dis (2022)

  • · Ntoumi F, Kremsner PG:

    · Vaccination with fractional doses: promise or illusion?

    ·· Lancet Infect Dis (2022)

  • · Ntoumi F, Nachega JB, Aklillu E, Chakaya J, Felker I, Amanullah F, Yeboah-Manu D, Castro KG, Zumla A:

    · World Tuberculosis Day 2022: aligning COVID-19 and tuberculosis innovations to save lives and to end tuberculosis

    · Lancet Infect Dis (2022)

  • · Vianello E, Gonzalez-Dias P, van Veen S, Engele CG, Quinten E, Monath TP, Medaglini D, VSV-EBOVAC Consortium , VSV-EBOPLUS Consortium , Santoro F, Huttner A, Dubey S, Eichberg M, Ndungu FM, Kremsner PG, Essone PN, Agnandji ST, Siegrist CA, Nakaya HI, Ottenhoff THM, Haks MC:

    · Transcriptomic signatures induced by the Ebola virus vaccine rVSVΔG-ZEBOV-GP in adult cohorts in Europe, Africa, and North America: a molecular biomarker study.

    · Lancet Microbe (2022)

  • · Abe H, Ushijima Y, Bikangui R, Ondo GN, Lell B, Adegnika AA, Yasuda J:

    ·· Delays in the arrival of the waves of COVID-19: a comparison between Gabon and the African continent.

    · Lancet Microbe (2022)

  • · Ntoumi F:

    · From mink to malaria

    · NAT. MICROBIOL (2022)

  • · Wahl I, Obraztsova AS, Puchan J, Hundsdorfer R, Chakravarty S, Sim BKL, Hoffman SL, Kremsner PG, Mordmüller B, Wardemann H:

    · Clonal evolution and TCR specificity of the human TFH cell response to Plasmodium falciparum CSP

    · Sci Immunol (2022)

  • · Houwaart T, Belhaj S, Tawalbeh E, Nagels D, Fröhlich Y, Finzer P, Ciruela P, Sabrià A, Herrero M, Andrés C, Antón A, Benmoumene A, Asskali D, Haidar H, von Dahlen J, Nicolai J, Stiller M, Blum J, Lange C, Adelmann C, Schroer B, Osmers U, Grice C, Kirfel PP, Jomaa H, Strelow D, Hülse L, Pigulla M, Kreuzer P, Tyshaieva A, Weber J, Wienemann T, Kohns Vasconcelos M, Hoffmann K, Lübke N, Hauka S, Andree M, Scholz CJ, Jazmati N, Göbels K, Zotz R, Pfeffer K, Timm J, Ehlkes L, Walker A, Dilthey AT, German COVID-19 OMICS Initiative (DeCOI) , German COVID-19 OMICS Initiative (DeCOI):

    · Integrated genomic surveillance enables tracing of person-to-person SARS-CoV-2 transmission chains during community transmission and reveals extensive onward transmission of travel-imported infections, Germany, June to July 2021

    · Euro Surveill (2022)

  • · Silva JC, Dwivedi A, Moser KA, Sissoko MS, Epstein JE, Healy SA, Lyke KE, Mordmüller B, Kremsner PG, Duffy PE, Murshedkar T, Sim BKL, Richie TL, Hoffman SL:

    · Plasmodium falciparum 7G8 challenge provides conservative prediction of efficacy of PfNF54-based PfSPZ Vaccine in Africa.

    · Nat Commun (2022)

  • · Meyer Zu Natrup C, Tscherne A, Dahlke C, Ciurkiewicz M, Shin DL, Fathi A, Rohde C, Kalodimou G, Halwe S, Limpinsel L, Schwarz JH, Klug M, Esen M, Schneiderhan-Marra N, Dulovic A, Kupke A, Brosinski K, Clever S, Schünemann LM, Beythien G, Armando F, Mayer L, Weskamm LM, Jany S, Freudenstein A, Tuchel T, Baumgärtner W, Kremsner P, Fendel R, Addo MM, Becker S, Sutter G, Volz A:

    · Stabilized recombinant SARS-CoV-2 spike antigen enhances vaccine immunogenicity and protective capacity

    · J Clin Invest (2022)

  • · Adegbite BR, Edoa JR, Agbo Achimi Abdul J, Epola M, Mevyann C, Dejon-Agobé JC, Zinsou JF, Honkpehedji YJ, Mpagama SG, Alabi AS, Kremsner PG, Klipstein-Grobusch K, Adegnika AA, Grobusch MP:

    · Non-communicable disease co-morbidity and associated factors in tuberculosis patients: A cross-sectional study in Gabon

    · EClinicalMedicine (2022)

  • · Schnyder JL, de Jong HK, Grobusch MP:

    · Intradermal immunization-a dose-sparing strategy to combat global shortages of severe acute respiratory syndrome coronavirus 2 vaccines?

    · Clin Microbiol Infect (2022)

  • · Schnyder JL, de Jong HK, Schlagenhauf P, Borrmann S, Hanscheid T, Grobusch MP:

    · Discontinuing atovaquone/proguanil prophylaxis ad-hoc post-exposure and during-travel dose-sparing prophylactic regimens against P. falciparum malaria: An update with pointers for future research.

    · Travel Med Infect Dis (2022)

  • · Grobusch MP, Connor BA:

    · Factors impacting severe disease from chikungunya infection: Prioritizing chikungunya vaccine when available.

    · Travel Med Infect Dis (2022)

  • · Schaumburg F, Schuler F, Grobusch MP:

    · New recommendation on yellow fever booster vaccination in Germany

    ·Travel Med Infect Dis (2022)

  • · Schmitt EK, Ndayisaba G, Yeka A, Asante KP, Grobusch MP, Karita E, Mugerwa H, Asiimwe S, Oduro A, Fofana B, Doumbia S, Su G, Csermak Renner K, Venishetty VK, Sayyed S, Straimer J, Demin I, Barsainya S, Boulton C, Gandhi P:

    · Efficacy of Cipargamin (KAE609) in a Randomized, Phase II Dose-Escalation Study in Adults in Sub-Saharan Africa With Uncomplicated Plasmodium falciparum Malaria.

    · Clin Infect Dis (2022)

  • · Walker A, Houwaart T, Finzer P, Ehlkes L, Tyshaieva A, Damagnez M, Strelow D, Duplessis A, Nicolai J, Wienemann T, Tamayo T, Kohns Vasconcelos M, Hülse L, Hoffmann K, Lübke N, Hauka S, Andree M, Däumer MP, Thielen A, Kolbe-Busch S, Göbels K, Zotz R, Pfeffer K, Timm J, Dilthey AT, German COVID-19 OMICS Initiative (DeCOI):

    · Characterization of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection Clusters Based on Integrated Genomic Surveillance, Outbreak Analysis and Contact Tracing in an Urban Setting

    · Clin Infect Dis (2022)

  • · Boutry C, Hastie A, Diez-Domingo J, Tinoco JC, Yu CJ, Andrews C, Beytout J, Caso C, Cheng HS, Cheong HJ, Choo EJ, Curiac D, Di Paolo E, Dionne M, Eckermann T, Esen M, Ferguson M, Ghesquiere W, Hwang SJ, Avelino-Silva TJ, Kosina P, Liu CS, Markkula J, Moeckesch B, Murta de Oliveira C, Park DW, Pauksens K, Pirrotta P, Plassmann G, Pretswell C, Rombo L, Salaun B, Berglund JS, Schenkenberger I, Schwarz T, Shi M, Ukkonen B, Zahaf T, Zerbini C, Schuind A, Cunningham AL, Zoster-049 Study Group:

    · The Adjuvanted Recombinant Zoster Vaccine Confers Long-Term Protection Against Herpes Zoster: Interim Results of an Extension Study of the Pivotal Phase 3 Clinical Trials ZOE-50 and ZOE-70

    · Clin Infect Dis (2022)

  • · Nordmann T, Borrmann S, Ramharter M:

    · Drug-induced hypersensitivity to artemisinin-based therapies for malaria.

    ·· Trends Parasitol (2022)

  • · WorldWide Antimalarial Resistance Network Falciparum Haematology Study Group:

    ·· Haematological consequences of acute uncomplicated falciparum malaria: a WorldWide Antimalarial Resistance Network pooled analysis of individual patient data.

    ·· BMC Med (2022)

  • · Ibanez J, Fendel R, Lorenz FR, Granados-Bayon P, Brückner S, Esen M, Sulyok M, Sulyok Z, Borrmann S, Bacher P, Scheffold A, Hoffman SL, Kremsner PG, Mordmüller B:

    · Efficacy, T cell activation and antibody responses in accelerated Plasmodium falciparum sporozoite chemoprophylaxis vaccine regimens

    · npj Vaccines (2022)

  • · Mordmüller B, Sulyok Z, Sulyok M, Molnar Z, Lalremruata A, Calle CL, Bayon PG, Esen M, Gmeiner M, Held J, Heimann HL, Woldearegai TG, Ibáñez J, Flügge J, Fendel R, Kreidenweiss A, Kc N, Murshedkar T, Chakravarty S, Riyahi P, Billingsley PF, Church LWP, Richie TL, Sim BKL, Hoffman SL, Kremsner PG:

    · A PfSPZ vaccine immunization regimen equally protective against homologous and heterologous controlled human malaria infection.

    · npj Vaccines (2022)

  • · Petersen E, Ntoumi F, Hui DS, Abubakar A, Kramer LD, Obiero C, Tambyah PA, Blumberg L, Yapi R, Al-Abri S, Pinto TCA, Yeboah-Manu D, Haider N, Asogun D, Velavan TP, Kapata N, Bates M, Ansumana R, Montaldo C, Mucheleng'anga L, Tembo J, Mwaba P, Himwaze CM, Hamid MMA, Mfinanga S, Mboera L, Raj T, Aklillu E, Veas F, Edwards S, Kaleebu P, McHugh TD, Chakaya J, Nyirenda T, Bockarie M, Nyasulu PS, Wejse C, Muyembe-Tamfum JJ, Azhar EI, Maeurer M, Nachega JB, Kock R, Ippolito G, Zumla A:

    · Emergence of new SARS-CoV-2 Variant of Concern Omicron (B.1.1.529) - highlights Africa's research capabilities, but exposes major knowledge gaps, inequities of vaccine distribution, inadequacies in global COVID-19 response and control efforts

    · Int J Infect Dis (2022)

  • · Himwaze C, Mucheleng'anga LA, Telendiy V, Hamukale A, Tembo J, Kapata N, Ntoumi F, Zumla A:

    ·· Cardiac cysticercosis and neurocysticercosis in sudden and unexpected community deaths in Lusaka, Zambia: a descriptive medico-legal post-mortem examination study

    · Int J Infect Dis (2022)

  • · Grobusch LC, Grobusch MP:

    · A hot topic at the environment-health nexus: investigating the impact of climate change on infectious diseases

    · Int J Infect Dis (2022)

  • · Manouana GP, Nzamba Maloum M, Bikangui R, Oye Bingono SO, Ondo Nguema G, Honkpehedji JY, Rossatanga EG, Zoa-Assoumou S, Pallerla SR, Rachakonda S, Ndong Mintsa A, Lekana-Douki JB, Djoba Siawaya JF, Borrmann S, Kremsner PG, Lell B, Velavan TP, Adegnika AA:

    · Emergence of B.1.1.318 SARS-CoV-2 viral lineage and high incidence of alpha B.1.1.7 variant of concern in the Republic of Gabon

    · Int J Infect Dis (2022)

  • · Huyen PTM, Dung DTN, Weiß PJ, Hoan PQ, Giang DP, Uyen NT, Van Tuan N, Trung NT, Velavan TP, Song LH, Hoan NX:

    · Circulating level of sPD-1 and PD-1 genetic variants are associated with hepatitis B infection and related liver disease progression

    · Int J Infect Dis (2022)

  • · Rüter J, Pallerla SR, Meyer CG, Casadei N, Sonnabend M, Peter S, Nurjadi D, Linh LTK, Fendel R, Göpel S, Riess O, Kremsner PG, Velavan TP:

    · Host genetic loci LZTFL1 and CCL2 associated with SARS-CoV-2 infection and severity of COVID-19

    ·· Int J Infect Dis (2022)

  • · Tembo J, Egbe NF, Maluzi K, Mulonga K, Chilufya M, Kapata N, Mukonka V, Simulundu E, Zumla A, Fwoloshi S, Mulenga L, Pallerla SR, Velavan TP, Bates M:

    · Evaluation of SARS-CoV-2 diagnostics and risk factors associated with SARS-CoV-2 infection in Zambia

    · Int J Infect Dis (2022)

  • · Haider N, Guitian J, Simons D, Asogun D, Ansumana R, Honeyborne I, Velavan TP, Ntoumi F, Valdoleiros SR, Petersen E, Kock R, Zumla A:

    · Increased outbreaks of monkeypox highlight gaps in actual disease burden in Sub-Saharan Africa and in animal reservoirs.

    · Int J Infect Dis (2022)

  • · Petersen E, Zumla A, Hui DS, Blumberg L, Valdoleiros SR, Amao L, Ntoumi F, Asogun D, Simonsen L, Haider N, Traore T, Kapata N, Dar O, Nachega J, Abbara A, Al Balushi A, Kock R, Maeurer M, Lee SS, Lucey DR, Ippolito G, Koopmans M:

    · Vaccination for monkeypox prevention in persons with high-risk sexual behaviours to control on-going outbreak of monkeypox virus clade 3

    · Int J Infect Dis (2022)

  • · Sindato C, Karimuribo ED, Vairo F, Misinzo G, Rweyemamu MM, Hamid MMA, Haider N, Tungu PK, Kock R, Rumisha SF, Mbilu T, Ntoumi F, Zumla A, Mboera LEG:

    · Rift Valley fever seropositivity in humans and domestic ruminants and associated risk factors in Sengerema, Ilala, and Rufiji districts, Tanzania

    · Int J Infect Dis (2022)

  • · Mucheleng'anga LA, Himwaze CM, Telendiy V, Simumba S, Soko J, Kayonde N, Mulenga B, Hamukale A, Shibemba AL, Lungu PS, Tembo J, Bates M, Chanda-Kapata P, Mwaba P, Kapata N, Ntoumi F, Zumla A:

    · Incidental Tuberculosis in sudden, unexpected, and violent deaths in the community Lusaka, Zambia - A descriptive forensic post-mortem examination study

    · Int J Infect Dis (2022)

  • · Jeremiah C, Petersen E, Nantanda R, Mungai BN, Migliori GB, Amanullah F, Lungu P, Ntoumi F, Kumarasamy N, Maeurer M, Zumla A:

    ·· The WHO Global Tuberculosis 2021 Report - not so good news and turning the tide back to End TB

    ·· Int J Infect Dis (2022)

  • · Osei-Wusu S, Otchere ID, Asare P, Ntoumi F, Zumla A, Asante-Poku A, Yeboah-Manu D:

    · Relevance of genomic diversity of Mycobacterium tuberculosis complex in Africa

    ·· Int J Infect Dis (2022)

  • · Petersen E, Al-Abri S, Chakaya J, Goletti D, Parolina L, Wejse C, Mucheleng'anga LA, Khalili SA, Yeboah-Manu D, Chanda-Kapata P, Nasiri MJ, Lungu PS, Maeurer M, Tiberi S, Ntoumi F, Battista-Migliori G, Zumla A:

    · World TB Day 2022: Revamping and Reshaping Global TB Control Programs by Advancing Lessons learnt from the COVID-19 pandemic.

    · Int J Infect Dis (2022)

  • · Chanda-Kapata P, Ntoumi F, Kapata N, Lungu P, Mucheleng'anga LA, Chakaya J, Tembo J, Himwaze C, Ansumana R, Asogun D, Mfinanga S, Nyasulu P, Mwaba P, Yeboah-Manu D, Zumla A, Nachega JB:

    · Tuberculosis, HIV/AIDS and Malaria Health Services in sub-Saharan Africa - A Situation Analysis of the Disruptions and Impact of the COVID-19 Pandemic

    · Int J Infect Dis (2022)

  • · Ntoumi F, Petersen E, Mwaba P, Aklillu E, Mfinanga S, Yeboah-Manu D, Maeurer M, Zumla A:

    · Blue Skies research is essential for ending the Tuberculosis pandemic and advancing a personalized medicine approach for holistic management of Respiratory Tract infections

    · Int J Infect Dis (2022)

  • · Nana-Djeunga HC, Djune-Yemeli L, Domche A, Donfo-Azafack C, Efon-Ekangouo A, Lenou-Nanga C, Nzune-Toche N, Balog YA, Bopda JG, Mbickmen-Tchana S, Velavan TP, Penlap-Beng V, Ntoumi F, Kamgno J:

    ·· Correction to: High infection rates for onchocerciasis and soil-transmitted helminthiasis in children under five not receiving preventive chemotherapy: a bottleneck to elimination

    · Infect Dis Poverty (2022)

  • · Nana-Djeunga HC, Djune-Yemeli L, Domche A, Donfo-Azafack C, Efon-Ekangouo A, Lenou-Nanga C, Nzune-Toche N, Balog YA, Bopda JG, Mbickmen-Tchana S, Velavan TP, Penlap-Beng V, Ntoumi F, Kamgno J:

    · High infection rates for onchocerciasis and soil-transmitted helminthiasis in children under five not receiving preventive chemotherapy: a bottleneck to elimination

    · Infect Dis Poverty (2022)

  • · Lewis HC, Ware H, Whelan M, Subissi L, Li Z, Ma X, Nardone A, Valenciano M, Cheng B, Noel K, Cao C, Yanes-Lane M, Herring BL, Talisuna A, Ngoy N, Balde T, Clifton D, Van Kerkhove MD, Buckeridge D, Bobrovitz N, Okeibunor J, Arora RK, Bergeri I, UNITY Studies Collaborator Group:

    · SARS-CoV-2 infection in Africa: a systematic review and meta-analysis of standardised seroprevalence studies, from January 2020 to December 2021

    · BMJ Glob Health (2022)

  • ·· Macià D, Campo JJ, Moncunill G, Jairoce C, Nhabomba AJ, Mpina M, Sorgho H, Dosoo D, Traore O, Kusi KA, Williams NA, Oberai A, Randall A, Sanz H, Valim C, Asante KP, Owusu-Agyei S, Tinto H, Agnandji ST, Kariuki S, Gyan B, Daubenberger C, Mordmüller B, Petrone P, Dobaño C:

    · Strong off-target antibody reactivity to malarial antigens induced by RTS,S/AS01E vaccination is associated with protection

    ·· JCI Insight (2022)

  • · Moncunill G, Carnes J, Chad Young W, Carpp L, De Rosa S, Campo JJ, Nhabomba A, Mpina M, Jairoce C, Finak G, Haas P, Muriel C, Van P, Sanz H, Dutta S, Mordmüller B, Agnandji ST, Díez-Padrisa N, Williams NA, Aponte JJ, Valim C, Neafsey DE, Daubenberger C, McElrath MJ, Dobaño C, Stuart K, Gottardo R:

    · Transcriptional correlates of malaria in RTS,S/AS01-vaccinated African children: a matched case-control study

    · Elife (2022)

  • · Pugliese CM, Adegbite BR, Edoa JR, Mombo-Ngoma G, Obone-Atome FA, Heuvelings CC, Bélard S, Kalkman LC, Leopold SJ, Hänscheid T, Adegnika AA, Huson MA, Grobusch MP:

    · Point-of-care ultrasound to assess volume status and pulmonary oedema in malaria patients

    · Infection (2022)

  • · Essone PN, Adegbite BR, Mbadinga MJM, Mbouna AV, Lotola-Mougeni F, Alabi A, Edoa JR, Lell B, Alabi AS, Adegnika AA, Ramharter M, Siawaya JFD, Grobusch MP, Kremsner PG, Agnandji ST:

    · Creatine kinase-(MB) and hepcidin as candidate biomarkers for early diagnosis of pulmonary tuberculosis: a proof-of-concept study in Lambaréné, Gabon

    ·· Infection (2022)

  • · Dalimot JJ, Klei TRL, Beuger BM, Dikmen Z, Bouwman SAM, Mombo-Ngoma G, Zoleko-Manego R, Ndzebe-Ndoumba WF, Egée S, Kuijpers TW, Grobusch MP, van Bruggen R:

    · Malaria-associated adhesion molecule activation facilitates the destruction of uninfected red blood cells

    · Blood Adv (2022)

  • · Siekman SL, Pongracz T, Wang W, Nouta J, Kremsner PG, da Silva-Neto PV, Esen M, Kreidenweiss A, Held J, Trapé ÁA, Fendel R, de Miranda Santos IKF, Wuhrer M, ImmunoCovid Consortium:

    · The IgG glycome of SARS-CoV-2 infected individuals reflects disease course and severity

    ·· Front Immunol (2022)

  • · Adukpo S, Adedoja A, Esen M, Theisen M, Ntoumi F, Ojurongbe O:

    · Humoral antimalaria immune response in Nigerian children exposed to helminth and malaria parasites

    · Front Immunol (2022)

  • · Kc N, Church LWP, Riyahi P, Chakravarty S, Seder RA, Epstein JE, Lyke KE, Mordmüller B, Kremsner PG, Sissoko MS, Healy S, Duffy PE, Jongo SA, Nchama VUNN, Abdulla S, Mpina M, Sirima SB, Laurens MB, Steinhardt LC, Oneko M, Li M, Murshedkar T, Billingsley PF, Sim BKL, Richie TL, Hoffman SL:

    · Increased levels of anti-PfCSP antibodies in post-pubertal females versus males immunized with PfSPZ Vaccine does not translate into increased protective efficacy

    · Front Immunol (2022)

  • · Singh P, Sharma C, Sharma B, Mishra A, Agarwal D, Kannan D, Held J, Singh S, Awasthi SK

    ·· N-sulfonylpiperidinedispiro-1,2,4,5-tetraoxanes exhibit potent in vitro antiplasmodial activity and in vivo efficacy in mice infected with P. berghei ANKA

    · Eur J Med Chem (2022)

  • · Poje G, Pessanha de Carvalho L, Held J, Moita D, Prudêncio M, Perković I, Tandarić T, Vianello R, Rajić Z:

    · Design and synthesis of harmiquins, harmine and chloroquine hybrids as potent antiplasmodial agents

    · Eur J Med Chem (2022)

  • · Hildebrand D, Nurjadi D, Hoan NX, Linh MTH, Sang VV, Bang MH, Pallerla SR, Kremsner PG, Heeg K, Song LH, Velavan TP:

    · Association Between Soluble Notch Ligand Delta-like Ligand 1 and Bleeding Complications in Patients With Dengue Fever Infection

    · J Infect Dis (2022)

  • · Sandri TL, Kreidenweiss A, Cavallo S, Weber D, Juhas S, Rodi M, Woldearegai TG, Gmeiner M, Veletzky L, Ramharter M, Tazemda-Kuitsouc GB, Matsiegui PB, Mordmüller B, Held J:

    · Corrigendum to: Molecular Epidemiology of Mansonella Species in Gabon

    · J Infect Dis (2022)

  • · Bell GJ, Goel V, Essone P, Dosoo D, Adu B, Mensah BA, Gyaase S, Wiru K, Mougeni F, Osei M, Minsoko P, Sinai C, Niaré K, Juliano JJ, Hudgens M, Ghansah A, Kamthunzi P, Mvalo T, Agnandji ST, Bailey JA, Asante KP, Emch M:

    · Malaria Transmission Intensity Likely Modifies RTS, S/AS01 Efficacy Due to a Rebound Effect in Ghana, Malawi, and Gabon.

    · J Infect Dis (2022)

  • · de Carvalho LP, Groeger-Otero S, Kreidenweiss A, Kremsner PG, Mordmüller B, Held J:

    ·· Boromycin has Rapid-Onset Antibiotic Activity Against Asexual and Sexual Blood Stages of Plasmodium falciparum

    · Front Cell Infect Microbiol (2022)

  • · Pallerla SR, Van Dong D, Linh LTK, Van Son T, Quyen DT, Hoan PQ, Trung NT, The NT, Rüter J, Boutin S, Nurjadi D, Sy BT, Kremsner PG, Meyer CG, Song LH, Velavan TP:

    · Diagnosis of pathogens causing bacterial meningitis using Nanopore sequencing in a resource-limited setting

    · Ann Clin Microbiol Antimicrob (2022)

  • · Poje G, Marinović M, Pavić K, Mioč M, Kralj M, de Carvalho LP, Held J, Perković I, Rajić Z:

    · Harmicens, Novel Harmine and Ferrocene Hybrids: Design, Synthesis and Biological Activity

    · Int J Mol Sci (2022)

  • · Adegbite BR, Edoa JR, Schaumburg F, Alabi AS, Adegnika AA, Grobusch MP:

    · Knowledge and perception on antimicrobial resistance and antibiotics prescribing attitude among physicians and nurses in Lambaréné region, Gabon: a call for setting-up an antimicrobial stewardship program

    · Antimicrob Resist Infect Control (2022)

  • · Wahl I, Hoffmann S, Hundsdorfer R, Puchan J, Hoffman SL, Kremsner PG, Mordmüller B, Busse CE, Wardemann H:

    ·· An efficient single-cell-based method for linking human T cell phenotype to T cell receptor sequence and specificity

    · Eur J Immunol (2022)

  • · Saison N, Franetich JF, Pinilla YT, Hoffmann A, Boussougou-Sambe ST, Ngossanga B, Tefit M, Ashraf K, Amanzougaghene N, Tajeri S, Adegnika AA, Mazier D, Borrmann S:

    · Rapid and Specific Action of Methylene Blue against Plasmodium Transmission Stages

    ·· Pharmaceutics (2022)

  • · Moore CM, Wang J, Lin Q, Ferreira P, Avery MA, Elokely K, Staines HM, Krishna S:

    · Selective Inhibition of Plasmodium falciparum ATPase 6 by Artemisinins and Identification of New Classes of Inhibitors after Expression in Yeast

    · Antimicrob Agents Chemother (2022)

  • · Engle-Stone R, Miller JC, Reario MFD, Arnold CD, Stormer A, Lafuente E, Oxley A, Capanzana MV, Cabanilla CVD, Ford JL, Clark A, Velavan TP, Brown KH, Lietz G, Haskell MJ:

    · Filipino Children with High Usual Vitamin A Intakes and Exposure to Multiple Sources of Vitamin A Have Elevated Total Body Stores of Vitamin A But Do Not Show Clear Evidence of Vitamin A Toxicity

    · Curr Dev Nutr (2022)

  • · Souris M, Tshilolo L, Parzy D, Lobaloba Ingoba L, Ntoumi F, Kamgaing R, Ndour M, Mbongi D, Phoba B, Tshilolo MA, Mbungu R, Sosso MS, Fainguem N, Ndiaye Dieye T, Sylla M, Morand P, Gonzalez JP:

    · Pre-Pandemic Cross-Reactive Immunity against SARS-CoV-2 among Central and West African Populations

    · Viruses 2022

  • · Schultheiss HP, Bock CT, Aleshcheva G, Baumeier C, Poller W, Escher F:

    · Interferon-β Suppresses Transcriptionally Active Parvovirus B19 Infection in Viral Cardiomyopathy: A Subgroup Analysis of the BICC-Trial

    · Viruses (2022)

    ·

  • · Hoan NX, Huyen PTM, Binh MT, Trung NT, Giang DP, Linh BT, Dung DTN, Pallerla SR, Kremsner PG, Velavan TP, Bang MH, Song LH:

    · Author Correction: Genetic variants of programmed cell death 1 are associated with HBV infection and liver disease progression

    · Sci Rep (2022)

    ·

  • · Gabor JJ, Anh CX, Sy BT, Hoan PQ, Quyen DT, The NT, Kuk S, Kremsner PG, Meyer CG, Song LH, Velavan TP:

    ·· Aetiologies and clinical presentation of central nervous system infections in Vietnamese patients: a prospective study

    · Sci Rep (2022)

  • · Manurung MD, de Jong SE, Kruize Y, Mouwenda YD, Ongwe MEB, Honkpehedji YJ, Zinsou JF, Dejon-Agobe JC, Hoffman SL, Kremsner PG, Adegnika AA, Fendel R, Mordmüller B, Roestenberg M, Lell B, Yazdanbakhsh M:

    · Immunological profiles associated with distinct parasitemic states in volunteers undergoing malaria challenge in Gabon

    · Sci Rep (2022)

  • · von Bredow L, Schäfer TM, Hogenkamp J, Tretbar M, Stopper D, Kraft FB, Schliehe-Diecks J, Schöler A, Borkhardt A, Bhatia S, Held J, Hansen FK:

    ·· Synthesis, Antiplasmodial, and Antileukemia Activity of Dihydroartemisinin-HDAC Inhibitor Hybrids as Multitarget Drugs

    · Pharmaceuticals (Basel) (2022)

  • · Kay GA, Owen SI, Giorgi E, Clark DJ, Williams CT, Menzies S, Cuevas LE, Davies BMO, Eckersley NM, Hughes GL, Kirwan DE, Krishna S, Patterson EI, Planche T, Staines HM, Adams ER:

    · SARS-CoV-2 enzyme-linked immunosorbent assays as proxies for plaque reduction neutralisation tests

    ·· Sci Rep (2022)

  • · Grebe T, Rudolf V, Gouleu CS, Löffler B, Adegnika AA, Shittu AO, Deinhardt-Emmer S, Niemann S, Schaumburg F:

    · Neutralization of the Staphylococcus aureus Panton-Valentine leukocidin by African and Caucasian sera

    · BMC Microbiol (2022)

  • · Strezova A, Diez-Domingo J, Al Shawafi K, Tinoco JC, Shi M, Pirrotta P, Mwakingwe-Omari A, Zoster-049 Study Group:

    · Long-term Protection Against Herpes Zoster by the Adjuvanted Recombinant Zoster Vaccine: Interim Efficacy, Immunogenicity, and Safety Results up to 10 Years After Initial Vaccination

    ·· Open Forum Infect Dis (2022)

  • · van der Werf TS, Grobusch MP:

    · Clinical standards for drug-susceptible TB: putting patients first

    · Int J Tuberc Lung Dis

  • · Kalkman LC, Hanscheid T, Krishna S, Grobusch MP:

    · Fluid therapy in sepsis? Pathogen-specific perspectives

    · New Microbes New Infect (2022)

  • · Weber SF, Ruby LC, Heller T, Hande M, Shastry BA, Acharya RV, Bhat R, Shankar S, Prabhu M, Mohapatra AK, Magazine R, Kadavigere R, Denkinger CM, Gehring S, Bélard S, Saravu K:

    · TB disease patterns by HIV and diabetes status

    · Int J Tuberc Lung Dis

  • · Stevens EJ, Morse DJ, Bonini D, Duggan S, Brignoli T, Recker M, Lees JA, Croucher NJ, Bentley S, Wilson DJ, Earle SG, Dixon R, Nobbs A, Jenkinson H, van Opijnen T, Thibault D, Wilkinson OJ, Dillingham MS, Carlile S, McLoughlin RM, Massey RC:

    · Targeted control of pneumolysin production by a mobile genetic element in Streptococcus pneumoniae

    · Microb Genom (2022)

  • · Lekana-Douki SE, N'dilimabaka N, Levasseur A, Colson P, Andeko JC, Zong Minko O, Banga Mve-Ella O, Fournier PE, Devaux C, Ondo BM, Akombi FL, Yacka Mouele Bolo L, Ngonga Dikongo AM, Diané A, Mabika Mabika A, Mathouet JF, Dzembo C, Atiga NC, Mouity Matoumba A, Ndjangangoye NK, Bréchard L, Bedotto-Buffet M, Mangombi Pambou JB, Kandet Yattara M, Mbongo Nkama EA, Mintsa Ndong A, Adegnika AA, Raoult D, Fenollar F, Lekana-Douki JB:

    · Screening and Whole Genome Sequencing of SARS-CoV-2 Circulating During the First Three Waves of the COVID-19 Pandemic in Libreville and the Haut-Ogooué Province in Gabon

    · Front Med (Lausanne) (2022)

  • · Koehne E, Zander N, Rodi M, Held J, Hoffmann W, Zoleko-Manego R, Ramharter M, Mombo-Ngoma G, Kremsner PG, Kreidenweiss A:

    · Correction: Evidence for in vitro and in vivo activity of the antimalarial pyronaridine against Schistosoma

    · PLoS Negl Trop Dis (2022)

  • · Seifert SN, Fischer RJ, Kuisma E, Badzi Nkoua C, Bounga G, Akongo MJ, Schulz JE, Escudero-Pérez B, Akoundzie BJ, Ampiri VRB, Dieudonne A, Indolo GD, Kaba SD, Louzolo I, Macosso LN, Mavoungou Y, Miegakanda VB, Nina RA, Samabide KT, Ondzie AI, Ntoumi F, Muñoz-Fontela C, Mombouli JV, Olson SH, Walzer C, Niama FR, Munster VJ:

    · Zaire ebolavirus surveillance near the Bikoro region of the Democratic Republic of the Congo during the 2018 outbreak reveals presence of seropositive bats

    · PLoS Negl Trop Dis (2022)

  • · Grüner B, Peters L, Hillenbrand A, Voßberg P, Schweiker J, Rollmann EG, Rodriguez LH, Blumhardt J, Burkert S, Kern P, Köhler C, Soboslay PT:

    · Echinococcus multilocularis specific antibody, systemic cytokine, and chemokine levels, as well as antigen-specific cellular responses in patients with progressive, stable, and cured alveolar echinococcosis: A 10-year follow-up

    · PLoS Negl Trop Dis (2022)

  • · Johanns SI, Gantin RG, Wangala B, Komlan K, Halatoko WA, Banla M, Karabou P, Luty AJ, Schulz-Key H, Köhler C, Soboslay PT:

    · Onchocerca volvulus-specific antibody and cellular responses in onchocerciasis patients treated annually with ivermectin for 30 years and exposed to parasite transmission in central Togo

    · PLoS Negl Trop Dis (2022)

  • · Ozeki T, Abe H, Ushijima Y, Nze-Nkogue C, Akomo-Okoue EF, Ella GWE, Koumba LBM, Nso BCBB, Mintsa-Nguema R, Makouloutou-Nzassi P, Makanga BK, Nguelet FLM, Ondo GN, Mbadinga MJVM, Igasaki Y, Okada S, Hirano M, Yoshii K, Lell B, Bonney LC, Hewson R, Kurosaki Y, Yasuda J:

    · Identification of novel orthonairoviruses from rodents and shrews in Gabon, Central Africa

    · J Gen Virol (2022)

  • · Zoleko-Manego R, Okwu DG, Handrich C, Dimessa-Mbadinga LB, Akinosho MA, Ndzebe-Ndoumba WF, Davi SD, Stelzl D, Veletzky L, Kreidenweiss A, Nordmann T, Adegnika AA, Lell B, Kremsner PG, Ramharter M, Mombo-Ngoma G:

    · Effectiveness of antimalarial drug combinations in treating concomitant urogenital schistosomiasis in malaria patients in Lambaréné, Gabon: A non-randomised event-monitoring study

    · PLoS Negl Trop Dis (2022)

  • · Veletzky L, Eberhardt KA, Hergeth J, Stelzl DR, Zoleko Manego R, Mombo-Ngoma G, Kreuzmair R, Burger G, Adegnika AA, Agnandji ST, Matsiegui PB, Boussinesq M, Mordmüller B, Ramharter M:

    · Distinct loiasis infection states and associated clinical and hematological manifestations in patients from Gabon

    · PLoS Negl Trop Dis (2022)

  • · Batchi-Bouyou AL, Djontu JC, Vouvoungui JC, Mfoutou Mapanguy CC, Lobaloba Ingoba L, Mougany JS, Boumpoutou KR, Diafouka-Kietela S, Ampa R, Ntoumi F:

    · Assessment of neutralizing antibody responses after natural SARS-CoV-2 infection and vaccination in congolese individuals

    · BMC Infect Dis (2022)

  • · Betouke Ongwe ME, Mouwenda YD, Stam KA, Kremsner PG, Lell B, Diemert D, Bethony J, Bottazzi ME, Hotez PJ, Leeuwen RV, Grobusch MP, Adegnika AA, Mayboroda OA, Yazdanbakhsh M:

    · Investigation of urinary metabolomics in a phase I hookworm vaccine trial in Gabon

    · PLoS ONE (2022)

  • · Diederichs M, Glawion R, Kremsner PG, Mitze T, Müller GJ, Papies D, Schulz F, Wälde K:

    · Is large-scale rapid CoV-2 testing a substitute for lockdowns?

    · PLoS ONE (2022)

  • · Tung TT, Schmid J, Nghia VX, Cao LC, Linh LTK, Rungsung I, Sy BT, My TN, The NT, Hoan NX, Meyer CG, Wedemeyer H, Kremsner PG, Toan NL, Song LH, Bock CT, Velavan TP:

    · Low Risk of Occult Hepatitis B Infection among Vietnamese Blood Donors

    · Pathogens (2022)

  • · Sulyok M, Walker M:

    · Social mobility and gonorrhoea in Germany during 2020

    · Sex Transm Infect (2022)

  • · Arnold B, Bélard S, Alabi A, Hufnagel M, Berner R, Toepfner N:

    · High Diversity of emm Types and Marked Tetracycline Resistance of Group A Streptococci and Other ß-Hemolytic Streptococci in Gabon, Central Africa

    · Pediatr Infect Dis J (2022)

  • · Xuan Hoan N, Thi Minh Huyen P, Dinh Tung B, Phuong Giang D, Tat Trung N, Tien Sy B, Thi Tuan N, Thi Ngoc Dung D, Reddy Pallerla S, Velavan TP, Hong Bang M, Huu Song L:

    · Association of PD-L1 gene polymorphisms and circulating sPD-L1 levels with HBV infection susceptibility and related liver disease progression

    · Gene (2022)

  • · Shuaib YA, Utpatel C, Kohl TA, Barilar I, Diricks M, Ashraf N, Wieler LH, Kerubo G, Mesfin EA, Diallo AB, Al-Hajoj S, Ndung'u P, Fitzgibbon MM, Vaziri F, Sintchenko V, Martinez E, Viegas SO, Zhou Y, Azmy A, Al-Amry K, Godreuil S, Varma-Basil M, Narang A, Ali S, Beckert P, Dreyer V, Kabwe M, Bates M, Hoelscher M, Rachow A, Gori A, Tekwu EM, Sidze LK, Jean-Paul AA, Beng VP, Ntoumi F, Frank M, Diallo AG, Mboup S, Tessema B, Beyene D, Khan SN, Diel R, Supply P, Maurer FP, Hoffmann H, Niemann S, Merker M:

    · Origin and Global Expansion of Mycobacterium tuberculosis Complex Lineage 3

    ·· Genes (Basel) (2022)

  • · Velavan TP, Meyer CG:

    · Monkeypox 2022 outbreak: An update

    · Trop Med Int Health (2022)

  • · Nsanzimana S, Rawat A, Wilson LA, Forrest JI, Reis G, Ramagopalan S, Muyembe-Tamfum JJ, Ntoumi F, Zumla A, Sow PS, Nachega JB, Binagwaho A, Dybul M, Mills EJ:

    · Toward a New Paradigm of North-South and South-South Partnerships for Pandemic Preparedness: Lessons Learned from COVID-19 and Other Outbreaks

    ·· Am J Trop Med Hyg (2022)

  • · Rosenthal PJ, Björkman A, Dhorda M, Djimde A, Dondorp AM, Gaye O, Guerin PJ, Juma E, Kwiatkowski DP, Merson L, Ntoumi F, Price RN, Raman J, Roos DS, Ter Kuile F, Tinto H, Tomko SS, White NJ, Barnes KI:

    · Cooperation in Countering Artemisinin Resistance in Africa: Learning from COVID-19

    ·· Am J Trop Med Hyg (2022)

  • · Meulah B, Oyibo P, Bengtson M, Agbana T, Lontchi RAL, Adegnika AA, Oyibo W, Hokke CH, Diehl JC, van Lieshout L:

    · Performance Evaluation of the Schistoscope 5.0 for (Semi-)automated Digital Detection and Quantification of Schistosoma haematobium Eggs in Urine: A Field-based Study in Nigeria

    ·· Am J Trop Med Hyg (2022)

  • · Epola Dibamba Ndanga M, Achimi Agbo Abdul JBP, Edoa JR, Chester Mevyann R, Adegbite BR, Mfoumbi A, Mebiame Biyogho C, Beh Mba R, Mahoumbou J, McCall MBB, Grobusch MP, Adegnika AA, Alabi AS:

    · Non-tuberculous mycobacteria isolation from presumptive tuberculosis patients in Lambaréné, Gabon

    · Trop Med Int Health (2022)

  • · Mbassi FE, Mombo-Ngoma G, Ndoumba WN, Yovo EK, Eberhardt KA, Mbassi DE, Adegnika AA, Agnandji ST, Bouyou-Akotet MK, Ramharter M, Zoleko-Manego R:

    · Performance of Field's Stain Compared with Conventional Giemsa Stain for the Rapid Detection of Blood Microfilariae in Gabon

    · Am J Trop Med Hyg (2022)

  • · Boussougou-Sambe ST, Woldearegai TG, Doumba-Ndalembouly AG, Ngossanga B, Mba RB, Edoa JR, Zinsou JF, Honkpehedji YJ, Ngoa UA, Dejon-Agobé JC, Borrmann S, Kremsner PG, Mordmüller B, Adegnika AA:

    · Assessment of malaria transmission intensity and insecticide resistance mechanisms in three rural areas of the Moyen Ogooué Province of Gabon

    · Parasit Vectors (2022)

  • · Mbama Ntabi JD, Lissom A, Djontu JC, Diafouka-Kietela S, Vouvoungui C, Boumpoutou RK, Mayela J, Nguiffo-Nguete D, Nkemngo FN, Ndo C, Akoton R, Agonhossou R, Lenga A, Boussougou-Sambe ST, Djogbénou L, Wondji C, Adegnika AA, Borrmann S, Ntoumi F:

    · Prevalence of non-Plasmodium falciparum species in southern districts of Brazzaville in The Republic of the Congo

    · Parasit Vectors (2022)

  • · Kalkman LC, Hanscheid T, Krishna S, Kremsner PG, Grobusch MP:

    · Antimalarial treatment in infants

    ·· Expert Opin Pharmacother (2022)

  • WorldWide Antimalarial Resistance Network Methodology Study Group:

    · Temporal distribution of Plasmodium falciparum recrudescence following artemisinin-based combination therapy: an individual participant data meta-analysis

    · Malar J (2022)

  • · Nouatin O, Ibáñez J, Fendel R, Ngoa UA, Lorenz FR, Dejon-Agobé JC, Edoa JR, Flügge J, Brückner S, Esen M, Theisen M, Hoffman SL, Moutairou K, Luty AJF, Lell B, Kremsner PG, Adegnika AA, Mordmüller B:

    · Cellular and antibody response in GMZ2-vaccinated Gabonese volunteers in a controlled human malaria infection trial

    · Malar J (2022)

    ·

  • · Massamba JE, Djontu JC, Vouvoungui CJ, Kobawila C, Ntoumi F:

    · Plasmodium falciparum multiplicity of infection and pregnancy outcomes in Congolese women from southern Brazzaville, Republic of Congo.

    · Malar J (2022)

  • · Krishna S, Kremsner PG:

    · Need for optimized dosages in the design of comparative clinical trials of anti-malarial drugs

    · Malar J (2022)

  • · Bassat Q, Maïga-Ascofaré O, May J, Clain J, Mombo-Ngoma G, Groger M, Adegnika AA, Agobé JD, Djimde A, Mischlinger J, Ramharter M, ASAAP and Multimal Consortia:

    · Challenges in the clinical development pathway for triple and multiple drug combinations in the treatment of uncomplicated falciparum malaria

    · Malar J (2022)

  • · Brignoli T, Recker M, Lee WWY, Dong T, Bhamber R, Albur M, Williams P, Dowsey AW, Massey RC:

    · Diagnostic MALDI-TOF MS can differentiate between high and low toxic Staphylococcus aureus bacteraemia isolates as a predictor of patient outcome

    · Microbiology (2022)

  • · Adegbite BR, Kawale P, Kalitsilo L, Jacob ST, Rylance J, Adegnika AA, Grobusch MP:

    · Recognising Sepsis as a Health Priority in Sub-Saharan African Country: Learning Lessons from Engagement with Gabon's Health Policy Stakeholders

    · Healthcare (Basel) 2022)

  • · Kawale P, Kalitsilo L, Mphande J, Romeo Adegbite B, Grobusch MP, Jacob ST, Rylance J, Madise NJ:

    · On prioritising global health's triple crisis of sepsis, COVID-19 and antimicrobial resistance: a mixed-methods study from Malawi

    · BMC Health Serv Res (2022)

  • · Dejon-Agobé JC, Edoa JR, Adegnika AA, Grobusch MP:

    · Schistosomiasis in Gabon from 2000 to 2021 - A review

    · Acta Trop (2022)

  • · Pallerla SR, Hoan NX, Rachakonda S, Meyer CG, Van Tong H, Toan NL, Linh LTK, Giang DP, Kremsner PG, Bang MH, Song LH, Velavan TP:

    · Custom gene expression panel for evaluation of potential molecular markers in hepatocellular carcinoma

    · BMC Med Genomics (2022)

  • · van Kesteren J, van Duinen AJ, Marah F, van Delft D, Spector AL, Cassidy LD, Groen RS, Jabbi SB, Bah S, Medo JA, Kamanda-Bongay A, van Leerdam D, Westendorp J, Mathéron HM, Mönnink GLE, Vas Nunes J, Lindenbergh KC, Hoel SK, Løvdal SM, Østensen MN, Solberg H, Boateng D, Klipstein-Grobusch K, van Herwaarden D, Martens JPJ, Bonjer HJ, Sankoh O, Grobusch MP, Bolkan HA, PRESSCO 2020 study group:

    · PREvalence Study on Surgical COnditions (PRESSCO) 2020: A Population-Based Cross-Sectional Countrywide Survey on Surgical Conditions in Post-Ebola Outbreak Sierra Leone

    · World J Surg (2022)

  • · Agonhossou R, Akoton R, Dossou YA, Avokpaho E, Mbama DNJ, Boussougou-Sambe TS, Francis NN, Ndo C, Ntoumi F, Wondji CS, Adegnika AA, Borrmann S, Issifou S, Djogbénou LS:

    · Surveillance of Plasmodium malariae infection among inhabitants of rural areas in Ouidah-Kpomasse-Tori Bossito health district, Benin

    · Parasitol Res (2022)

  • · Agonhossou R, Akoton R, Lagnika H, Djihinto OY, Sovegnon PM, Saizonou HD, Ntoumi F, Wondji CS, Borrmann S, Adegnika AA, Djogbénou LS:

    · P. falciparum msp1 and msp2 genetic diversity in P. falciparum single and mixed infection with P. malariae among the asymptomatic population in Southern Benin

    · Parasitol Int (2022)

  • · Elenga VA, Lissom A, Vouvoungui C, Tsengue-Tsengue , Ahombo G, Ntoumi F:

    · Human African trypanosomiasis (HAT) in the Republic of Congo: why the Congolese population is reluctant to screening?

    · Pan Afr Med J (2022)

  • · Rothe C, Rosenbusch D, Alberer M, Buehler S, Burchard G, Erkens K, Feldt T, Grobusch MP, Koehler C, Kapaun A, Loebermann M, Meischner K, Metzger W, Mueller A, Nothdurft HD, Ramharter M, Rieke B, Schlaich C, Schoenfeld C, Schulze MH, Siedenburg J, Steiner F, Veit O, Weitzel T, Boecken G

    · Recommendations for antimalarial prophylaxis

    · Flugmedizin Tropenmedizin Reisemedizin (2022)

  • · Rothe C, Rosenbusch D, Alberer M, Buhler S, Burchard G, Feldt T, Grobusch MP, Kapaun A, Koehler C, Kreuzberg C, Kusi E, Loebermann M, Meischner K, Metzger W, Mueller A, Dieter H, Ramharter M, Rieke B, Schlaich C, Schoenfeld C, Schulze MH, Siedenburg J, Steiner F, Veit O, Weitzel T, Boecken G

    · Reiseimpfungen - Hinweise und Empfehlungen: Vaccinations for international travel - clinical practice recommendations

    ·· Flugmedizin Tropenmedizin Reisemedizin (2022)

  • · Koehler C, Fleischer B:

    · Dear members and those interested in the DTG

    ·· Flugmedizin Tropenmedizin Reisemedizin (2022)

  • · Mfoutou Mapanguy CC, Batchi-Bouyou AL, Djontu JC, Pallerla SR, Ngoma CH, Linh LTK, Rachakonda S, Casadei N, Angelov A, Sonnabend M, Vouvoungui JC, Ampa R, Nguimbi E, Peter S, Kremsner PG, Montaldo C, Velavan TP, Ntoumi F:

    · SARS-CoV-2 B.1.214.1, B.1.214.2 and B.1.620 are predominant lineages between December 2020 and July 2021 in the Republic of Congo

    · IJID Reg (2022)

  • · Hoan NX, Pallerla SR, Huy PX, Krämer H, My TN, Tung TT, Hoan PQ, Toan NL, Song LH, Velavan TP:

    · SARS-CoV-2 viral dynamics of the first 1000 sequences from Vietnam and neighbouring ASEAN countries.

    · IJID Reg (2022)

  • · Bock T, Bewarder M, Cetin O, Fadle N, Regitz E, Schwarz EC, Held J, Roth S, Lohse S, Pfuhl T, Wagener R, Smola S, Becker SL, Bohle RM, Trümper L, Siebert R, Hansmann ML, Pfreundschuh M, Drexler HG, Hoth M, Kubuschok B, Roemer K, Preuss KD, Hartmann S, Thurner L:

    · B-cell receptors of EBV-negative Burkitt lymphoma bind modified isoforms of autoantigens

    ·· EJHaem (2022)

  • · Lobaloba Ingoba L, Djontu JC, Mfoutou Mapanguy CC, Mouzinga F, Diafouka Kietela S, Vouvoungui C, Kuisma E, Nguimbi E, Ntoumi F:

    · Seroprevalence of anti-SARS-CoV-2 antibodies in a population living in Bomassa village, Republic of Congo

    · IJID Reg (2022)

  • · Ushijima Y, Abe H, Mbadinga MJVM, Ondo GN, Bikangui R, Agnandji ST, Lell B, Yasuda J:

    · Re-emergence of dengue, chikungunya, and Zika viruses in 2021 after a 10-year gap in Gabon

    ·· IJID Reg (2022)

2021

  • · Kremsner PG, Mann P, Kroidl A, Leroux-Roels I, Schindler C, Gabor JJ, Schunk M, Leroux-Roels G, Bosch JJ, Fendel R, Kreidenweiss A, Velavan TP, Fotin-Mleczek M, Mueller SO, Quintini G, Schönborn-Kellenberger O, Vahrenhorst D, Verstraeten T, Alves de Mesquita M, Walz L, Wolz OO, Oostvogels L, CV-NCOV-001 Study Group:

    Safety and immunogenicity of an mRNA-lipid nanoparticle vaccine candidate against SARS-CoV-2 : A phase 1 randomized clinical trial.

    Wien Klin Wochenschr: 275-285 (2021)

  • · Ramharter M, Agnandji ST, Adegnika AA, Lell B, Mombo-Ngoma G, Grobusch MP, McCall M, Muranaka R, Kreidenweiss A, Velavan TP, Esen M, Schaumburg F, Alabi A, Druml C, Mordmüller B, Köhler C, Kremsner PG:

    Development of sustainable research excellence with a global perspective on infectious diseases: Centre de Recherches Médicales de Lambaréné (CERMEL), Gabon.

    Wien Klin Wochenschr: 500-508 (2021)

  • · Hoan NX, Hoechel M, Tomazatos A, Anh CX, Pallerla SR, Linh LTK, Binh MT, Sy BT, Toan NL, Wedemeyer H, Bock CT, Kremsner PG, Meyer CG, Song LH, Velavan TP:

    Predominance of HBV Genotype B and HDV Genotype 1 in Vietnamese Patients with Chronic Hepatitis.

    Viruses (2021)

  • · Osamudiamen FT, Akanbi OA, Zander S, Oluwayelu DO, Bock CT, Klink:

    Identification of a Putative Novel Genotype of Avian Hepatitis E Virus from Apparently Healthy Chickens in Southwestern Nigeria.

    Viruses (2021)

  • · Manouana GP, Nguema-Moure PA, Mbong Ngwese M, Bock CT, Kremsner PG, Borrmann S, Eibach D, Mordmüller B, Velavan TP, Niendorf S, Adegnika AA:

    Genetic Diversity of Enteric Viruses in Children under Five Years Old in Gabon.

    Viruses (2021)

  • · Adesina OA, Akanbi OA, Opaleye OO, Japhet MO, Wang B, Oluyege AO, Klink P, Bock CT:

    Detection of Q129H Immune Escape Mutation in Apparently Healthy Hepatitis B Virus Carriers in Southwestern Nigeria.

    Viruses (2021)

  • · Opaleye OO, Akanbi OA, Osundare FA, Wang B, Adesina O, Oluremi AS, Sunday ST, Akindele AA, Klink P, Bock CT:

    Prevalence and characteristics of hepatitis B and D virus infections among HIV-positive individuals in Southwestern Nigeria.

    Virol J (2021)

  • · Dassah S, Adu B, Sirima SB, Mordmüller B, Ngoa UA, Atuguba F, Arthur FKN, Mensah BA, Kaddumukasa M, Bang P, Kremsner PG, Mategula D, Flach C, Milligan P, Theisen M:

    Extended follow-up of children in a phase2b trial of the GMZ2 malaria vaccine.

    Vaccine: 4314-4319 (2021)

  • · Ihling CM, Schnitzler P, Heinrich N, Mangu C, Sudi L, Souares A, Gies S, Sié A, Coulibaly B, Ouédraogo AT, Mordmüller B, Held J, Adegnika AA, Fernandes JF, Eckerle I, May J, Hogan B, Eibach D, Tabatabai J:

    Molecular epidemiology of respiratory syncytial virus in children in sub-Saharan Africa.

    Trop Med Int Health: 810-822 (2021)

  • · Veletzky L, Hergeth J, Stelzl DR, Eberhardt K, Manego RZ, Mombo-Ngoma G, Kreuzmair R, Burger GM, McCall MBB, Adegnika AA, Lagler H, Mordmueller B, Budke C, Ramharter M:

    Clinical manifestations and laboratory changes due to loiasis in an endemic cohort.

    Trop Med Int Health: 106-106 (2021)

  • · Honkpéhèdji YJ, Adegbite BR, Zinsou JF, Dejon-Agobé JC, Edoa JR, Zoleko Manego R, McCall M, Mbong Ngwese M, Lotola Mougeni F, Mombo-Ngoma G, Ramharter M, Kremsner PG, Lell B, Yazdanbakhsh M, Esen M, Adegnika AA:

    Association of low birth weight and polyparasitic infection during pregnancy in Lambaréné, Gabon.

    Trop Med Int Health: 973-981 (2021)

  • · Dejon Agobé JC, Kariuki HC, Zinsou JF, Honkpehedji YJ, Grobusch MP, Adegnika AA:

    Pilot Malacology Surveys for the Intermediate Hosts of Schistosomiasis in Rural and Semi-Urban Areas of the Moyen-Ogooué Province, Gabon.

    Trop Med Infect Dis (2021)

  • · Fusco D, Rakotozandrindrainy R, Rakotoarivelo RA, Andrianarivelo MR, Rakotozandrindrainy N, Rasamoelina T, Puradiredja DI, Klein P, Stahlberg K, Dechenaud M, Lorenz E, Jaeger A, Kreidenweiss A, Hoekstra PT, Adegnika AA, Sicuri E, Corstjens PLAM, van Dam GJ, May J, Schwarz NG, freeBILy consortium:

    A cluster randomized controlled trial for assessing POC-CCA test based praziquantel treatment for schistosomiasis control in pregnant women and their young children: study protocol of the freeBILy clinical trial in Madagascar.

    Trials (2021)

  • · Krishna S, Augustin Y, Wang J, Xu C, Staines HM, Platteeuw H, Kamarulzaman A, Sall A, Kremsner P:

    Repurposing Antimalarials to Tackle the COVID-19 Pandemic.

    Trends Parasitol: 8-11 (2021)

  • · Sulyok M, Walker MD:

    Mobility and COVID-19 mortality across Scandinavia: A modeling study.

    Travel Med Infect Dis (2021)

  • · Sulyok M, Ferenci T, Walker M:

    Google Trends Data and COVID-19 in Europe: Correlations and model enhancement are European wide.

    Transbound Emerg Dis: 2610-2615 (2021)

  • · Amaral AFS, Burney PGJ, Patel J, Minelli C, Mejza F, Mannino DM, Seemungal TAR, Mahesh PA, Lo LC, Janson C, Juvekar S, Denguezli M, Harrabi I, Wouters EFM, Cherkaski H, Mortimer K, Jogi R, Bateman ED, Fuertes E, Al Ghobain M, Tan W, Obaseki DO, El Sony A, Studnicka M, Aquart-Stewart A, Koul P, Lawin H, Nafees AA, Awopeju O, Erhabor GE, Gislason T, Welte T, Gulsvik A, Nielsen R, Gnatiuc L, Kocabas A, Marks GB, Sooronbaev T, Mbatchou Ngahane BH, Barbara C, Buist AS, BOLD (Burden of Obstructive Lung Disease) Collaborative Research Group , BOLD (Burden of Obstructive Lung Disease) Collaborative Research Group:

    Chronic airflow obstruction and ambient particulate air pollution.

    Thorax:1236-1241 (2021)

  • · Sulyok M, Walker M:

    Social mobility and gonorrhoea in Germany during 2020.

    Sex Transm Infect (2021)

  • · Figueroa-Miranda G, Chen S, Neis M, Zhou L, Zhang YT, Lo Y, Tanner JA, Kreidenweiss A, Offenhausser A, Mayer D:

    Multi-target electrochemical malaria aptasensor on flexible multielectrode arrays for detection in malaria parasite blood samples.

    Sens Actuators B Chem (2021)

  • · Velavan TP, Kuk S, Linh LTK, Lamsfus Calle C, Lalremruata A, Pallerla SR, Kreidenweiss A, Held J, Esen M, Gabor J, Neurohr EM, Shamsrizi P, Fathi A, Biecker E, Berg CP, Ramharter M, Addo MM, Kreuels B, Kremsner PG:

    Longitudinal monitoring of laboratory markers characterizes hospitalized and ambulatory COVID-19 patients.

    Sci Rep: 1041-1044 (2021)

  • · Hoan NX, Huyen PTM, Binh MT, Trung NT, Giang DP, Linh BT, Dung DTN, Pallerla SR, Kremsner PG, Velavan TP, Bang MH, Song LH:

    Genetic variants of programmed cell death 1 are associated with HBV infection and liver disease progression.

    Sci Rep (2021)

  • · Sandri TL, Inoue J, Geiger J, Griesbaum JM, Heinzel C, Burnet M, Fendel R, Kremsner PG, Held J, Kreidenweiss A:

    Complementary methods for SARS-CoV-2 diagnosis in times of material shortage.

    Sci Rep (2021)

  • · Huy PX, Chung DT, Linh DT, Hang NT, Rachakonda S, Pallerla SR, Linh LTK, Tong Hv, Dung LM, Mao CV, Wedemeyer H, Bock CT, Kremsner PG, Song LH, Sy BT, Toan NL, Velavan TP:

    Low Prevalence of HEV Infection and No Associated Risk of HEV Transmission from Mother to Child among Pregnant Women in Vietnam.

    Pathogens (2021)

  • · Calle CL, Mordmüller B, Singh A:

    Immunosuppression in Malaria: Do Plasmodium falciparum Parasites Hijack the Host?

    Pathogens (2021)

  • · Lidani KCF, Andrade FA, Beltrame MH, Chakravarti I, Tizzot MR, Cavalcanti EO, Sandri TL, Luz PR, Messias-Reason IJ:

    Ficolin-3 in chronic Chagas disease: Low serum levels associated with the risk of cardiac insufficiency.

    Parasite Immunol (2021)

  • · Dejon-Agobé JC, Zinsou JF, Honkpehedji YJ, Edoa JR, Adegbité BR, Beh-Mba R, Kremsner PG, Adegnika AA, Grobusch MP:

    Knowledge, attitudes and practices pertaining to urogenital schistosomiasis in Lambaréné and surrounding areas, Gabon.

    Parasit Vectors (2021)

  • · Osamudiamen FT, Akanbi OA, Oluwayelu DO, Bock CT, Klink:

    Serological evidence of avian HEV antibodies in apparently healthy chickens in southwest Nigeria.

    PLoS ONE (2021)

  • · Trung NT, Lien TT, Sang VV, Hoan NX, Manh ND, Thau NS, Quyen DT, Hien TTT, Hoan PQ, Bang MH, Velavan TP, Song LH:

    Circulating miR-147b as a diagnostic marker for patients with bacterial sepsis and septic shock.

    PLoS ONE (2021)

  • · Adegnika AA, Agnandji ST, Lell B, Kremsner PG, Matsiegui PB, González R, Menendez C, Ramharter M, Mombo-Ngoma G:

    Birth weight, growth, nutritional status and mortality of infants from Lambaréné and Fougamou in Gabon in their first year of life.

    PLoS ONE (2021)

  • · Savage HR, Santos VS, Edwards T, Giorgi E, Krishna S, Planche TD, Staines HM, Fitchett JRA, Kirwan DE, Cubas Atienzar AI, Clark DJ, Adams ER, Cuevas LE:

    Prevalence of neutralising antibodies against SARS-CoV-2 in acute infection and convalescence: A systematic review and meta-analysis.

    PLoS Negl Trop Dis (2021)

  • · Nouatin O, Mengue JB, Dejon-Agobé JC, Fendel R, Ibáñez J, Ngoa UA, Edoa JR, Adégbité BR, Honkpéhédji YJ, Zinsou JF, Hounkpatin AB, Moutairou K, Homoet A, Esen M, Kreidenweiss A, Hoffman SL, Theisen M, Luty AJF, Lell B, Agnandji ST, Mombo-Ngoma G, Ramharter M, Kremsner P, Mordmüller B, Adegnika AA:

    Exploratory analysis of the effect of helminth infection on the immunogenicity and efficacy of the asexual blood-stage malaria vaccine candidate GMZ2.

    PLoS Negl Trop Dis (2021)

  • · Koehne E, Zander N, Rodi M, Held J, Hoffmann W, Zoleko-Manego R, Ramharter M, Mombo-Ngoma G, Kremsner PG, Kreidenweiss A:

    Evidence for in vitro and in vivo activity of the antimalarial pyronaridine against Schistosoma.

    PLoS Negl Trop Dis (2021)

  • · Lim JK, Fernandes JF, Yoon IK, Lee JS, Mba RO, Lee KS, Namkung S, Yang JS, Bae SH, Lim SK, Lell B, Esen M, Loembe MM, Kremsner PG, Alexander N, Agnandji ST:

    Epidemiology of dengue fever in Gabon: Results from a health facility-based fever surveillance in Lambaréné and its surroundings.

    PLoS Negl Trop Dis (2021)

  • · Mischlinger J, Manego RZ, Mombo-Ngoma G, Ekoka Mbassi D, Hackbarth N, Ekoka Mbassi FA, Davi SD, Kreuzmair R, Veletzky L, Hergeth J, Ndoumba WN, Pitzinger P, Groger M, Matsiegui PB, Adegnika AA, Agnandji ST, Lell B, Ramharter M:

    Diagnostic performance of capillary and venous blood samples in the detection of Loa loa and Mansonella perstans microfilaraemia using light microscopy.

    PLoS Negl Trop Dis (2021)

  • · Mouwenda YD, Betouke Ongwe ME, Sonnet F, Stam KA, Labuda LA, De Vries S, Grobusch MP, Zinsou FJ, Honkpehedji YJ, Dejon Agobe JC, Diemert DJ, van Leeuwen R, Bottazzi ME, Hotez PJ, Kremsner PG, Bethony JM, Jochems SP, Adegnika AA, Massinga Loembe M, Yazdanbakhsh M:

    Characterization of T cell responses to co-administered hookworm vaccine candidates Na-GST-1 and Na-APR-1 in healthy adults in Gabon.

    PLoS Negl Trop Dis (2021)

  • · Tona Lutete G, Mombo-Ngoma G, Assi SB, Bigoga JD, Koukouikila-Koussounda F, Ntamabyaliro NY, Ntoumi F, Agnandji ST, Groger M, Shin J, Borghini-Fuhrer I, Arbe-Barnes S, Allen SJ, Kremsner PG, Miller R, Duparc S, Ramharter M, CANTAM study group:

    Pyronaridine-artesunate real-world safety, tolerability, and effectiveness in malaria patients in 5 African countries: A single-arm, open-label, cohort event monitoring study.

    PLoS Med (2021)

  • · Elton L, Haider N, Kock R, Thomason MJ, Tembo J, Arruda LB, Ntoumi F, Zumla A, McHugh TD, And the PANDORA-ID-NET consortium:

    Zoonotic disease preparedness in sub-Saharan African countries.

    One Health Outlook (2021)

  • · Osundare FA, Klink P, Akanbi OA, Wang B, Harms D, Ojurongbe O, Ajayi MA, Babaranti EO, Bock CT, Opaleye OO:

    Hepatitis E virus infection in high-risk populations in Osun State, Nigeria.

    One Health (2021)

  • · Becker M, Dulovic A, Junker D, Ruetalo N, Kaiser PD, Pinilla YT, Heinzel C, Haering J, Traenkle B, Wagner TR, Layer M, Mehrlaender M, Mirakaj V, Held J, Planatscher H, Schenke-Layland K, Krause G, Strengert M, Bakchoul T, Althaus K, Fendel R, Kreidenweiss A, Koeppen M, Rothbauer U, Schindler M, Schneiderhan-Marra N:

    Immune response to SARS-CoV-2 variants of concern in vaccinated individuals.

    Nat Commun (2021)

  • · Sulyok Z, Fendel R, Eder B, Lorenz FR, Kc N, Karnahl M, Lalremruata A, Nguyen TT, Held J, Adjadi FAC, Klockenbring T, Flügge J, Woldearegai TG, Lamsfus Calle C, Ibáñez J, Rodi M, Egger-Adam D, Kreidenweiss A, Köhler C, Esen M, Sulyok M, Manoj A, Richie TL, Sim BKL, Hoffman SL, Mordmüller B, Kremsner PG:

    Heterologous protection against malaria by a simple chemoattenuated PfSPZ vaccine regimen in a randomized trial.

    Nat Commun (2021)

  • · Fougeroux C, Goksøyr L, Idorn M, Soroka V, Myeni SK, Dagil R, Janitzek CM, Søgaard M, Aves KL, Horsted EW, Erdoğan SM, Gustavsson T, Dorosz J, Clemmensen S, Fredsgaard L, Thrane S, Vidal-Calvo EE, Khalifé P, Hulen TM, Choudhary S, Theisen M, Singh SK, Garcia-Senosiain A, Van Oosten L, Pijlman G, Hierzberger B, Domeyer T, Nalewajek BW, Strøbæk A, Skrzypczak M, Andersson LF, Buus S, Buus AS, Christensen JP, Dalebout TJ, Iversen K, Harritshøj LH, Mordmüller B, Ullum H, Reinert LS, de Jongh WA, Kikkert M, Paludan SR, Theander TG, Nielsen MA, Salanti A, Sander AF:

    Capsid-like particles decorated with the SARS-CoV-2 receptor-binding domain elicit strong virus neutralization activity.

    Nat Commun (2021)

  • · Larsen MD, Lopez-Perez M, Dickson EK, Ampomah P, Tuikue Ndam N, Nouta J, Koeleman CAM, Ederveen ALH, Mordmüller B, Salanti A, Nielsen MA, Massougbodji A, van der Schoot CE, Ofori MF, Wuhrer M, Hviid L, Vidarsson G:

    · Afucosylated Plasmodium falciparum-specific IgG is induced by infection but not by subunit vaccination.

    Nat Commun (2021)

  • · Pessanha de Carvalho L, Kreidenweiss A, Held J:

    Drug Repurposing: A Review of Old and New Antibiotics for the Treatment of Malaria: Identifying Antibiotics with a Fast Onset of Antiplasmodial Action.

    Molecules (2021)

  • · Coscolla M, Gagneux S, Menardo F, Loiseau C, Ruiz-Rodriguez P, Borrell S, Otchere ID, Asante-Poku A, Asare P, Sánchez-Busó L, Gehre F, Sanoussi CN, Antonio M, Affolabi D, Fyfe J, Beckert P, Niemann S, Alabi AS, Grobusch MP, Kobbe R, Parkhill J, Beisel C, Fenner L, Böttger EC, Meehan CJ, Harris SR, de Jong BC, Yeboah-Manu D, Brites D:

    Phylogenomics of Mycobacterium africanum reveals a new lineage and a complex evolutionary history.

    Microb Genom (2021)

  • · Tichkule S, Jex AR, van Oosterhout C, Sannella AR, Krumkamp R, Aldrich C, Maiga-Ascofare O, Dekker D, Lamshöft M, Mbwana J, Rakotozandrindrainy N, Borrmann S, Thye T, Schuldt K, Winter D, Kremsner PG, Oppong K, Manouana P, Mbong M, Gesase S, Minja DTR, Mueller I, Bahlo M, Nader J, May J, Rakotozandrindrain R, Adegnika AA, Lusingu JPA, Amuasi J, Eibach D, Caccio SM:

    Comparative genomics revealed adaptive admixture in Cryptosporidium hominis in Africa.

    Microb Genom (2021)

  • · Walker MD, Sulyok M:

    The Relationship between Mobility and COVID-19 in Germany: Modeling Case Occurrence using Apple's Mobility Trends Data.

    Methods Inf Med: 179-182 (2021)

  • Seidel-Greven M, Addai-Mensah O, Spiegel H, Chiegoua Dipah GN, Schmitz S, Breuer G, Frempong M, Reimann A, Klockenbring T, Fischer R, Barth S, Fendel R:

    Isolation and light chain shuffling of a Plasmodium falciparum AMA1-specific human monoclonal antibody with growth inhibitory activity.

    Malar J (2021)

  • ·Ndayisaba G, Yeka A, Asante KP, Grobusch MP, Karita E, Mugerwa H, Asiimwe S, Oduro A, Fofana B, Doumbia S, Jain JP, Barsainya S, Kullak-Ublick GA, Su G, Schmitt EK, Csermak K, Gandhi P, Hughes D:

    Hepatic safety and tolerability of cipargamin (KAE609), in adult patients with Plasmodium falciparum malaria: a randomized, phase II, controlled, dose-escalation trial in sub-Saharan Africa.

    Malar J (2021)

  • Ikegbunam M, Ojo JA, Kokou K, Morikwe U, Nworu C, Uba C, Esimone C, Velavan TP, Ojurongbe O:

    Absence of Plasmodium falciparum artemisinin resistance gene mutations eleven years after the adoption of artemisinin-based combination therapy in Nigeria.

    Malar J (2021)

  • · Adoke Y, Zoleko-Manego R, Ouoba S, Tiono AB, Kaguthi G, Bonzela JE, Duong TT, Nahum A, Bouyou-Akotet M, Ogutu B, Ouedraogo A, Macintyre F, Jessel A, Laurijssens B, Cherkaoui-Rbati MH, Cantalloube C, Marrast AC, Bejuit R, White D, Wells TNC, Wartha F, Leroy D, Kibuuka A, Mombo-Ngoma G, Ouattara D, Mugenya I, Phuc BQ, Bohissou F, Mawili-Mboumba DP, Olewe F, Soulama I, Tinto H, FALCI Study Group:

    A randomized, double-blind, phase 2b study to investigate the efficacy, safety, tolerability and pharmacokinetics of a single-dose regimen of ferroquine with artefenomel in adults and children with uncomplicated Plasmodium falciparum malaria.

    Malar J (2021)

  • Velavan TP, Pallerla SR, Johne R, Todt D, Steinmann E, Schemmerer M, Wenzel JJ, Hofmann J, Shih JWK, Wedemeyer H, Bock CT:

    Hepatitis E: An update on One Health and clinical medicine.

    Liver Int: 1462-1473 (2021)

  • Song LH, Hoan NX, Bang MH, Kremsner PG, Velavan TP:

    Viral and serological testing of SARS-CoV-2 among health care workers and patients in Vietnam.

    Lancet Reg Health West Pac (2021)

  • · Zoa-Assoumou S, Ndeboko B, Manouana GP, Houechenou RMA, Bikangui R, Mveang-Nzoghe A, Ondo GN, Mbongo-Kama E, Lell B, Abe H, Ushijima Y, Antchouey AM, Yasuda J, Adegnika AA, Siawaya JFD:

    SARS-CoV-2 emerging variants in Africa: view from Gabon.

    Lancet Microbe: E349-E349 (2021).

  • Pearson MS, Tedla BA, Mekonnen GG, Proietti C, Becker L, Nakajima R, Jasinskas A, Doolan DL, Amoah AS, Knopp S, Rollinson D, Ali SM, Kabole F, Hokke CH, Adegnika AA, Field MA, van Dam G, Corstjens PLAM, Mduluza T, Mutapi F, Oeuvray C, Greco B, Chaiyadet S, Laha T, Cai P, McManus DP, Bottazzi ME, Felgner PL, Sotillo J, Loukas A:

    Immunomics-guided discovery of serum and urine antibodies for diagnosing urogenital schistosomiasis: a biomarker identification study.

    Lancet Microbe e:617-e626 (2021)

  • Adegnika AA, de Vries SG, Zinsou FJ, Honkepehedji YJ, Dejon Agobé JC, Vodonou KG, Bikangui R, Bouyoukou Hounkpatin A, Bache EB, Massinga Loembe M, van Leeuwen R, Molemans M, Kremsner PG, Yazdanbakhsh M, Hotez PJ, Bottazzi ME, Li G, Bethony JM, Diemert DJ, Grobusch MP, HookVac Consortium:

    Safety and immunogenicity of co-administered hookworm vaccine candidates Na-GST-1 and Na-APR-1 in Gabonese adults: a randomised, controlled, double-blind, phase 1 dose-escalation trial.

    Lancet Infect Dis:275-285 (2021)

  • Ntoumi F, Velavan TP:

    COVID-19 in Africa: between hope and reality.

    Lancet Infect Dis (2021)

  • Ackerman H, Olola CHO, Krishna S, Roberts DJ, Kremsner PG, Newton CR, Taylor T, Valim C, Casals-Pascual C:

    Time-to-death is a potential confounder in observational studies of blood transfusion in severe malaria - Authors' reply.

    Lancet Haematol e:12-e13 (2021)

  • Nachega JB, Sam-Agudu NA, Masekela R, van der Zalm MM, Nsanzimana S, Condo J, Ntoumi F, Rabie H, Kruger M, Wiysonge CS, Ditekemena JD, Chirimwami RB, Ntakwinja M, Mukwege DM, Noormahomed E, Paleker M, Mahomed H, Tamfum JM, Zumla A, Suleman F:

    Addressing challenges to rolling out COVID-19 vaccines in African countries.

    Lancet Glob Health: e746-e748 (2021)

  • IJsselmuiden C, Ntoumi F, Lavery JV, Montoya J, Karim SA, Kaiser K:

    Should global financing be the main priority for pandemic preparedness?

    Lancet 388-388 (2021)

  • Pinilla YT, Friessinger E, Griesbaum JM, Berner L, Heinzel C, Elsner K, Fendel R, Held J, Kreidenweiss A:

    Prevalence of SARS-CoV-2 Infection in Children by Antibody Detection in Saliva: Protocol for a Prospective Longitudinal Study (Coro-Buddy).

    JMIR Res Protoc (2021)

  • ·Koehne E, Kreidenweiss A, Adegbite BR, Manego RZ, McCall MBB, Mombo-Ngoma G, Adegnika AA, Agnandji ST, Mordmüller B, Held J:

    In vitro activity of eravacycline, a novel synthetic halogenated tetracycline, against the malaria parasite Plasmodium falciparum.

    J. Glob. Antimicrob. Resist.: 93-97 (2021)

  • Boukoumba FM, Lekana-Douki JB, Matsiegui PB, Moukodoum DN, Adegnika AA, Oyegue-Liabagui SL:

    High prevalence of genotypes associated with sulfadoxine/pyrimethamine resistance in the rural area of Fougamou, Gabon.

    J. Glob. Antimicrob. Resist.: 181-186 (2021)

  • Pallerla SR, Schembecker S, Meyer CG, Linh LTK, Johne R, Wedemeyer H, Bock CT, Kremsner PG, Velavan TP:

    Hepatitis E virus genome detection in commercial pork livers and pork meat products in Germany.

    J Viral Hepat 196-204 (2021)

  • ·Abe H, Ushijima Y, Bikangui R, Zoa-Assoumou S, Ondo GN, Manouana GP, More A, Skarwan E, Yali-Assy-Oyamli Y, Ndeboko B, Myrabelle Avome Houechenou R, Djoba Siawaya JF, Lell B, Adegnika AA, Yasuda J:

    Unrecognized introduction of SARS-CoV-2 variants of concern to Central Africa: Import and local transmission of B.1.1.7 in Gabon in the very early stage of the variant spread to the African continent.

    J Med Virol 6054-6058 (2021)

  • Hofmann P, Alabi A, Manouana GP, Onwugamba FC, Hasenauer A, Agbanrin MD, Gouleu CSM, Bingoulou G, Borrmann S, McCall MBB, Adegnika AA:

    High ESBL-E colonization rate among children in Gabon: a follow-up study.

    J Med Microbiol (2021)

  • · Knaab TC, Held J, Burckhardt BB, Rubiano K, Okombo J, Yeo T, Mok S, Uhlemann AC, Lungerich B, Fischli C, Pessanha de Carvalho L, Mordmüller B, Wittlin S, Fidock DA, Kurz T:

    3-Hydroxy-propanamidines, a New Class of Orally Active Antimalarials Targeting Plasmodium falciparum.

    J Med Chem 3035-3047 (2021)

  • Sandri TL, Kreidenweiss A, Cavallo S, Weber D, Juhas S, Rodi M, Woldearegai TG, Gmeiner M, Veletzky L, Ramharter M, Tazemda-Kuitsouc GB, Matsiegui PB, Mordmüller B, Held J:

    Molecular Epidemiology of Mansonella Species in Gabon.

    J Infect Dis 287-296 (2021)

  • Pinilla YT, Boussougou-Sambe ST, Gräßle S, Ngossanga B, Doumba-Ndalembouly AG, Weierich A, Bingoulou G, Malinga EG, Nguiffo D, Ntoumi F, Djogbénou L, Issifou S, Wondji CS, Adegnika AA, Borrmann S, COMAL Study Group:

    Experimental Transmission of Plasmodium malariae to Anopheles gambiae.

    J Infect Dis: 522-526 (2021)

  • · Habib M, Adegnika AA, Honkpehedji J, Klug SJ, Lobmaier S, Vogg K, Bustinduy AL, Ullrich A, Reinhard-Rupp J, Esen M, Prazeres da Costa C:

    The challenges for women's health in sub-Saharan Africa: Lessons learned from an integrative multistakeholder workshop in Gabon.

    J Glob Health (2021)

  • Nguyen MLT, Bui KC, Scholta T, Xing J, Bhuria V, Sipos B, Wilkens L, Nguyen Linh T, Velavan TP, Bozko P, Plentz RR:

    Targeting interleukin 6 signaling by monoclonal antibody siltuximab on cholangiocarcinoma.

    J Gastroenterol Hepatol: 1334-1345 (2021)

  • Schultheiss HP, Baumeier C, Aleshcheva G, Bock CT, Escher F:

    Viral Myocarditis-From Pathophysiology to Treatment.

    J Clin Med (2021)

  • Schultheiss HP, Bock T, Pietsch H, Aleshcheva G, Baumeier C, Fruhwald F, Escher F:

    Nucleoside Analogue Reverse Transcriptase Inhibitors Improve Clinical Outcome in Transcriptional Active Human Parvovirus B19-Positive Patients.

    J Clin Med (2021)

  • Kremsner G:

    Becoming an inclusive teacher: reducing gaps in theory and practice through inclusive research.

    Int. J. Incl. Educ. (2021)

  • ·Velavan TP, Meyer CG:

    Reply to: Asymptomatic infection by SARS 2 coronavirus: invisible but invincible.

    Int J Infect Dis 85-86 (2021)

  • · Pallerla SR, Elion Assiana DO, Linh LTK, Cho FN, Meyer CG, Fagbemi KA, Adegnika AA, Beng VP, Achidi EA, Kahunu GM, Bates M, Grobusch MP, Kremsner PG, Ntoumi F, Velavan TP:

    Pharmacogenetic considerations in the treatment of co-infections with HIV/AIDS, tuberculosis and malaria in Congolese populations of Central Africa.

    Int J Infect Dis 207-213 (2021)

  • Nachega JB, Kapata N, Sam-Agudu NA, Decloedt EH, Katoto PDMC, Nagu T, Mwaba P, Yeboah-Manu D, Chanda-Kapata P, Ntoumi F, Geng EH, Zumla A:

    Minimizing the impact of the triple burden of COVID-19, tuberculosis and HIV on health services in sub-Saharan Africa.

    Int J Infect Dis: S16-S21 (2021)

  • Ushijima Y, Abe H, Ozeki T, Ondo GN, Mbadinga MJVM, Bikangui R, Nze-Nkogue C, Akomo-Okoue EF, Ella GWE, Koumba LBM, Nso BCBB, Mintsa-Nguema R, Makouloutou-Nzassi P, Makanga BK, Nguelet FLM, Zadeh VR, Urata S, Mbouna AVN, Massinga-Loembe M, Agnandji ST, Lell B, Yasuda J:

    Identification of potential novel hosts and the risk of infection with lymphocytic choriomeningitis virus in humans in Gabon, Central Africa.

    Int J Infect Dis: 452-459 (2021)

  • Velavan TP, Pallerla SR, Kremsner PG:

    · How to (ab)use a COVID-19 antigen rapid test with soft drinks?

    Int J Infect Dis: 28-30 (2021)

  • Mfoutou Mapanguy CC, Adedoja A, Kecka LGV, Vouvoungui JC, Nguimbi E, Velavan TP, Ntoumi F:

    High prevalence of antibiotic-resistant Escherichia coli in Congolese students.

    Int J Infect Dis: 119-123 (2021)

  • Batchi-Bouyou AL, Lobaloba L, Ndounga M, Vouvoungui JC, Mfoutou CM, Boumpoutou KR, Ntoumi F.:

    High SARS-CoV-2 IgG/IGM seroprevalence in asymptomatic Congolese in Brazzaville, the Republic of Congo.

    Int J Infect Dis: 3-7 (2021)

  • Chakaya J, Khan M, Ntoumi F, Aklillu E, Fatima R, Mwaba P, Kapata N, Mfinanga S, Hasnain SE, Katoto PDMC, Bulabula ANH, Sam-Agudu NA, Nachega JB, Tiberi S, McHugh TD, Abubakar I, Zumla A:

    Global Tuberculosis Report 2020 - Reflections on the Global TB burden, treatment and prevention efforts.

    Int J Infect Dis: S7-S12 (2021)

  • Ntoumi F, Mfoutou Mapanguy CC, Tomazatos A, Pallerla SR, Linh LTK, Casadei N, Angelov A, Sonnabend M, Peter S, Kremsner PG, Velavan TP:

    Genomic surveillance of SARS-CoV-2 in the Republic of Congo.

    Int J Infect Dis 735-738 (2021)

  • Grobusch MP, Hanscheid T:

    Dracunculiasis X in Vietnam: Emerging public health threat or exotic gem?

    Int J Infect Dis: 416-417 (2021)

  • Lobaloba Ingoba L, Adedoja A, Peko SM, Vairo F, Haider N, Kock R, Ippolito G, Zumla A, Nguimbi E, Pallerla SR, Velavan TP, Ntoumi F:

    Diagnosis of Chikungunya Virus in Febrile Patients from a Malaria Holoendemic Area.

    Int J Infect Dis: 247-252 (2021)

  • Velavan TP, Meyer CG:

    COVID-19: A PCR-defined pandemic.

    Int J Infect Dis 278-279 (2021)

  • Velavan TP, Meyer CG, Esen M, Kremsner PG, Ntoumi F, PANDORA-ID-NET and CANTAM consortium:

    COVID-19 and syndemic challenges in 'Battling the Big Three': HIV, TB and malaria.

    Int J Infect Dis: 29-32 (2021)

  • Gabor JJ, Kreidenweiss A, Weber S, Salama M, Sulyok M, Sulyok Z, Koehne E, Esen M, Kreuels B, Shamsrizi P, Biecker E, Mordmüller B, Berg CP, Fusco S, Köhler C, Kubicka S, Leitlein J, Addo M, Ramharter M, Schwab M, Bissinger AL, Velavan TP, Krishna S, Kremsner PG:

    A call to caution when hydroxychloroquine is given to elderly patients with COVID-19

    Int J Infect Dis: 265-268 (2021)

  • Antunes Andrade F, Goeldner Eibofner I, Pieczarka C, van Tong H, Sena L, Skare T, Ramos da Rosa Utiyama S, Jose de Messias-Reason I, P Velavan T:

    Impact of VSIG4 gene polymorphisms on susceptibility and functional status of rheumatoid arthritis.

    Int J Immunogenet 260-265 (2021)

  • Dejon-Agobé JC, Adegnika AA, Grobusch MP:

    Haematological changes in Schistosoma haematobium infections in school children in Gabon.

    Infection 645-651 (2021)

  • Krämer B, Knoll R, Bonaguro L, ToVinh M, Raabe J, Astaburuaga-García R, Schulte-Schrepping J, Kaiser KM, Rieke GJ, Bischoff J, Monin MB, Hoffmeister C, Schlabe S, De Domenico E, Reusch N, Händler K, Reynolds G, Blüthgen N, Hack G, Finnemann C, Nischalke HD, Strassburg CP, Stephenson E, Su Y, Gardner L, Yuan D, Chen D, Goldman J, Rosenstiel P, Schmidt SV, Latz E, Hrusovsky K, Ball AJ, Johnson JM, Koenig PA, Schmidt FI, Haniffa M, Heath JR, Kümmerer BM, Keitel V, Jensen B, Stubbemann P, Kurth F, Sander LE, Sawitzki B, Deutsche COVID-19 OMICS Initiative (DeCOI) , Aschenbrenner AC, Schultze JL, Nattermann J:

    Early IFN-α signatures and persistent dysfunction are distinguishing features of NK cells in severe COVID-19.

    Immunity: 2650-2669.e14 (2021)

  • Mveang Nzoghe A, Essone PN, Leboueny M, Maloupazoa Siawaya AC, Bongho EC, Mvoundza Ndjindji O, Avome Houechenou RM, Agnandji ST, Djoba Siawaya JF:

    Evidence and implications of pre-existing humoral cross-reactive immunity to SARS-CoV-2.

    Immun Inflamm Dis 128-133 (2021)

  • Singh Y, Trautwein C, Fendel R, Krickeberg N, Berezhnoy G, Bissinger R, Ossowski S, Salker MS, Casadei N, Riess O, Deutsche COVID-19 OMICS Initiative (DeCOI):

    SARS-CoV-2 infection paralyzes cytotoxic and metabolic functions of the immune cells.

    Heliyon (2021)

  • Nann D, Walker M, Frauenfeld L, Ferenci T, Sulyok M:

    Forecasting the future number of pertussis cases using data from Google Trends.

    Heliyon (2021)

  • Müller SJ, Schurz H, Tromp G, van der Spuy GD, Hoal EG, van Helden PD, Owusu-Dabo E, Meyer CG, Muntau B, Thye T, Niemann S, Warren RM, Streicher E, Möller M, Kinnear C:

    A multi-phenotype genome-wide association study of clades causing tuberculosis in a Ghanaian- and South African cohort.

    Genomics: 1802-1815 (2021)

  • Pinilla YT, Heinzel C, Caminada LF, Consolaro D, Esen M, Kremsner PG, Held J, Kreidenweiss A, Fendel R:

    SARS-CoV-2 Antibodies Are Persisting in Saliva for More Than 15 Months After Infection and Become Strongly Boosted After Vaccination.

    Front Immunol (2021)

  • Heinzel C, Pinilla YT, Elsner K, Friessinger E, Mordmüller B, Kremsner PG, Held J, Fendel R, Kreidenweiss A:

    Non-Invasive Antibody Assessment in Saliva to Determine SARS-CoV-2 Exposure in Young Children.

    Front Immunol (2021)

  • Schöllhorn A, Schuhmacher J, Besedovsky L, Fendel R, Jensen ATR, Stevanović S, Lange T, Rammensee HG, Born J, Gouttefangeas C, Dimitrov S:

    Integrin Activation Enables Sensitive Detection of Functional CD4+ and CD8+ T Cells: Application to Characterize SARS-CoV-2 Immunity.

    Front Immunol (2021)

  • Boldt ABW, Oliveira-Toré CF, Kretzschmar GC, Weinschutz Mendes H, Stinghen ST, Andrade FA, Bumiller-Bini V, Gonçalves LB, Braga ACM, Stahlke EVRS, Velavan TP, Thiel S, de Messias-Reason IJT:

    Hepatitis B Virus Infection Among Leprosy Patients: A Case for Polymorphisms Compromising Activation of the Lectin Pathway and Complement Receptors.

    Front Immunol (2021)

  • Lamsfus Calle C, Fendel R, Singh A, Richie TL, Hoffman SL, Kremsner PG, Mordmüller B:

    Expansion of Functional Myeloid-Derived Suppressor Cells in Controlled Human Malaria Infection.

    Front Immunol (2021)

  • Rothe C, Rosenbusch D, Alberer M, Buhler S, Burchard G, Erkens K, Feldt T, Grobusch MP, Kohler C, Kapaun A, Lobermann M, Meischner K, Metzger W, Muller A, Dieter Nothdurft HD, Ramharter M, Rieke B, Schlaich C, Schonfeld C, Schulze MH, Siedenburg J, Steiner F, Veit O, Weitzel T, Boecken G:

    Travel Vaccinations - Tips and Recommendations

    Flugmedizin Tropenmedizin Reisemedizin: 47-80 (2021)

  • Rothe C, Rosenbusch D, Alberer M, Buehler S, Burchard G, Erkens K, Feldt T, Grobusch MP, Koehler C, Kapaun A, Loebermann M, Meischner K, Metzger W, Mueller A, Nothdurft HD, Ramharter M, Rieke B, Schlaich C, Schoenfeld C, Schulze MH, Siedenburg J, Steiner F, Veit O, Weitzel T, Boecken G:

    Recommendations for antimalarial prophylaxis

    Flugmedizin Tropenmedizin Reisemedizin: 162-198 (2021)

  • Stanisic DI, McCall MBB:

    Correlates of malaria vaccine efficacy.

    Expert Rev Vaccines 143-161 (2021)

  • Koehne E, Adegnika AA, Held J, Kreidenweiss A:

    Pharmacotherapy for artemisinin-resistant malaria.

    Expert Opin Pharmacother 2483-2493 (2021)

  • de Carvalho LP, Kreidenweiss A, Held J:

    The preclinical discovery and development of rectal artesunate for the treatment of malaria in young children: a review of the evidence.

    Expert Opin Drug Discov 13-22 (2021)

  • Mackwitz MKW, Hesping E, Eribez K, Schöler A, Antonova-Koch Y, Held J, Winzeler EA, Andrews KT, Hansen FK:

    Investigation of the in vitro and in vivo efficacy of peptoid-based HDAC inhibitors with dual-stage antiplasmodial activity.

    Eur J Med Chem (2021)

  • Marinović M, Poje G, Perković I, Fontinha D, Prudêncio M, Held J, Pessanha de Carvalho L, Tandarić T, Vianello R, Rajić Z:

    Further investigation of harmicines as novel antiplasmodial agents: Synthesis, structure-activity relationship and insight into the mechanism of action.

    Eur J Med Chem (2021)

  • Wichers JS, Tonkin-Hill G, Thye T, Krumkamp R, Kreuels B, Strauss J, von Thien H, Scholz JA, Smedegaard Hansson H, Weisel Jensen R, Turner L, Lorenz FR, Schöllhorn A, Bruchhaus I, Tannich E, Fendel R, Otto TD, Lavstsen T, Gilberger TW, Duffy MF, Bachmann A:

    Common virulence gene expression in adult first-time infected malaria patients and severe cases.

    Elife (2021)

  • Adegbite BR, Edoa JR, Ndzebe Ndoumba WF, Dimessa Mbadinga LB, Mombo-Ngoma G, Jacob ST, Rylance J, Hänscheid T, Adegnika AA, Grobusch MP:

    A comparison of different scores for diagnosis and mortality prediction of adults with sepsis in Low-and-Middle-Income Countries: a systematic review and meta-analysis.

    EClinicalMedicine (2021)

  • Manouana GP, Niendorf S, Tomazatos A, Mbong Ngwese M, Nzamba Maloum M, Nguema Moure PA, Bingoulou Matsougou G, Ategbo S, Rossatanga EG, Bock CT, Borrmann S, Mordmüller B, Eibach D, Kremsner PG, Velavan TP, Adegnika AA:

    Molecular surveillance and genetic divergence of rotavirus A antigenic epitopes in Gabonese children with acute gastroenteritis.

    EBioMedicine (2021)

  • Velavan TP, Pallerla SR, Rüter J, Augustin Y, Kremsner PG, Krishna S, Meyer CG:

    Host genetic factors determining COVID-19 susceptibility and severity.

    EBioMedicine (2021)

  • Bell GJ, Agnandji ST, Asante KP, Ghansah A, Kamthunzi P, Emch M, Bailey JA:

    Impacts of Ecology, Parasite Antigenic Variation, and Human Genetics on RTS, S/AS01e Malaria Vaccine Efficacy.

    Curr. Epidemiol. Rep. 2021

  • Levine MM, Abdullah S, Arabi YM, Darko DM, Durbin AP, Estrada V, Jamrozik E, Kremsner PG, Lagos R, Pitisuttithum P, Plotkin SA, Sauerwein R, Shi SL, Sommerfelt H, Subbarao K, Treanor JJ, Vrati S, King D, Balasingam S, Weller C, Aguilar AO, Cassetti MC, Krause PR, Restrepo AMH:

    Viewpoint of a WHO Advisory Group Tasked to Consider Establishing a Closely-monitored Challenge Model of Coronavirus Disease 2019 (COVID-19) in Healthy Volunteers.

    Clin Infect Dis 2035-2041 (2021)

  • Krumkamp R, Aldrich C, Maiga-Ascofare O, Mbwana J, Rakotozandrindrainy N, Borrmann S, Caccio SM, Rakotozandrindrainy R, Adegnika AA, Lusingu JPA, Amuasi J, May J, Eibach D, CRYPTO study group:

    Transmission of Cryptosporidium Species Among Human and Animal Local Contact Networks in Sub-Saharan Africa: A Multicountry Study.

    Clin Infect Dis 1358-1366 (2021)

  • Boutry C, Hastie A, Diez-Domingo J, Tinoco JC, Yu CJ, Andrews C, Beytout J, Caso C, Cheng HS, Cheong HJ, Choo EJ, Curiac D, Di Paolo E, Dionne M, Eckermann T, Esen M, Ferguson M, Ghesquiere W, Hwang SJ, Avelino-Silva TJ, Kosina P, Liu CS, Markkula J, Moeckesch B, Murta de Oliveira C, Park DW, Pauksens K, Pirrotta P, Plassmann G, Pretswell C, Rombo L, Salaun B, Berglund JS, Schenkenberger I, Schwarz T, Shi M, Ukkonen B, Zahaf T, Zerbini C, Schuind A, Cunningham AL, Zoster-049 Study Group:

    The Adjuvanted Recombinant Zoster Vaccine Confers Long-term Protection Against Herpes Zoster: Interim Results of an Extension Study of the Pivotal Phase III Clinical Trials (ZOE-50 and ZOE-70).

    Clin Infect Dis (2021)

  • Marks F, Liu J, Soura AB, Gasmelseed N, Operario D, Grundy B, Wieser J, Gratz J, Meyer CG, Im J, Lim JK, von Kalckreuth V, Cruz Espinoza LM, Konings F, Jeon HJ, Rakotozandrindrainy R, Zhang J, Panzner U, Houpt E:

    Pathogens That Cause Acute Febrile Illness Among Children and Adolescents in Burkina Faso, Madagascar, and Sudan.

    Clin Infect Dis 1338-1345 (2021)

  • Schmitt EK, Ndayisaba G, Yeka A, Asante KP, Grobusch MP, Karita E, Mugerwa H, Asiimwe S, Oduro A, Fofana B, Doumbia S, Su G, Csermak Renner K, Venishetty VK, Sayyed S, Straimer J, Demin I, Barsainya S, Boulton C, Gandhi P:

    Efficacy of cipargamin (KAE609) in a randomized, Phase II dose-escalation study in adults in sub-Saharan Africa with uncomplicated Plasmodium falciparum malaria.

    Clin Infect Dis (2021)

  • Petersen E, Grobusch MP:

    Accurate Malaria Diagnosis: Not Only Essential for Malaria Case Management, But Prerequisite for Managing Febrile Disease in the Tropics.

    Clin Infect Dis: e1168-e1169 (2021)

  • Boutin S, Hildebrand D, Boulant S, Kreuter M, Rüter J, Pallerla SR, Velavan TP, Nurjadi D:

    Host factors facilitating SARS-CoV-2 virus infection and replication in the lungs.

    Cell Mol Life Sci: 5953-5976 (2021)

  • Danko D, Bezdan D, Afshin EE, Ahsanuddin S, Bhattacharya C, Butler DJ, Chng KR, Donnellan D, Hecht J, Jackson K, Kuchin K, Karasikov M, Lyons A, Mak L, Meleshko D, Mustafa H, Mutai B, Neches RY, Ng A, Nikolayeva O, Nikolayeva T, Png E, Ryon KA, Sanchez JL, Shaaban H, Sierra MA, Thomas D, Young B, Abudayyeh OO, Alicea J, Bhattacharyya M, Blekhman R, Castro-Nallar E, Cañas AM, Chatziefthimiou AD, Crawford RW, De Filippis F, Deng Y, Desnues C, Dias-Neto E, Dybwad M, Elhaik E, Ercolini D, Frolova A, Gankin D, Gootenberg JS, Graf AB, Green DC, Hajirasouliha I, Hastings JJA, Hernandez M, Iraola G, Jang S, Kahles A, Kelly FJ, Knights K, Kyrpides NC, Łabaj PP, Lee PKH, Leung MHY, Ljungdahl PO, Mason-Buck G, McGrath K, Meydan C, Mongodin EF, Moraes MO, Nagarajan N, Nieto-Caballero M, Noushmehr H, Oliveira M, Ossowski S, Osuolale OO, Özcan O, Paez-Espino D, Rascovan N, Richard H, Rätsch G, Schriml LM, Semmler T, Sezerman OU, Shi L, Shi T, Siam R, Song LH, Suzuki H, Court DS, Tighe SW, Tong X, Udekwu KI, Ugalde JA, Valentine B, Vassilev DI, Vayndorf EM, Velavan TP, Wu J, Zambrano MM, Zhu J, Zhu S, Mason CE, International MetaSUB Consortium:

    A global metagenomic map of urban microbiomes and antimicrobial resistance.

    Cell: 3376-3393.e17 (2021)

  • Schultheiss HP, Baumeier C, Pietsch H, Bock CT, Poller W, Escher F:

    Cardiovascular consequences of viral infections: from COVID to other viral diseases.

    Cardiovasc Res: 2610-2623 (2021)

  • Baker EH, Patel K, Ball J, Edwards S, Harrison TS, Kaul A, Koh M, Krishna S, Leaver S, Kumar V, Forton DM:

    Insights from compassionate use of tocilizumab for COVID-19 to inform appropriate design of randomised controlled trials.

    Br J Clin Pharmacol: 1584-1586 (2021)

  • Escher F, Aleshcheva G, Pietsch H, Baumeier C, Gross UM, Schrage BN, Westermann D, Bock CT, Schultheiss HP

    Transcriptional Active Parvovirus B19 Infection Predicts Adverse Long-Term Outcome in Patients with Non-Ischemic Cardiomyopathy.

    Biomedicines (2021)

  • González R, Nhampossa T, Mombo-Ngoma G, Mischlinger J, Esen M, Tchouatieu AM, Pons-Duran C, Dimessa LB, Lell B, Lagler H, Garcia-Otero L, Zoleko Manego R, El Gaaloul M, Sanz S, Piqueras M, Sevene E, Ramharter M, Saute F, Menendez C:

    Evaluation of the safety and efficacy of dihydroartemisinin-piperaquine for intermittent preventive treatment of malaria in HIV-infected pregnant women: protocol of a multicentre, two-arm, randomised, placebo-controlled, superiority clinical trial (MAMAH project).

    BMJ Open (2021)

  • Adegnika OS, Honkpehedji YJ, Mougeni Lotola F, Agnandji ST, Adegnika AA, Lell B, Sicuri E:

    Funding patterns for biomedical research and infectious diseases burden in Gabon.

    BMC Public Health (2021)

  • Elbadawi HS, Elhag KM, Mahgoub E, Altayb HN, Ntoumi F, Elton L, McHugh TD, Tembo J, Ippolito G, Osman AY, Zumla A, Hamid MMA:

    Detection and characterization of carbapenem resistant Gram-negative bacilli isolates recovered from hospitalized patients at Soba University Hospital, Sudan.

    BMC Microbiol (2021)

  • Ushijima Y, Abe H, Nguema Ondo G, Bikangui R, Massinga Loembé M, Zadeh VR, Essimengane JGE, Mbouna AVN, Bache EB, Agnandji ST, Lell B, Yasuda J:

    Surveillance of the major pathogenic arboviruses of public health concern in Gabon, Central Africa: increased risk of West Nile virus and dengue virus infections.

    BMC Infect Dis (2021)

  • Vigenschow A, Edoa JR, Adegbite BR, Agbo PA, Adegnika AA, Alabi A, Massinga-Loembe M, Grobusch MP:

    Knowledge, attitudes and practices regarding tuberculosis amongst healthcare workers in Moyen-Ogooué Province, Gabon.

    BMC Infect Dis (2021)

  • Vigenschow A, Adegbite BR, Edoa JR, Alabi A, Adegnika AA, Grobusch MP, Massinga-Loembe M:

    Tuberculosis infection control measures in healthcare facilities in Moyen-Ogooué Province, Gabon.

    BMC Health Serv Res (2021)

  • Alabi A, Hussain M, Hoogerwerf MA, Mengome CN, Egesa M, Driciru E, Wammes LJ, Kruize YCM, Sartono E, Adegnika AA, Kremsner PG, Yazdanbakhsh M, Agnandji ST:

    Establishing a controlled hookworm human infection (CHHI) model for Africa: A report from the stakeholders meeting held in Lambaréné, Gabon, November 10-11, 2019.

    Arch Public Health (2021)

  • Pernaute-Lau L, Adegnika AA, Zhou Y, Zinsou JF, Gil JP, Krishna S, Kremsner PG, Lauschke VM, Velavan TP:

    Pharmacogene Sequencing of a Gabonese Population with Severe Plasmodium falciparum Malaria Reveals Multiple Novel Variants with Putative Relevance for Antimalarial Treatment.

    Antimicrob Agents Chemother (2021)

  • Zaloumis SG, Whyte JM, Tarning J, Krishna S, McCaw JM, Cao P, White MT, Dini S, Fowkes FJI, Maude RJ, Kremsner P, Dondorp A, Price RN, White NJ, Simpson JA:

    Development and Validation of an In Silico Decision Tool To Guide Optimization of Intravenous Artesunate Dosing Regimens for Severe Falciparum Malaria Patients.

    Antimicrob Agents Chemother (2021)

  • Viet NT, Van Du V, Thuan ND, Van Tong H, Toan NL, Van Mao C, Van Tuan N, Pallerla SR, Nurjadi D, Velavan TP, Son HA:

    Maternal Vaginal Colonization and Extended-Spectrum Beta-Lactamase-Producing Bacteria in Vietnamese Pregnant Women.

    Antibiotics (Basel) (2021)

  • Son TV, Manh ND, Trung NT, Quyen DT, Meyer CG, Phuong NTK, Hoan PQ, Sang VV, Nurjadi D, Velavan TP, Bang MH, Song LH:

    Molecular detection of blaCTX-M gene to predict phenotypic cephalosporin resistance and clinical outcome of Escherichia coli bloodstream infections in Vietnam.

    Ann Clin Microbiol Antimicrob (2021)

  • Elion Assiana DO, Abdul JBPA, Linguissi LSG, Epola M, Vouvoungui JC, Mabiala A, Biyogho CM, Ronald Edoa J, Adegbite BR, Adegnika AA, Elton L, Canseco JO, McHugh TD, Ahombo G, Ntoumi F:

    Epidemiological profile of multidrug-resistant and extensively drug-resistant Mycobacterium Tubrculosis among Congolese patients.

    Ann Clin Microbiol Antimicrob (2021)

  • · Manouana GP, Byrne N, Mbong Ngwese M, Nguema Moure A, Hofmann P, Bingoulou Matsougou G, Lotola Mougeni F, Nnoh Dansou E, Agbanrin MD, Mapikou Gouleu CS, Ategbo S, Zinsou JF, Adegbite BR, Edoa JR, Kremsner PG, Mordmüller B, Eibach D, McCall M, Abraham A, Borrmann S, Adegnika AA:

    Prevalence of Pathogens in Young Children Presenting to Hospital with Diarrhea from Lambaréné, Gabon.

    Am J Trop Med Hyg: 254-260 (2021)

  • Velavan TP, Kieu Linh LT, Kreidenweiss A, Gabor J, Krishna S, Kremsner PG:

    Longitudinal Monitoring of Lactate in Hospitalized and Ambulatory COVID-19 Patients.

    Am J Trop Med Hyg: 1041-1044 (2021)

  • Zininga T, Böttger E, Multhoff G:

    Role of Heat Shock Proteins in Immune Modulation in Malaria.

    Adv Exp Med Biol 169-186 (2021)

  • Adegbite BR, Edoa JR, Rylance J, Jacob ST, Kawale P, Adegnika AA, Grobusch MP:

    Knowledge of health workers relating to sepsis awareness and management in Lambaréné, Gabon.

    Acta Trop (2021)

2020

  • Mihály Sulyok:

    The Relationship between Mobility and COVID-19 in Germany: Modeling Case Occurrence using Apple's Mobility Trends Data.

    Methods Inf Med (2020)

  • Zita Sulyok:

    Forecasting tuberculosis using diabetes-related google trends data.

    Pathog Glob Health (2020)

  • Kremsner PG, Wolfram Metzger:

    Human challenge trial workshop: Focus on quality requirements for challenge agents, Langen, Germany, October 22, 2019.

    Biologicals (2020)

  • Pejoski D, de Rham C, Martinez-Murillo P, Santoro F, Auderset F, Medaglini D, Pozzi G, Vono M, Lambert PH, Huttner A, Haks MC, Ottenhoff THM, Villard J, Siegrist CA, VEBCON:Consortium , VSV-EBOVAC Consortium , VSV-EBOPLUS Consortium:

    Rapid dose-dependent Natural Killer (NK) cell modulation and cytokine responses following human rVSV-ZEBOV Ebolavirus vaccination.

    npj Vaccines (2020)

  • Nkemngo FN, Mugenzi LMJ, Terence E, Niang A, Wondji MJ, Tchoupo M, Nguete ND, Tchapga W, Irving H, Ntabi JDM, Agonhossou R, Boussougou-Sambe TS, Akoton RB, Koukouikila-Koussounda F, Pinilla YT, Ntoumi F, Djogbenou LS, Ghogomu SM, Ndo C, Adegnika AA, Borrmann S, Wondji CS:

    Multiple insecticide resistance and Plasmodium infection in the principal malaria vectors Anopheles funestus and Anopheles gambiae in a forested locality close to the Yaoundé airport, Cameroon.

    Wellcome Open Res (2020)

  • C Vairo F, Aimè Coussoud-Mavoungou MP, Ntoumi F, Castilletti C, Kitembo L, Haider N, Carletti F, Colavita F, Gruber CEM, Iannetta M, Messina F, Lanini S, Ulrich Judicaël B, Giombini E, Montaldo C, Portella C, Diafouka-Diatela S, Rueca M, Kock R, Bartolini B, Mboera L, Munster V, Fischer R, Seifert S, Muñoz-Fontela C, Escudero-Pérez B, Gomez-Medina S, Nelson EV, Kjia Tungu P, Nicastri E, Puro V, Di Caro A, Capobianchi MR, Mikolo JL, Zumla A, Ippolito G, On Behalf Of The Pandora-Id-Net Consortium Chikungunya Outbreak Group Taskforce:

    Hikungunya Outbreak in the Republic of the Congo, 2019-Epidemiological, Virological and Entomological Findings of a South-North Multidisciplinary Taskforce Investigation.

    Viruses (2020)

  • Flügge J, Adegnika AA, Honkpehedji YJ, Sandri TL, Askani E, Manouana GP, Massinga Loembe M, Brückner S, Duali M, Strunk J, Mordmüller B, Agnandji ST, Lell B, Kremsner PG, Esen M:

    Impact of Helminth Infections during Pregnancy on Vaccine Immunogenicity in Gabonese Infants.

    Vaccines (Basel) (2020)

  • Nouatin O, Ateba Ngoa U, Ibáñez J, Dejon-Agobe JC, Mordmüller B, Edoa JR, Mougeni F, Brückner S, Bouyoukou Hounkpatin A, Esen M, Theisen M, Moutairou K, Hoffman SL, Issifou S, Luty AJF, Loembe MM, Agnandji ST, Lell B, Kremsner PG, Adegnika AA:

    Effect of immune regulatory pathways after immunization with GMZ2 malaria vaccine candidate in healthy lifelong malaria-exposed adults.

    Vaccine: 4263-4272 (2020)

  • Velavan TP, Meyer CG:

    The COVID-19 epidemic.

    Trop Med Int Health: 278-280 (2020)

  • Metzger WG, Theurer A, Pfleiderer A, Molnar Z, Maihöfer-Braatting D, Bissinger AL, Sulyok Z, Köhler C, Egger-Adam D, Lalremruata A, Esen M, Lee Sim K, Hoffman S, Rabinovich R, Chaccour C, Alonso P, Mordmüller BG, Kremsner PG:

    Ivermectin for causal malaria prophylaxis: a randomised controlled human infection trial.

    Trop Med Int Health: 380-386 (2020)

  • Hahn A, Meyer CG, Frickmann H:

    Impact of diagnostic methods on efficacy estimation - a proof-of-principle based on historical examples.

    Trop Med Int Health: 357-363 (2020)

  • Bouwman SA, Zoleko-Manego R, Renner KC, Schmitt EK, Mombo-Ngoma G, Grobusch MP:

    The early preclinical and clinical development of cipargamin (KAE609), a novel antimalarial compound.

    Travel Med Infect Dis 2020

  • Nowak-Harnau S, Hering B, Mordmueller B, Bakchoul T:

    Donor Screening Strategy for Malaria-Deferred Donors.

    Transfusionsmedizin: 29-34 (2020)

  • Sulyok M, Richter H, Sulyok Z, Kapitány-Fövény M, Walker MD:

    Predicting tick-borne encephalitis using Google Trends.

    Ticks Tick Borne Dis 2020

  • Binh MT, Hoan NX, Giang DP, Tong HV, Bock CT, Wedemeyer H, Toan NL, Bang MH, Kremsner PG, Meyer CG, Song LH, Velavan TP:

    Upregulation of SMYD3 and SMYD3 VNTR 3/3 polymorphism increase the risk of hepatocellular carcinoma.

    Sci Rep: 347-353 (2020)

  • Giang NT, van Tong H, Quyet D, Hoan NX, Nghia TH, Nam NM, Hung HV, Anh DT, Van Mao C, Son HA, Meyer CG, Velavan TP, Toan NL:

    Complement protein levels and MBL2 polymorphisms are associated with dengue and disease severity.

    Sci Rep (2020)

  • Kremsner S, Steinicke A, Szolgyenyi M:

    A Deep Neural Network Algorithm for Semilinear Elliptic PDEs with Applications in Insurance Mathematics.

    Risks (2020)

  • Nguetse CN, Purington N, Ebel ER, Shakya B, Tetard M, Kremsner PG, Velavan TP, Egan ES:

    A common polymorphism in the mechanosensitive ion channel PIEZO1 is associated with protection from severe malaria in humans.

    Proc Natl Acad Sci U S A: 9074-9081 (2020)

  • Osundare FA, Klink P, Majer C, Akanbi OA, Wang B, Faber M, Harms D, Bock CT, Opaleye OO:

    Hepatitis E Virus Seroprevalence and Associated Risk Factors in Apparently Healthy Individuals from Osun State, Nigeria.

    Pathogens (2020)

  • Pallerla SR, Harms D, Johne R, Todt D, Steinmann E, Schemmerer M, Wenzel JJ, Hofmann J, Shih JWK, Wedemeyer H, Bock CT, Velavan TP:

    Hepatitis E Virus Infection: Circulation, Molecular Epidemiology, and Impact on Global Health.

    Pathogens (2020)

  • Woitok M, Grieger E, Akinrinmade OA, Bethke S, Pham AT, Stein C, Fendel R, Fischer R, Barth S, Niesen J:

    Using the SNAP-Tag technology to easily measure and demonstrate apoptotic changes in cancer and blood cells with different dyes.

    PLoS ONE (2020)

  • Ntoumi F:

    Tropical diseases need attention, too.

    Nature: 331-331 (2020)

  • I Chng KR, Li C, Bertrand D, Ng AHQ, Kwah JS, Low HM, Tong C, Natrajan M, Zhang MH, Xu L, Ko KKK, Ho EXP, Av-Shalom TV, Teo JWP, Khor CC, MetaSUB Consortium , Chen SL, Mason CE, Ng OT, Marimuthu K, Ang B, Nagarajan N:

    Cartography of opportunistic pathogens and antibiotic resistance genes in a tertiary hospital environment.

    Nat Med: 941-951 2(020)

  • Marinović M, Perković I, Fontinha D, Prudêncio M, Held J, Pessanha de Carvalho L, Tandarić T, Vianello R, Zorc B, Rajić Z:

    Novel Harmicines with Improved Potency against Plasmodium.

    Molecules (2020)

  • Quyet D, Son HA, Velavan TP:

    Molecular surveillance and temporal monitoring of malaria parasites in focal Vietnamese provinces.

    Malar J (2020)

  • Dimonte S, Bruske EI, Enderes C, Otto TD, Turner L, Kremsner P, Frank M:

    Identification of a conserved var gene in different Plasmodium falciparum strains.

    Malar J (2020)

  • Pezzani MD, Carrara E, Sibani M, Presterl E, Gastmeier P, Renk H, Kanj SS, Velavan TP, Song LH, Leibovici L, Torumkuney D, Kostyanev T, Mendelson M, Tacconelli E, ARCH working group:

    White Paper: Bridging the gap between human and animal surveillance data, antibiotic policy and stewardship in the hospital sector-practical guidance from the JPIAMR ARCH and COMBACTE-MAGNET EPI-Net networks.

    J Antimicrob Chemother Suppl 2: ii20-ii32 (2020)

  • Kock RA, Karesh WB, Veas F, Velavan TP, Simons D, Mboera LEG, Dar O, Arruda LB, Zumla A:

    2019-nCoV in context: lessons learned?

    Lancet Planet Health: e87-e88 (2020)

  • Veletzky L, Hergeth J, Stelzl DR, Mischlinger J, Manego RZ, Mombo-Ngoma G, McCall MBB, Adegnika AA, Agnandji ST, Metzger WG, Matsiegui PB, Lagler H, Mordmüller B, Budke C, Ramharter M:

    Burden of disease in Gabon caused by loiasis: a cross-sectional survey.

    Lancet Infect Dis 1339-1346 (2020)

  • T Ackerman H, Ayestaran A, Olola CHO, Jallow M, Agbenyega T, Bojang K, Roberts DJ, Krishna S, Kremsner PG, Newton CR, Taylor T, Valim C, Casals-Pascual C:

    The effect of blood transfusion on outcomes among African children admitted to hospital with Plasmodium falciparum malaria: a prospective, multicentre observational study.

    Lancet Haematol: e789-e797 (2020)

  • Wang J, Xu C, Wong YK, He Y, Adegnika AA, Kremsner PG, Agnandji ST, Sall AA, Liang Z, Qiu C, Liao FL, Jiang T, Krishna S, Tu Y:

    Preparedness is essential for malaria-endemic regions during the COVID-19 pandemic.

    Lancet: 1094-1096 (2020)

  • Abe H, Ushijima Y, Bikangui R, Ondo GN, Zadeh VR, Pemba CM, Mpingabo PI, Igasaki Y, de Vries SG, Grobusch MP, Loembe MM, Agnandji ST, Lell B, Yasuda J:

    First evidence for continuous circulation of hepatitis A virus subgenotype IIA in Central Africa.

    J Viral Hepat: 1234-1242 (2020)

  • Abe H, Ushijima Y, Bikangui R, Loembe MM, Agnandji ST, de Vries SG, Grobusch MP, Lell B, Yasuda J:

    Ongoing evolution of hepatitis B virus during viremia in patients with febrile in Central Africa.

    J Med Virol: 251-256 (2020)

  • McCall MBB, Yap XZ, Bousema T:

    Optimizing RTS,S Vaccination Strategies: Give It Your Best Parting Shot.

    J Infect Dis (2020)

  • Zumla A, Marais BJ, McHugh TD, Maeurer M, Zumla A, Kapata N, Ntoumi F, Chanda-Kapata P, Mfinanga S, Centis R, Cirillo DM, Petersen E, Hui DS, Ippolito G, Leung CC, Migliori GB, Tiberi S:

    COVID-19 and tuberculosis-threats and opportunities.

    Int J Tuberc Lung Dis: 757-760 (2020)

  • Abe H, Ushijima Y, Loembe MM, Bikangui R, Nguema-Ondo G, Mpingabo PI, Zadeh VR, Pemba CM, Kurosaki Y, Igasaki Y, de Vries SG, Grobusch MP, Agnandji ST, Lell B, Yasuda J:

    Re-emergence of dengue virus serotype 3 infections in Gabon in 2016-2017, and evidence for the risk of repeated dengue virus infections.

    Int J Infect Dis: 129-136 (2020)

  • Lytton SD, Nematollahi G, van Tong H, Xuan Anh C, Hung HV, Hoan NX, Diez G, Schumacher T, Landt O, Melchior W, Fuchs D, Toan NL, Velavan TP, Song LH:

    Predominant secondary dengue infection among Vietnamese adults mostly without warning signs and severe disease.

    Int J Infect Dis: 316-323 (2020)

  • Nguekeng Tsague B, Mikounou Louya V, Ntoumi F, Adedoja A, Vouvoungui CJ, Peko SM, Abena AA:

    Occurrence of human astrovirus associated with gastroenteritis among Congolese children in Brazzaville, Republic of Congo.

    Int J Infect Dis: 142-147 (2020)

  • Geisler S, Lytton SD, Toan NL, Nghia TH, Nam NM, Hung HV, Son NT, Anh DT, Tuyen HT, Tien TV, Quyet D, Van Tong H, Hoan NX, Song LH, Pallerla SR, Gostner JM, Fuchs D, Velavan TP:

    Neopterin levels and Kyn/Trp ratios were significantly increased in dengue virus patients and subsequently decreased after recovery.

    Int J Infect Dis: 162-168 (2020)

  • Auer ED, Tong HV, Amorim LM, Malheiros D, Hoan NX, Issler HC, Petzl-Erler ML, Beltrame MH, Boldt ABW, Toan NL, Song LH, Velavan TP, Augusto DG:

    Natural killer cell receptor variants and chronic hepatitis B virus infection in the Vietnamese population.

    Int J: Infect Dis: 541-547 (2020)

  • Velavan TP, Meyer CG:

    Mild versus severe COVID-19: Laboratory markers.

    Int J Infect Dis: 304-307 (2020)

  • I Kapata N, Ihekweazu C, Ntoumi F, Raji T, Chanda-Kapata P, Mwaba P, Mukonka V, Bates M, Tembo J, Corman V, Mfinanga S, Asogun D, Elton L, Arruda LB, Thomason MJ, Mboera L, Yavlinsky A, Haider N, Simons D, Hollmann L, Lule SA, Veas F, Abdel Hamid MM, Dar O, Edwards S, Vairo F, McHugh TD, Drosten C, Kock R, Ippolito G, Zumla A:

    Is Africa prepared for tackling the COVID-19 (SARS-CoV-2) epidemic. Lessons from past outbreaks, ongoing pan-African public health efforts, and implications for the future.

    Int J Infect Dis: 233-236 (2020)

  • Velavan TP, Pollard AJ, Kremsner PG:

    Herd immunity and vaccination of children for COVID-19.

    Int J Infect Dis: 14-15 (2020)

  • Petersen E, McCloskey B, Hui DS, Kock R, Ntoumi F, Memish ZA, Kapata N, Azhar EI, Pollack M, Madoff LC, Hamer DH, Nachega JB, Pshenichnaya N, Zumla A:

    COVID-19 travel restrictions and the International Health Regulations - Call for an open debate on easing of travel restrictions.

    Int J Infect Dis: 88-90 (2020)

  • Nikolai LA, Meyer CG, Kremsner PG, Velavan TP:

    Asymptomatic SARS Coronavirus 2 infection: Invisible yet invincible.

    Int J Infect Dis: 112-116 (2020)

  • Giang NT, Tong HV, Nghia TH, Hung HV, Anh DT, Nam LV, Mao CV, Giang NT, Thanh LD, Son HA, Velavan TP, Do Q, Toan NL:

    Association of FCN2 polymorphisms and Ficolin-2 levels with dengue fever in Vietnamese patients.

    Int J Infect Dis: 253-261 (2020)

  • Hahn A, Kröger C, Meyer CG, Loderstädt U, Meyer T, Frickmann H, Zautner AE:

    Comparison of Self-Reported Sexual Activity Among Heterosexuals with Sexual Spread of Poorly Transmittable Agents: A Minimalistic Approach to Estimating Sexual Activity Based on HIV Incidence.

    Int J Environ Res Public Health (2020)

  • Fagbemi KA, Adebusuyi SA, Nderu D, Adedokun SA, Pallerla SR, Amoo AOJ, Thomas BN, Velavan TP, Ojurongbe O:

    Analysis of sulphadoxine-pyrimethamine resistance-associated mutations in Plasmodium falciparum isolates obtained from asymptomatic pregnant women in Ogun State, Southwest Nigeria.

    Infect Genet Evol (2020)

  • Im J, Balasubramanian R, Ouedraogo M, Wandji Nana LR, Mogeni OD, Jeon HJ, van Pomeren T, Haselbeck A, Lim JK, Prifti K, Baker S, Meyer CG, Kim JH, Clemens JD, Marks F, Soura AB:

    The epidemiology of dengue outbreaks in 2016 and 2017 in Ouagadougou, Burkina Faso.

    Heliyon (2020)

  • Bache BE, Grobusch MP, Agnandji ST:

    Safety, immunogenicity and risk-benefit analysis of rVSV-ΔG-ZEBOV-GP (V920) Ebola vaccine in Phase I-III clinical trials across regions.

    Future Microbiol: 85-106 (2020)

  • Moirongo RM, Lorenz E, Ntinginya NE, Dekker D, Fernandes J, Held J, Lamshöft M, Schaumburg F, Mangu C, Sudi L, Sie A, Souares A, Heinrich N, Wieser A, Mordmüller B, Owusu-Dabo E, Adegnika AA, Coulibaly B, May J, Eibach D:

    Regional Variation of Extended-Spectrum Beta-Lactamase (ESBL)-Producing Enterobacterales, Fluoroquinolone-Resistant Salmonella enterica and Methicillin-Resistant Staphylococcus aureus Among Febrile Patients in Sub-Saharan Africa.

    Front Microbiol (2020)

  • Rothe C, Rosenbusch D, Alberer M, Buehler S, Burchard G, Erkens K, Feldt T, Grobusch MP, Koehler C, Kapaun A, Loebermann M, Meischner K, Metzger W, Mueller A, Nothdurft HD, Rieke B, Schlaich C, Schoenfeld C, Schulze MH, Siedenburg J, Steiner F, Veit O, Weitzel T, Boecken G:

    Travel Vaccinations - Advice and Recommendations: Vaccinations for international travel - clinical practice recommendations

    Flugmedizin Tropenmedizin Reisemedizin: 56-88 (2020)

  • Pessanha de Carvalho L, Held J, de Melo EJT:

    Essential and nonessential metal effects on extracellular Leishmania amazonensis in vitro.

    Exp Parasitol (2020)

  • Perković I, Raić-Malić S, Fontinha D, Prudêncio M, Pessanha de Carvalho L, Held J, Tandarić T, Vianello R, Zorc B, Rajić Z:

    Harmicines - harmine and cinnamic acid hybrids as novel antiplasmodial hits.

    Eur J Med Chem 187: (2020)

  • Haider N, Yavlinsky A, Chang YM, Hasan MN, Benfield C, Osman AY, Uddin MJ, Dar O, Ntoumi F, Zumla A, Kock R:

    The Global Health Security index and Joint External Evaluation score for health preparedness are not correlated with countries' COVID-19 detection response time and mortality outcome.

    Epidemiol Infect (2020)

  • Escher F, Pietsch H, Aleshcheva G, Bock T, Baumeier C, Elsaesser A, Wenzel P, Hamm C, Westenfeld R, Schultheiss M, Gross U, Morawietz L, Schultheiss HP:

    Detection of viral SARS-CoV-2 genomes and histopathological changes in endomyocardial biopsies.

    ESC Heart Fail: 2440-2447 (2020)

  • Rothe C, Boecken G, Rosenbusch D, Alberer M, Buehler S, Erkens K, Feldt T, Grobusch MP, Koehler C, Loebermann M, Meischner K, Metzger W, Mueller A, Nothdurft HD, Rieke B, Schlaich C, Schoenfeld C, Schulze MH, Siedenburg J, Steiner F, Veit O, Weitzel T, Deutsch Gesell Tropenmed Globale:

    Travel vaccinations.

    Bundesgesundheitsblatt Gesundheitsforschung, Gesundheitsschutz: 74-84 (2020)

  • Honkpehedji YJ, Adegnika AA, Dejon-Agobe JC, Zinsou JF, Mba RB, Gerstenberg J, Rakotozandrindrainy R, Rakotoarivelo RA, Rasamoelina T, Sicuri E, Schwarz NG, Corstjens PLAM, Hoekstra PT, van Dam GJ, Kreidenweiss A, freeBILy Consortium:

    Prospective, observational study to assess the performance of CAA measurement as a diagnostic tool for the detection of Schistosoma haematobium infections in pregnant women and their child in Lambaréné, Gabon: study protocol of the freeBILy clinical trial in Gabon.

    BMC Infect Dis 211: (2020)

  • Elton L, Thomason MJ, Tembo J, Velavan TP, Pallerla SR, Arruda LB, Vairo F, Montaldo C, Ntoumi F, Abdel Hamid MM, Haider N, Kock R, Ippolito G, Zumla A, McHugh TD, the PANDORA-ID-NET consortium:

    Antimicrobial resistance preparedness in sub-Saharan African countries.

    Antimicrob Resist Infect Control (2020)

  • Dejon-Agobé JC, Honkpehedji YJ, Zinsou JF, Edoa JR, Adégbitè BR, Mangaboula A, Agnandji ST, Mombo-Ngoma G, Ramharter M, Kremsner PG, Lell B, Grobusch MP, Adegnika AA:

    Epidemiology of Schistosomiasis and Soil-Transmitted Helminth Coinfections among Schoolchildren Living in Lambaréné, Gabon.

    Am J Trop Med Hyg 103: 325-333 (2020)

  • Adegbite BR, Edoa JR, Achimi Agbo P, Dejon-Agobé JC, N Essone P, Lotola-Mougeni F, Mbong Ngwese M, Mfoumbi A, Mevyann C, Epola M, Zinsou JF, Honkpehedji YJ, Agnandji ST, Kremsner PG, Alabi AS, Adegnika AA, Grobusch MP:

    Epidemiological, Mycobacteriological, and Clinical Characteristics of Smoking Pulmonary Tuberculosis Patients, in Lambaréné, Gabon: A Cross-Sectional Study.

    Am J Trop Med Hyg 103: 2501-2505 (2020)

  • Priest JW, Stuchlik O, Reed M, Soboslay P, Cama V, Roy SL:

    Development of a Multiplex Bead Assay for the Detection of IgG Antibody Responses to Guinea Worm.

    Am J Trop Med Hyg: 103 6 2294-2304 (2020)

  • Hoekstra PT, Schwarz NG, Adegnika AA, Andrianarivelo MR, Corstjens PLAM, Rakotoarivelo RA, Rakotozandrindrainy R, Sicuri E, Kreidenweiss A, van Dam GJ, freeBILy consortium:

    Fast and reliable easy-to-use diagnostics for eliminating bilharzia in young children and mothers: An introduction to the freeBILy project.

    Acta Trop 211 (2020)

  • Manouana GP, Lorenz E, Mbong Ngwese M, Nguema Moure PA, Maiga Ascofaré O, Akenten CW, Amuasi J, Rakotozandrindrainy N, Rakotozandrindrainy R, Mbwana J, Lusingu J, Byrne N, Melhem S, Zinsou JF, Adegbite RB, Hogan B, Winter D, May J, Kremsner PG, Borrmann S, Eibach D, Adegnika AA:

    Performance of a rapid diagnostic test for the detection of Cryptosporidium spp. in African children admitted to hospital with diarrhea.

    PLoS Negl Trop Dis (2020)

  • Göpel S, Bethge W, Martus P, Kreth F, Iftner T, Joos S, Döbele S, Mordmüller B, Kremsner P, Ettrich T, Seufferlein T, Bitzer M, Malek N:

    Test and treat COVID 65 plus - Hydroxychloroquine versus placebo in early ambulatory diagnosis and treatment of older patients with COVID19: A structured summary of a study protocol for a randomised controlled trial.

    Trials 2020

  • A Danso EK, Asare P, Otchere ID, Akyeh LM, Asante-Poku A, Aboagye SY, Osei-Wusu S, Opare D, Ntoumi F, Zumla A, Duodu S, Yeboah-Manu D:

    Molecular and epidemiological study of Vibrio cholerae isolates from cholera outbreaks in southern Ghana.

    PLoS ONE (2020)

  • Zinsou JF, Janse JJ, Honpkehedji YY, Dejon-Agobé JC, García-Tardón N, Hoekstra PT, Massinga-Loembe M, Corstjens PLAM, van Dam GJ, Giera M, Kremsner PG, Yazdanbakhsh M, Adegnika AA, Guigas B:

    Schistosoma haematobium infection is associated with lower serum cholesterol levels and improved lipid profile in overweight/obese individuals.

    PLoS Negl Trop Dis (2020)

  • Matthewman J, Manego RZ, Dimessa Mbadinga LB, Šinkovec H, Völker K, Akinosho M, Haedrich C, Tardif d'Hamonville J, Lell B, Adegnika AA, Ramharter M, Mombo-Ngoma G:

    A randomized controlled trial comparing the effectiveness of individual versus household treatment for Scabies in Lambaréné, Gabon.

    PLoS Negl Trop Dis (2020)

  • Fernandes JF, Laubscher F, Held J, Eckerle I, Docquier M, Grobusch MP, Mordmüller B, Kaiser L, Cordey S:

    Unbiased metagenomic next-generation sequencing of blood from hospitalized febrile children in Gabon.

    Emerg Microbes Infect: 1242-1244 (2020)

  • Mbong Ngwese M, Prince Manouana G, Nguema Moure PA, Ramharter M, Esen M, Adégnika AA:

    Diagnostic Techniques of Soil-Transmitted Helminths: Impact on Control Measures.

    Trop Med Infect Dis 2020

  • Mbong Ngwese M, Prince Manouana G, Nguema Moure PA, Ramharter M, Esen M, Adégnika AA:

    Diagnostic Techniques of Soil-Transmitted Helminths: Impact on Control Measures.

    Trop Med Infect Dis 2020

  • Grobusch MP, van der Fluit KS, Stijnis C, De Pijper CA, Hanscheid T, Gautret P, Schlagenhauf P, Goorhuis A:

    Can dengue virus be sexually transmitted?

    Travel Med Infect Dis 2020

  • Moncunill G, Scholzen A, Mpina M, Nhabomba A, Hounkpatin AB, Osaba L, Valls R, Campo JJ, Sanz H, Jairoce C, Williams NA, Pasini EM, Arteta D, Maynou J, Palacios L, Duran-Frigola M, Aponte JJ, Kocken CHM, Agnandji ST, Mas JM, Mordmüller B, Daubenberger C, Sauerwein R, Dobaño C:

    Antigen-stimulated PBMC transcriptional protective signatures for malaria immunization.

    Sci Transl Med (2020)

  • Dossou-Yovo LR, Ntoumi F, Koukouikila-Koussounda F, Vouvoungui JC, Adedoja A, Nderu D, Velavan TP, Lenga A:

    Molecular surveillance of the Pfmdr1 N86Y allele among Congolese pregnant women with asymptomatic malaria.

    Malar J (2020)

  • Marais BJ, Chakaya J, Swaminathan S, Fox GJ, Ehtesham NZ, Ntoumi F, Zijenah L, Maurer M, Zumla A:

    Tackling long-term morbidity and mortality after successful tuberculosis treatment.

    Lancet Infect Dis: 641-642 (2020)

  • Harms D, Choi M, Allers K, Wang B, Pietsch H, Papp CP, Hanisch L, Kurreck J, Hofmann J, Bock CT:

    Specific circulating microRNAs during hepatitis E infection can serve as indicator for chronic hepatitis E.

    Sci Rep (2020)

  • Sahu S, Ditiu L, Lawson L, Ntoumi F, Arakaki D, Zumla A:

    UN General Assembly tuberculosis targets: are we on track?

    Lancet: 928-930 (2020)

  • Rougeron V, Elguero E, Arnathau C, Acuña Hidalgo B, Durand P, Houze S, Berry A, Zakeri S, Haque R, Shafiul Alam M, Nosten F, Severini C, Gebru Woldearegai T, Mordmüller B, Kremsner PG, González-Cerón L, Fontecha G, Gamboa D, Musset L, Legrand E, Noya O, Pumpaibool T, Harnyuttanakorn P, Lekweiry KM, Mohamad Albsheer M, Mahdi Abdel Hamid M, Boukary AOMS, Trape JF, Renaud F, Prugnolle F:

    Human Plasmodium vivax diversity, population structure and evolutionary origin.

    PLoS Negl Trop Dis (2020)

  • Petersen E, Hui D, Hamer DH, Blumberg L, Madoff LC, Pollack M, Lee SS, McLellan S, Memish Z, Praharaj I, Wasserman S, Ntoumi F, Azhar EI, Mchugh TD, Kock R, Ippolito G, Zumla A, Koopmans M:

    Li Wenliang, a face to the frontline healthcare worker. The first doctor to notify the emergence of the SARS-CoV-2, (COVID-19), outbreak.

    Int J Infect Dis: 205-207 (2020)

  • Chakaya JM, Marais B, du Cros P, Ntoumi F, Mfinanga S, Kapata N, Hasnain SE, Nathavitharana R, Zumla A:

    Programmatic versus personalised approaches to managing the global epidemic of multidrug-resistant tuberculosis.

    Lancet Respir Med: 334-335 (2020)

  • Wang B, Harms D, Yang XL, Bock CT:

    Orthohepevirus C: An Expanding Species of Emerging Hepatitis E Virus Variants.

    Pathogens (2020)

  • Lalremruata A, Nguyen TT, McCall MBB, Mombo-Ngoma G, Agnandji ST, Adegnika AA, Lell B, Ramharter M, Hoffman SL, Kremsner PG, Mordmüller B:

    Recombinase Polymerase Amplification and Lateral Flow Assay for Ultrasensitive Detection of Low-Density Plasmodium falciparum Infection from Controlled Human Malaria Infection Studies and Naturally Acquired Infections.

    J Clin Microbiol 2020

  • Haider N, Yavlinsky A, Simons D, Osman AY, Ntoumi F, Zumla A, Kock R:

    Passengers' destinations from China: low risk of Novel Coronavirus (2019-nCoV) transmission into Africa and South America.

    Epidemiol Infect (2020)

  • Bretscher MT, Dahal P, Griffin J, Stepniewska K, Bassat Q, Baudin E, D'Alessandro U, Djimde AA, Dorsey G, Espié E, Fofana B, González R, Juma E, Karema C, Lasry E, Lell B, Lima N, Menéndez C, Mombo-Ngoma G, Moreira C, Nikiema F, Ouédraogo JB, Staedke SG, Tinto H, Valea I, Yeka A, Ghani AC, Guerin PJ, Okell LC:

    The duration of chemoprophylaxis against malaria after treatment with artesunate-amodiaquine and artemether-lumefantrine and the effects of pfmdr1 86Y and pfcrt 76T: a meta-analysis of individual patient data.

    BMC Med (2020)

  • Tong HV, Hoan NX, Binh MT, Quyen DT, Meyer CG, Hang DTT, Hang DTD, Son HA, Van Luong H, Thuan ND, Giang NT, Quyet D, Bang MH, Song LH, Velavan TP, Toan NL:

    Upregulation of Enzymes involved in ISGylation and Ubiquitination in patients with hepatocellular carcinoma.

    Int J Med Sci: 347-353 (2020)

  • Fernandes JF, Held J, Dorn M, Lalremruata A, Schaumburg F, Alabi A, Agbanrin MD, Kokou C, Ben Adande A, Esen M, Eibach D, Adegnika AA, Agnandji ST, Lell B, Eckerle I, Henrichfreise B, Hogan B, May J, Kremsner PG, Grobusch MP, Mordmüller B:

    Causes of fever in Gabonese children: a cross-sectional hospital-based study.

    Sci Rep (2020)

  • Díaz-Menéndez M, Esteban ET, Ujiie M, Calleri G, Rothe C, Malvy D, Nicastri E, Bissinger AL, Grandadam M, Alpern JD, Gobbi F, Schlagenhauf P, Duvignaud A, Javelle E, Nakamoto T, Antinori S, Hamer DH:

    Travel-associated chikungunya acquired in Myanmar in 2019.

    Euro Surveill: 5-11 (2020)

  • Labuda LA, Adegnika AA, Rosa BA, Martin J, Ateba-Ngoa U, Amoah AS, Lima HM, Meurs L, Mbow M, Manurung MD, Zinsou JF, Smits HH, Kremsner PG, Mitreva M, Yazdanbakhsh M:

    A Praziquantel Treatment Study of Immune and Transcriptome Profiles in Schistosoma haematobium-Infected Gabonese Schoolchildren.

    J Infect Dis: 2103-2113 (2020)

  • Metzger WG, Sulyok Z, Theurer A, Köhler C:

    Development of malaria vaccines-state of the art.

    Bundesgesundheitsblatt Gesundheitsforschung, Gesundheitsschutz: 45-55 (2020)

  • Remppis J, Verheyden A, Bustinduy AL, Heller T, García-Tardón N, Manouana GP, Obiang R, Adegnika AA, Grobusch MP, Ramharter M, Joekes E, Bélard S:

    Focused Assessment with Sonography for Urinary Schistosomiasis (FASUS)-pilot evaluation of a simple point-of-care ultrasound protocol and short training program for detecting urinary tract morbidity in highly endemic settings.

    Trans R Soc Trop Med Hyg: 38-48 (2020)

  • Otieno L, Guerra Mendoza Y, Adjei S, Agbenyega T, Agnandji ST, Aide P, Akoo P, Ansong D, Asante KP, Berkley JA, Gesase S, Hamel MJ, Hoffman I, Kaali S, Kamthunzi P, Kariuki S, Kremsner P, Lanaspa M, Lell B, Lievens M, Lusingu J, Malabeja A, Masoud NS, Mtoro AT, Njuguna P, Ofori-Anyinam O, Otieno GA, Otieno W, Owusu-Agyei S, Schuerman L, Sorgho H, Tanner M, Tinto H, Valea I, Vandoolaeghe P, Sacarlal J, Oneko M:

    Safety and immunogenicity of the RTS,S/AS01 malaria vaccine in infants and children identified as HIV-infected during a randomized trial in sub-Saharan Africa.

    Vaccine: 897-906 (2020)

  • Wockner LF, Hoffmann I, Webb L, Mordmüller B, Murphy SC, Kublin JG, O'Rourke P, McCarthy JS, Marquart L:

    Growth Rate of Plasmodium falciparum: Analysis of Parasite Growth Data From Malaria Volunteer Infection Studies.

    J Infect Dis: 963-972 (2020)

  • Huijben S, Macete E, Mombo-Ngoma G, Ramharter M, Kariuki S, Desai M, Shi YP, Mwangoka G, Massougbodji A, Cot M, Ndam NT, Uberegui E, Gupta H, Cisteró P, Aponte JJ, González R, Menéndez C, Mayor A:

    Counter-Selection of Antimalarial Resistance Polymorphisms by Intermittent Preventive Treatment in Pregnancy.

    J Infect Dis: 293-303 (2020)

  • Eldh M, Hammar U, Arnot D, Beck HP, Garcia A, Liljander A, Mercereau-Puijalon O, Migot-Nabias F, Mueller I, Ntoumi F, Ross A, Smith T, Sondén K, Vafa Homann M, Yman V, Felger I, Färnert A:

    Multiplicity of Asymptomatic Plasmodium falciparum Infections and Risk of Clinical Malaria: A Systematic Review and Pooled Analysis of Individual Participant Data.

    J Infect Dis: 775-785 (2020)

  • Mirjam Groger, Ramharter M.

    Lin et al.

    Clin Infect Dis (2020)

  • van Aalst M, Garcia Garrido HM, van der Leun J, Meek B, van Leeuwen EMM, Löwenberg M, D'Haens GR, Ponsioen CYI, Grobusch MP, Goorhuis:

    Immunogenicity of the Currently Recommended Pneumococcal Vaccination Schedule in Patients With Inflammatory Bowel Disease.

    Clin Infect Dis: 595-604 (2020)

2019

  • O.A. Akanbi, D. Harms, B. Wang, O.O. Opaleye, O. Adesina, F.A. Osundare, A: Ogunniyi, D. Naidoo, I. Devaux, A. Wondimagegnehu, C. Peter, O. Ifeanyi, O. Ogundiran, U. Ugochukwu, N. Mba, S.A: Omilabu, C. Ihekweazu, C.T. Bock:

    Complete Genome Sequence of a Hepatitis E Virus Genotype 1e Strain from an Outbreak in Nigeria, 2017.

    Microbiology Resource Announcements 8(1): e01378-18 (2019)

  • M.T. Binh, N.X. Hoan, H. Van Tong, B.T. Sy, N.T. Trung, C.T. Bock, N.L. Toan, L.H. Song, M.H. Bang, C.G. Meyer, P.G. Kremsner, T.P. Velavan:

    NTCP S267F variant associates with decreased susceptibility to HBV and HDV infection and decelerated progression of related liver diseases.

    International Journal of Infectious Diseases 80: 147-152 (2019)

  • A.B.W. Boldt, H. van Tong, M.P. Grobusch, Y. Kalmbach, A. Dzeing Ella, M. Kombila, C.G. Meyer, J. Kun, P.G. Kremsner, T.P. Velavan:

    The blood transcriptome of childhood malaria.

    EBioMedicine 40: 614-662 (2019)

  • N.S. Gampio Gueye, S.M. Peko, D. Nderu, F. Koukouikila-Koussounda, C. Vouvoungui, S.C. Kobawila, T.P. Velavan, F. Ntoumi:

    An update on glucose-6-phosphate dehydrogenase deficiency in children from Brazzaville, Republic of Congo.

    Malaria Journal 18(1): 57 (2019)

  • A.B. Hounkpatin, A. Kreidenweiss, J.Held:

    Clinical utility of tafenoquine in the prevention of relapse of Plasmodium vivax malaria: a review on the mode of action and emerging trial data.

    Infection and Drug Resistance 12:553-570 (2019)

  • M.O. Japhet, O. Famurewa, O.A. Adesina, O.O. Opaleye, B. Wang, M. Höhne, C.T. Bock, A. Mas Marques, S. Niendorf:

    Viral gastroenteritis among children of 0-5 years in Nigeria: Characterization of the first Nigerian aichivirus, recombinant noroviruses and detection of a zoonotic astrovirus.

    Journal of Clinical Virology 111: 4-11 (2019)

  • Kapitány-Fövény, T. Ferenci, Z. Sulyok, J. Kegele, H. Richter, I. Vályi-Nagy, M. Sulyok:

    Can Google Trends data improve forecasting of Lyme disease incidence?

    Zoonoses and Public Health 66(1): 101-107 (2019)

  • M. Leven, J. Held, S. Duffy, L.A. Alves Avelar, S. Meister, M. Delves, D. Plouffe, K. Kuna, S. Tschan, V.M. Avery, E.A. Winzeler, B. Mordmüller, T. Kurz:

    8-Aminoquinolines with an Aminoxyalkyl Side Chain Exert in vitro Dual-Stage Antiplasmodial Activity.

    ChemMedChem 14(4):501-511 (2019)

  • Lötsch, C.M. Budke, H. Auer, K. Kaczirek, F. Waneck, H. Lagler, M. Ramharter:

    Evaluation of direct costs associated with alveolar and cystic echinococcosis in Austria.

    PLoS Neglected Tropical Diseases 13(1):e0007110 (2019)

  • M. Maixenchs, R. Anselmo, G. Martínez Pérez, K. Oruko, S.T. Agnandji, P.C. Angoissa Minsoko, K: Diarra, M. Djiteye, Z.A. Bhutta, S. Zaidi, C. Carrilho, A. Sanz, J. Ordi, C. Menendez C, Bassat Q, Munguambe K.

    Socio-anthropological methods to study the feasibility and acceptability of the minimally invasive autopsy from the perspective of local communities: lessons learnt from a large multi-centre study.

    Global Health Action 12(1):1559496 (2019)

  • J.B. Mengue, J. Held J, A. Kreidenweiss:

    AQ-13 - an investigational antimalarial drug.

    Expert Opinion on Investigational Drugs 28(3):217-222 (2019)

  • D. Nderu, F. Kimani, K. Thiong'o, E. Karanja, M. Akinyi, E. Too, W. Chege, E. Nambati, C.G. Meyer, T.P. Velavan:

    Plasmodium falciparum histidine-rich protein (PfHRP2 and 3) diversity in Western and Coastal Kenya.

    Scientific Reports 9(1): 1709 (2019)

  • F. Paquet-Durand, S.C Beck, S. Das, G. Huber, Le Chang, T. Schubert, N. Tanimoto, M. Garcia-Garrido, R. Mühlfriedel, S. Bolz, W. Hoffmann, S. Schraermeyer, B. Mordmüller, M.W. Seeliger:

    A retinal model of cerebral malaria.

    Scientific Reports 9(1): 3470 (2019)

  • J.H. Poetsch, C. Dahlke, M.E. Zinser, R. Kasonta, S. Lunemann, A. Rechtien, M.L. Ly, H.C. Stubbe, V. Krähling, N. Biedenkopf, M. Eickmann, S.K. Fehling, F. Olearo, T. Strecker, P. Sharma, K.S. Lang, A.W. Lohse, S. Schmiedel, S. Becker; VSV-Ebola Consortium (VEBCON) , M.M. Addo:

    Detectable Vesicular Stomatitis Virus (VSV)–Specific Humoral and Cellular Immune Responses Following VSV–Ebola Virus Vaccination in Humans

    Journal of Infectious Diseases 219(4) 556–561 (2019) PGK, Maxime

  • M. Ramharter, M. Schwab, G. Mombo-Ngoma, R. Zoleko Manego, D. Akerey-Diop, A. Basra, J.R. Mackanga, H. Würbel, J.G. Wojtyniak, R. Gonzalez, U. Hofmann, M. Geditz, P.B: Matsiegui, P.G. Kremsner, C. Menendez, R. Kerb, T. Lehr:

    Population Pharmacokinetics of Mefloquine Intermittent Preventive Treatment for Malaria in Pregnancy in Gabon.

    Antimicrobial Agents and Chemotherapy 63(2): e01113-1118 (2019)

  • M. Rao M, G. Ippolito, S. Mfinanga, F. Ntoumi, D. Yeboah-Manu, C. Vilaplana, A. Zumla, M. Maeurer:

    Latent TB Infection (LTBI) - Mycobacterium tuberculosis pathogenesis and the dynamics of the granuloma battleground.

    International Journal of Infectious Diseases 80: S:S58-S61 (2019) SUPPLEMENT

  • M: Rao, G. Ippolito, S. Mfinanga, F. Ntoumi, D. Yeboah-Manu, C. Vilaplana, A. Zumla, M. Maeurer:

    Improving treatment outcomes for MDR-TB - Novel host-directed therapies and personalised medicine of the future.

    International Journal of Infectious Diseases 80: S:S62-S67. (2019) SUPPLEMENT

  • S.P. Rosskopf, J. Held, M. Gmeiner, B. Mordmüller, P.B. Matsiégui, I. Eckerle, N. Weber, K. Matuschewski K, J. Schaer:

    Nycteria and Polychromophilus parasite infections of bats in Central Gabon

    Infection, Genetics and Evolution 68: 30-34 (2019)

  • F. Schaumburg, A. Witten, A. Flamen, M. Stoll, A.S. Alabi, P.G. Kremsner PG, B. Löffler, P.F. Zipfel, T.P. Velavan, G. Peters G.

    Complement 5a Receptor Polymorphisms Are Associated With Panton-Valentine Leukocidin-positive Staphylococcus aureus Colonization in African Pygmies.

    Clinical Infectious Diseases 15;68(5): 854-856 (2019)

  • M. Schmedding, B.R. Adegbite, S. Gould, J.O. Beyeme, A.A. Adegnika, M.P. Grobusch, M.A.M. Huson:

    A Prospective Comparison of Quick Sequential Organ Failure Assessment, Systemic Inflammatory Response Syndrome Criteria, Universal Vital Assessment, and Modified Early Warning Score to Predict Mortality in Patients with Suspected Infection in Gabon.

    American Journal of Tropical Medicine & Hygiene 100(1): 202-208 (2019)

  • T.P.Velavan:

    Epstein-Barr virus, malaria and endemic Burkitt lymphoma.

    EbioMedicine 39: 13-14 (2019)

  • P. Wang, L. Krüger, P. Machnowska, A: Eshetu, B. Gunsenheimer-Bartmeyer, V. Bremer, A. Hauser, N. Bannert, C.T. Bock:

    Characterization of a hepatitis C virus genotype 1 divergent isolate from an HIV-1 coinfected individual in Germany assigned to a new subtype 1o.

    Virolology Journal 16(1): 28 (2019)

  • B. Wangala, R. Gantin, P. Voßberg, A. Vovor, W.P. Poutouli, K. Komlan, M. Banla, C. Köhler, P.T. Soboslay PT:

    Inflammatory and regulatory CCL and CXCL chemokine and cytokine cellular responses in patients with patent Mansonella perstans filariasis.

    Clinical and Experimental Immunology 196(1):111-12 (2019)

  • H. Abe, Y. Ushijima, M.M. Loembe, R. Bikangui, G. Nguema-Ondo, P.I. Mpingabo, V.R. Zadeh, C.M. Pemba, Y. Kurosaki, Y. Igasaki, S.G. de Vries, M.P. Grobusch, S.T. Agnandji, B. Lell, J. Yasuda:

    Re-emergence of dengue virus serotype 3 infections in Gabon in 2016-2017, and evidence for the risk of repeated dengue virus infections.

    International Journal of Infectious Diseases 91: 129-136 (2019)

  • B.R. Adegbite, J.R. Edoa, Y.J. Honkpehedji, F.J. Zinsou , J.C. Dejon-Agobe, M. Mbong-Ngwese, F. Lotola-Mougueni, E. Koehne, A. Lalremruata, A. Kreidenweiss, T.T. Nguyen, J. Kun, S.T. Agnandji, B. Lell, A.R. Safiou, F.A. Obone Atome, G. Mombo-Ngoma, M. Ramharter, T.P. Velavan, B. Mordmüller, P.G. Kremsner, A.A.Adegnika:

    Monitoring of efficacy, tolerability and safety of artemether-lumefantrine and artesunate-amodiaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Lambaréné, Gabon: an open-label clinical trial.

    Malaria Journal 18(1): 424 (2019)

  • J. Arko-Mensah, J. Darko, E.N.N. Nortey, J. May, C.G. Meyer:

    Socioeconomic Status and Temporal Urban Environmental Change in Accra: a Comparative Analysis of Area-based Socioeconomic and Urban Environmental Quality Conditions Between Two Time Points.

    Environmental Management 63(5): 574-582 (2019)

  • U. Ateba-Ngoa, J.R. Edoa, B.R. Adegbite, E.G. Rossatanga, D. Madiou, A. Mfoumbi, C. Mevyann, P. Achimi Agbo, J. Mahoumbou, S. Gould, B. Lell, A.A. Adegnika, C. Köhler, P.G. Kremsner, M. Massinga-Loembe, A. Alabi, M.P. Grobusch:

    Implementation of multidrug-resistant tuberculosis (MDR-TB) treatment in Gabon: lessons learnt from the field.

    Infection 47(5): 811-816 (2019)

  • A. Bachmann, E. Bruske, R. Krumkamp, L. Turner, J.S. Wichers, M. Petter, J. Held, M.F. Duffy, B.K.L. Sim, S. Hoffman, P.G. Kremsner, B. Lell, T. Lavstsen, M. Frank, B. Mordmüller, E. Tannich:

    Controlled human malaria infection with Plasmodium falciparum demonstrates impact of naturally acquired immunity on virulence gene expression.

    PLoS Pathogens 15(7): e1007906 (2019)

  • S. Baker, M. Ali, J.F. Deerin, M.A. Eltayeb, L.M. Cruz Espinoza, N. Gasmelseed, J. Im, U. Panzner, V.V. Kalckreuth, K.H. Keddy, G.D. Pak, J.K. Park, S.E. Park, A. Sooka, A.G. Sow, A. Tall, S. Luby, C.G. Meyer, F. Marks:

    The Typhoid Fever Surveillance in Africa Program: Geospatial Sampling Frames for Household-based Studies: Lessons Learned From a Multicountry Surveillance Network in Senegal, South Africa, and Sudan.

    Clinical Infectious Diseases 69(Supplement_6): S474-S482 (2019)

  • Beus, D. Fontinha, J. Held, Z. Rajić, L. Uzelac, M. Kralj, M. Prudêncio, B. Zorc:

    Primaquine and Chloroquine Fumardiamides as Promising Antiplasmodial Agents.

    Molecules 24(15): pii: E2812 (2019)

  • M. Beus, D. Fontinha, J. Held, Z. Rajić, M. Prudêncio, B. Zorc:

    Synthesis and antiplasmodial evaluation of novel mefloquine-based fumardiamides.

    Acta Pharmaceutica 69(2): 233-48 (2019)

  • A.K. Boggild, E. Caumes, M.P. Grobusch, E. Schwartz, N.A. Hynes, M. Libman, B.A. Connor, S. Chakrabarti, P. Parola, J.S. Keystone, T. Nash, A.J. Showler, M. Schunk, H. Asgeirsson, D.H. Hamer, K.C. Kain; GeoSentinel Surveillance Network:

    Cutaneous and mucocutaneous leishmaniasis in travellers and migrants: a 20-year GeoSentinel Surveillance Network analysis.

    Journal of Travel Medicine 26(8). pii: taz055 (2019)

  • L.P. de Carvalho, T.L. Sandri, E. José Tenório de Melo, R. Fendel, P.G. Kremsner, B. Mordmüller, J. Held:

    Ivermectin Impairs the Development of Sexual and Asexual Stages of Plasmodium falciparum In Vitro.

    Antimicrobial Agents and Chemotherapy 63(8): pii: e00085-19 (2019)

  • J.C. Dejon-Agobe, U. Ateba-Ngoa, A. Lalremruata, A. Homoet, J. Engelhorn, O.P. Nouatin, J.R. Edoa, J. Fernandes, M. Esen, Y.D. Mouwenda, E.M. Betouke Ongwe, M. Massinga-Loembe, S.L. Hoffman, B.K.L. Sim, M. Theisen, P.G. Kremsner, A.A. Adegnika, B. Lell, B. Mordmüller:

    Controlled Human Malaria Infection of Healthy Adults With Lifelong Malaria Exposure to Assess Safety, Immunogenicity, and Efficacy of the Asexual Blood Stage Malaria Vaccine Candidate GMZ2.

    Clinical Infectious Diseases 69(8): 1377-1384 (2019)

  • J.C. Dejon-Agobé, J.R. Edoa, Y.J. Honkpehedji, J.F. Zinsou, B.R. Adégbitè, M.M. Ngwese, A. Mangaboula B. Lell, M.P. Grobusch, B. Mordmüller, A.A. Adegnika:

    Schistosoma haematobium infection morbidity, praziquantel effectiveness and reinfection rate among children and young adults in Gabon.

    Parasites and Vectors 12(1):577 (2019)

  • C. Dobaño, H. Sanz, H. Sorgho, D. Dosoo, M. Mpina, I. Ubillos, R. Aguilar, T. Ford, N. Díez-Padrisa, N.A. Williams, A. Ayestaran, O. Traore, A.J. Nhabomba, C. Jairoce, J. Waitumbi, S.T. Agnandji, S. Kariuki, S. Abdulla, J.J. Aponte, B. Mordmüller, K.P. Asante, S. Owusu-Agyei, H. Tinto, J.J. Campo, G. Moncunill, B. Gyan, C. Valim, C. Daubenberger:

    Concentration and avidity of antibodies to different circumsporozoite epitopes correlate with RTS,S/AS01E malaria vaccine efficacy.

    Nature Communications 10(1): 2174 (2019)

  • B.V.A. Eder, H. Bösmüller, T. Schubert, A.L. Bissinger:

    Sigmoid colon cancer due to Schistosomiasis.

    Infection 47(6): 1071-1072 (2019)

  • P.N. Essone, M. Leboueny, A.C. Maloupazoa Siawaya, A.K. Alame-Emane, O.C. Aboumegone Biyogo, P.H. Dapnet Tadatsin, A. Mveang Nzoghe, D.U. Essamazokou, O. Mvoundza Ndjindji, G.S. Padzys, S.T. Agnandji, H. Takiff, B. Gicquel, J.F. Djoba Siawaya:

    M. tuberculosis infection and antigen specific cytokine response in healthcare workers frequently exposed to tuberculosis.

    Scientific Reports 9(1): 8201 (2019)

  • A.M. Fonseca, R. González, A. Bardají, C. Jairoce, M. Rupérez, A. Jiménez, L. Quintó, P. Cisteró, A. Vala, C. Sacoor, H. Gupta, J. Hegewisch-Taylor, J. Brew, N.T. Ndam, S. Kariuki, M. López, C. Dobaño, C.E. Chitnis, P. Ouma, M. Ramharter, S. Abdulla, J.J. Aponte, A. Massougbodji, V. Briand, G. Mombo-Ngoma, M. Desai, M. Cot, A. Nhacolo, E. Sevene, E. Macete, C. Menéndez, A. Mayor:

    VAR2CSA Serology to Detect Plasmodium falciparum Transmission Patterns in Pregnancy.

    Emerging Infectious Diseases 25(10): 1851-1860 (2019)

  • R. Funwei, D. Nderu, C.N. Nguetse, B.N. Thomas, C.O. Falade, T.P. Velavan, O. Ojurongbe:

    Molecular surveillance of pfhrp2 and pfhrp3 genes deletion in Plasmodium falciparum isolates and the implications for rapid diagnostic tests in Nigeria.

    Acta Tropica 196: 121-125 (2019)

  • S. Geisler, S.D. Lytton, N.L. Toan, T.H. Nghia, N.M. Nam, H.V. Hung, N.T. Son, D.T. Anh, H.T. Tuyen, V. Tien, D. Quye, H. Van Tong, N.X. Hoan, L.H. Song, S.R. Pallerla, J.M. Gostner, D. Fuchs, T.P. Velavan:

    Neopterin levels and Kyn/Trp ratios were significantly increased in dengue virus patients and subsequently decreased after recovery.

    International Journal of Infectious Diseases 91: 162-168 (2019)

  • O. Goovaerts, M. Massinga-Loembé, P. Ondoa, Ceulemans, W. Worodria, H. Mayanja-Kizza, R. Colebunders, L. Kestens; TB-IRIS Study Group:

    Increased KLRG1 and PD-1 expression on CD8 T lymphocytes in TB-IRIS.

    PLoS One 14(4): e0215991 (2019)

  • M. Groger, L. Veletzky, A. Lalremruata, C. Cattaneo, J. Mischlinger, R. Manego Zoleko, J. Kim, A. Klicpera, E.L. Meyer, D. Blessborn, M. Winterberg, A.A. Adegnika, S.T. Agnandji, P.G. Kremsner, B. Mordmüller, G. Mombo-Ngoma, H.P. Fuehrer, M. Ramharter:

    Prospective Clinical and Molecular Evaluation of Potential Plasmodium ovale curtisi and wallikeri Relapses in a High-transmission Setting.

    Clinical Infectious Diseases 69(12): 2119-2126 (2019)

  • Y. Guerra Mendoza, E. Garric, A. Leach, M. Lievens, O. Ofori-Anyinam, J.Y. Pirçon, J.U. Stegmann, P. Vandoolaeghe, L. Otieno, W. Otieno, S. Owusu-Agyei, J. Sacarlal, N.S. Masoud, H. Sorgho, M. Tanner, H. Tinto, I. Valea, A.T. Mtoro, P. Njuguna, M. Oneko, G.A. Otieno, K. Otieno, S. Gesase, M.J. Hamel, I. Hoffman, S. Kaali, P. Kamthunzi, P. Kremsner, M. Lanaspa, B. Lell, J. Lusingu, A. Malabeja, P. Aide, P. Akoo, D. Ansong, K.P. Asante, J.A. Berkley, S. Adjei, T. Agbenyega, S.T. Agnandji, L. Schuerman:

    Safety profile of the RTS,S/AS01 malaria vaccine in infants and children: additional data from a phase III randomized controlled trial in sub-Saharan Africa

    Human Vaccines & Immunotherapeutics 15(10): 2386-2398 (2019)

  • N.X. Hoan, P.X. Huy, B.T. Sy, C.G. Meyer, T.V. Son, M.T. Binh, D.P. Giang, D. Tu Anh, C.T. Bock, B. Wang, H.V. Tong, P.G. Kremsner, L.H. Song, N.L. Toan, T.P. Velavan:

    High Hepatitis E virus (HEV) Positivity Among Domestic Pigs and Risk of HEV Infection of Individuals Occupationally Exposed to Pigs and Pork Meat in Hanoi, Vietnam.

    Open Forum Infectious Diseases 6(9): ofz306 (2019)

  • N.X. Hoan, N. Khuyen, D.P. Giang, M.T. Binh, N.L. Toan, D.T. Anh, N.T. Trung, M.H. Bang, C.G. Meyer, T.P. Velavan, L.H. Song:

    Vitamin D receptor ApaI polymorphism associated with progression of liver disease in Vietnamese patients chronically infected with hepatitis B virus.

    BMC Medical Genetics 20(1): 201 (2019)

  • R. Hoo, E. Bruske, S. Dimonte, L. Zhu, B. Mordmüller, B.K.L. Sim, P.G. Kremsner, S.L. Hoffman, Z. Bozdech, M. Frank, P.R. Preiser:

    Transcriptome profiling reveals functional variation in Plasmodium falciparum parasites from controlled human malaria infection studies.

    EbioMedicine 48: 442-452 (2019)

  • E. Huizenga, J. van der Ende, N. Zwinkels, A. Jimissa, C. van der Ende-Bouwman, R. van Rooijen, B. Kargbo, S.T. Agnandji, T. Hanscheid, A. Goorhuis, M.P. Grobusch:

    A modified case definition to facilitate essential hospital care during Ebola outbreaks.

    Clinical Infectious Diseases 68(10): 1763–1768 (2019)

  • M. Iannetta, A. Di Caro, E. Nicastri, F. Vairo, H. Masanja, G. Kobinger, A. Mirazimi, F. Ntoumi, A. Zumla, G. Ippolito:

    Viral Hemorrhagic Fevers Other than Ebola and Lassa.

    Infectious Disease Clinics of North America 33(4): 977-1002 (2019)

  • M.N. Ikegbunam, C.N. Nkonganyi, B.N. Thomas, C.O. Esimone, T.P. Velavan, O. Ojurongbe:

    Analysis of Plasmodium falciparum Pfcrt and Pfmdr1 genes in parasite isolates from asymptomatic individuals in Southeast Nigeria 11 years after withdrawal of chloroquine.

    Malaria Journal 18(1): 343 (2019)

  • A. Kiefer, C.D. Bader, J. Held, A. Esser, J. Rybniker, M. Empting, R. Müller, U. Kazmaier:

    Synthesis of New Cyclomarin Derivatives and Their Biological Evaluation towards Mycobacterium Tuberculosis and Plasmodium Falciparum.

    Chemistry 25(37): 8894-8902 (2019)

  • S.L. Knackstedt, A. Georgiadou, F. Apel, U. Abu-Abed, C.A. Moxon, A.J. Cunnington, B. Raupach, D. Cunningham, J. Langhorne, R. Krüger, V. Barrera, S.P. Harding, A. Berg, S. Patel, K. Otterdal, B. Mordmüller, E. Schwarzer, V. Brinkmann, A. Zychlinsky, B. Amulic:

    Neutrophil extracellular traps drive inflammatory pathogenesis in malaria.

    Science Immunology 4(40): eaaw0336 (2019)

  • E. Koehne, A. Kreidenweiss, R. Zoleko Manego, M. McCall, G. Mombo-Ngoma, M.K.W. Mackwitz, F.K. Hansen, J. Held:

    Histone deacetylase inhibitors with high in vitro activities against Plasmodium falciparum isolates collected from Gabonese children and adults.

    Scientific Reports 9(1): 17336 (2019)

  • A. Kreidenweiss, F. Trauner, M. Rodi, E. Koehne, J. Held, L. Wyndorps, G.P. Manouana, M. McCall, A.A. Adegnika, A. Lalremruata, P.G. Kremsner, R. Fendel, T.L. Sandri:

    Monitoring the threatened utility of malaria rapid diagnostic tests by novel high-throughput detection of Plasmodium falciparum hrp2 and hrp3 deletions: A cross-sectional, diagnostic accuracy study.

    EbioMedicine 50: 14-22 (2019)

  • S. Krishna:

    Triple artemisinin-containing combination anti-malarial treatments should be implemented now to delay the emergence of resistance: the case against.

    Malaria Journal 18(1): 339 (2019)

  • D. Leroy, F. Macintyre, Y. Adoke, S. Ouoba, A. Barry, G. Mombo-Ngoma, Ndong Ngomo, R. Varo, Y. Dossou, A.K. Tshefu, T.T. Duong, B.Q. Phuc, B. Laurijssens, R. Klopper, N. Khim, E. Legrand, D. Ménard:

    African isolates show a high proportion of multiple copies of the Plasmodium falciparum plasmepsin-2 gene, a piperaquine resistance marker.

    Malaria Journal 18(1): 126 (2019)

  • K.C.F. Lidani, F.A. Andrade, L. Bavia, F.S. Damasceno, M.H. Beltrame, I.J. Messias-Reason, T.L. Sandri:

    Chagas Disease: From Discovery to a Worldwide Health Problem.

    Frontiers in Public Health7: 166 (2019)

  • C. Lienau, T. Gräwert, L.A Alves Avelar, B. Illarionov, J. Held, T.C. Knaab, B. Lungerich, L. van Geelen, D. Meier, S. Geissler, H. Cynis, U. Riederer, M. Buchholz, R. Kalscheuer, A. Bacher, B. Mordmüller, M. Fischer, T Kurz:

    Novel reverse thia-analogs of fosmidomycin: Synthesis and antiplasmodial activity.

    European Journal of Medicinal Chemistry 181: 111555 (2019)

  • F. Lötsch, F. Waneck, M. Groger, H. Auer, K. Kaczirek, I. Rausch, W. Wadsak, M. Hacker, H. Lagler, M. Ramharter, G. Karanikas:

    FDG-PET/MRI imaging for the management of alveolar echinococcosis: initial clinical experience at a reference centre in Austria.

    Tropical Medicine and International Health 24(6): 663-670 (2019)

  • M. López-Fauqued, L. Campora, F. Delannois, M. El Idrissi, L. Oostvogels, F.J. De Looze, J. Diez-Domingo, T.C. Heineman, H. Lal, J.E. McElhaney, S.A. McNeil, W. Yeo, F. Tavares-Da-Silva; ZOE-50/70 Study Group:

    Safety profile of the adjuvanted recombinant zoster vaccine: Pooled analysis of two large randomised phase 3 trials.

    Vaccine 37(18): 2482-2493 (2019)

  • E. Ludwig, J. Harder, M. Lacorcia, Y.J. Honkpehedji, O.P. Nouatin, G.J. van Dam, P.L.A.M.Corstjens, E. Sartono, M. Esen, S.M. Lobmaier, A.A. Adegnika, C. Prazeres da Costa:

    Placental gene expression and antibody levels of mother-neonate pairs reveal an enhanced risk for inflammation in a helminth endemic country.

    Scientific Reports 9(1): 15776 (2019)

  • M.K.W. Mackwitz, E. Hesping, Y. Antonova-Koch, D. Diedrich, T.G. Woldearegai, T. Skinner-Adams, M. Clarke, A. Schöler, L. Limbach, T. Kurz, E.A. Winzeler, J. Held, K.T. Andrews, F.K. Hansen:

    Structure-Activity and Structure-Toxicity Relationships of Peptoid-Based Histone Deacetylase Inhibitors with Dual-Stage Antiplasmodial Activity.

    ChemMedChem 14(9): 912-926 (2019)

  • A.C. Maloupazoa Siawaya, E. Kuissi Kamgaing, S. Minto'o Rogombe, T. Obiang, E. Moungoyi Massala, M.J.V. Magossou Mbadinga, M. Leboueny, O. Mvoundza Ndjindji, A. Mveang-Nzoghe, J.P. Ondo, A. Mintsa Ndong, P. Essone, S.T. Agnandji, M. Kaba, S. Ategbo, J.F. Djoba Siawaya:

    HIV-exposed uninfected compared with unexposed infants show the presence of leucocytes, lower lactoferrin levels and antimicrobial-resistant micro-organisms in the stool.

    Paediatrics and International Child Health 39(4): 249-258 (2019)

  • K. Matuschewski, S. Borrmann:

    Controlled Human Malaria Infection (CHMI) Studies: Over 100 Years of Experience with Parasite Injections.

    MethodsinMolecular Biology 2013: 91-101 (2019)

  • Y. Mbouamboua, F. Koukouikila-Koussounda, F. Ntoumi, S. Adukpo, M. Kombo, C. Vouvoungui, J. van Helden, S.C. Kobawila:

    Sub-microscopic Plasmodium falciparum infections in matched peripheral, placental and umbilical cord blood samples from asymptomatic Congolese women at delivery.

    Acta Tropica 193: 142-147 (2019)

  • M.M. Mebius, A.A. Adegnika, J.F. Zinsou, J.C.D. Agobe, Y.J. Honkpehedji, M. Yazdanbakhsh, G.J. van Dam, P.L.A.M. Corstjens, A.G.M. Tielens, P.G. de Groot, R.T. Urbanus, J.J. van Hellemond:

    Haemostatic changes in urogenital schistosomiasis haematobium: a case-control study in Gabonese schoolchildren.

    Journal of Helminthology 94: e84 (2019)

  • W.G. Metzger, H.J.Ehni, P.G. Kremsner, B.G. Mordmüller:

    Experimental infections in humans-historical and ethical reflections.

    Tropical Medicine and International Health 24(12): 1384-1390 (2019)

  • V. Mikounou Louya, C. Vouvoungui, F. Koukouikila-Koussounda, F. Veas, S.C. Kobawila, F. Ntoumi:

    Molecular characterization of norovirus infection responsible for acute diarrhea in Congolese hospitalized children under five years old in Brazzaville, Republic of Congo.

    International Journal of Infectious Diseases 88 :41-48 (2019)

  • V. Mikounou Louya, B. Nguekeng Tsague, F. Ntoumi, C. Vouvoungui, S.C. Kobawila:

    High prevalence of norovirus and rotavirus co-infection in children with acute gastroenteritis hospitalised in Brazzaville, Republic of Congo.

    Tropical Medicine and International Health 24(12): 1427-1433 (2019)

  • B. Mordmüller, M. Sulyok, D. Egger-Adam, M. Resende, W.A. de Jongh, M.H. Jensen, H.H. Smedegaard, S.B. Ditlev, M. Soegaard, L. Poulsen, C. Dyring, C.L. Calle, A. Knoblich, J. Ibáñez, M. Esen, P. Deloron, N. Ndam, S. Issifou, S. Houard, R.F. Howard, S.G. Reed, O. Leroy, A.J.F. Luty, T. Theander, P.G. Kremsner, A. Salanti, M.A. Nielsen:

    First-in-human, Randomized, Double-blind Clinical Trial of Differentially Adjuvanted PAMVAC, A Vaccine Candidate to Prevent Pregnancy-associated Malaria.

    Clinical Infectious Diseases 69(9): 1509-1516 (2019)

  • D. Nderu, F. Kimani, E. Karanja, K. Thiong'o, M. Akinyi, E. Too, W. Chege, E. Nambati, L.N. Wangai, C.G. Meyer, T.P. Velavan:

    Genetic diversity and population structure of Plasmodium falciparum in Kenyan-Ugandan border areas.

    Tropical Medicine and International Health 24(5): 647-656 (2019)

  • T.T. Nguyen, B. Nzigou Mombo, A. Lalremruata, E. Koehne, R. Zoleko ManegoL.B. Dimessa Mbadinga, A.A. Adegnika, S.T. Agnandji, B. Lell, P.G. Kremsner, T.P. Velavan, M. Ramharter, B. Mordmüller, G. Mombo-Ngoma:

    DNA recovery from archived RDTs for genetic characterization of Plasmodium falciparum in a routine setting in Lambaréné, Gabon.

    Malaria Journal 18(1): 336 (2019)

  • F. Ntoumi:

    Supporting female scientists in Africa.

    Lancet 393(10187): 2196 (2019)

  • F.A. Osundare, O.O. Opaleye, A.A. Akindele, S.A. Adedokun, O.A. Akanbi, C.T. Bock, S. Diedrich, S. Böttcher:

    Detection and Characterization of Human Enteroviruses, Human Cosaviruses, and a New Human Parechovirus Type in Healthy Individuals in Osun State, Nigeria, 2016/2017.

    Viruses 11(11): 1037 (2019)

  • S.E. Park, T. Toy, L.M. Cruz Espinoza, U. Panzner, O.D. Mogeni, J. Im, N. Poudyal, G.D. Pak, H. Seo, Y. Chon, H. Schütt-Gerowitt, V. Mogasale, E. Ramani, A. Dey, J.Y. Park, J.H. Kim, H.J. Seo, H.J. Jeon, A. Haselbeck, K. Conway Roy, W. MacWright, Y. Adu-Sarkodie, E. Owusu-Dabo, I. Osei, M. Owusu, R. Rakotozandrindrainy, A.B. Soura, L.P. Kabore, M. Teferi, I.N. Okeke, A. Kehinde, O. Popoola, J. Jacobs, O. Lunguya Metila, C.G. Meyer, J.A. Crump, S. Elias, C.A. Maclennan, C.M. Parry, S. Baker, E.D. Mintz, R.F. Breiman, J.D. Clemens, F. Marks:

    The Severe Typhoid Fever in Africa Program: Study Design and Methodology to Assess Disease Severity, Host Immunity, and Carriage Associated With Invasive Salmonellosis.

    Clinical Infectious Diseases 69(Supplement_6): S422-S434 (2019)

  • K. Pavić, B. Rubinić, Z. Rajić, D. Fontinha, M. Prudêncio, L. Uzelac, M. Kralj, J. Held, B. Zorc:

    Primaquine homodimers as potential antiplasmodial and anticancer agents.

    Bioorganic & Medicinal Chemistry Letters 29(19): 126614 (2019)

  • S.M. Peko, N.S.G. Gueye, C. Vouvoungui, F. Koukouikila-Koussounda, S.C. Kobawila, D. Nderu, T.P. Velavan, F. Ntoumi:

    Cytochrome P450 CYP2B6*6 distribution among Congolese individuals with HIV, Tuberculosis and Malaria infection.

    International Journal of Infectious Diseases 82: 111-116 (2019)

  • S.M. Peko, F. Ntoumi, C. Vouvoungui D. Nderu, S.C. Kobawila, T.P. Velavan, F. Koukouikila-Koussounda:

    Distribution of the cytochrome P450 CYP2C8*2 allele in Brazzaville, Republic of Congo.

    International Journal of Infectious Diseases 85: 49-53 (2019)

  • E. Reiterer, S. Reider, P. Lackner, N. Fischer, D. Dejaco, H. Riechelmann, P. Zorowka, P.G. Kremsner, A.A. Adegnika, E. Schmutzhard, J. Schmutzhard:

    A long-term follow-up study on otoacoustic emissions testing in paediatric patients with severe malaria in Gabon.

    Malaria Journal 18(1): 212 (2019)

  • C. Rothe, G. Boecken, D. Rosenbusch, M. Alberer, S. Buehler, G. Burchard, K. Erkens, T. Feldt, M.P. Grobusch, C. Koehler, M. Loebermann, K. Meischner, W. Metzger, A. Mueller, H.D. Nothdurft, B. Rieke, C. Schlaich, C. Schoenfeld, M.H. Schulze, J. Siedenburg, F. Steiner, T. Weitzel, O. Veit:

    Recommendations for antimalarial prophylaxis.

    Flugmedizin Tropenmedizin Reisemedizin 26(3): 105-132

  • T.L. Sandri, F.A. Andrade, K.C.F. Lidani, E. Einig, A.B.W. Boldt, B. Mordmüller, M. Esen, I.J. Messias-Reason:

    Human collectin-11 (COLEC11) and its synergic genetic interaction with MASP2 are associated with the pathophysiology of Chagas Disease.

    PLoS Neglected Tropical Diseases13(4): e0007324 (2019)

  • K. Scheu, A.A. Adegnika, M.M. Addo, D. Ansong, J.P. Cramer, S. Fürst, P.G. Kremsner, F Kurth, T. Jacobs, J. May, M. Ramharter, J.Sylverken, C.D. Vinnemeier, T. Agbenyega, T. Rolling:

    Determinants of post-malarial anemia in African children treated with parenteral artesunate.

    Scientific Reports 9(1): 18134 (2019)

  • T. Toy G.D. Pak, T.P. Duc, J.L. Campbell, M.A. El Tayeb, V. Von Kalckreuth, J. Im, U. Panzner, L.M. Cruz Espinoza, D. Eibach, D.M. Dekker, S.E. Park, H.J. Jeon, F. Konings, O.D. Mogeni, L. Cosmas, M. Bjerregaard-Andersen, N. Gasmelseed, J.T. Hertz, A. Jaeger, R. Krumkamp, B. Ley, K. Thriemer, L:P. Kabore, A. Niang, T.M. Raminosoa, E. Sampo, N. Sarpong, A. Soura, E. Owusu-Dabo, M. Teferi, B. Yeshitela, S. Poppert, J. May, J.H. Kim, Y. Chon, J.K. Park, A. Aseffa, R.F. Breiman, H. Schütt-Gerowitt, P. Aaby, Y. Adu-Sarkodie, J.A. Crump, R. Rakotozandrindrainy, C.G. Meyer, A.G. Sow, J.D. Clemens, T.F. Wierzba, S. Baker, F. Marks:

    Multicountry Distribution and Characterization of Extended-spectrum β-Lactamase-associated Gram-negative Bacteria From Bloodstream Infections in Sub-Saharan Africa.

    Clinical Infectious Diseases 69(Supplement_6): S449-S458 (2019)

  • N.T. Trung, L.T. Hai, D.P. Giang, P.Q. Hoan, M.T. Binh, N.X. Hoan, N.L. Toan, C.G. Meyer, T.P. Velavan, M.H. Bang, L.H. Song:

    No expression of HBV-human chimeric fusion transcript (HBx-LINE1) among Vietnamese patients with HBV-associated hepatocellular carcinoma.

    Annals of Hepatology18(2): 404-405 (2019)

  • N.T. Trung, D.T. Quyen, N.X. Hoan, D.P. Giang, T.T.H. Trang, T.P. Velavan, M.H. Bang, L.H. Song:

    Rapid, low cost and sensitive detection of Calreticulin mutations by a PCR based amplicon length differentiation assay for diagnosis of myeloproliferative neoplasms.

    BMC Medical Genetics 20(1): 115 (2019)

  • F. Vairo, N. Haider, R. Kock, F. Ntoumi, G. Ippolito, A. Zumla:

    Chikungunya: Epidemiology, Pathogenesis, Clinical Features, Management, and Prevention.

    Infectious Disease Clinics of North America 33(4): 1003-1025 (2019)

  • T.P. Velavan, D. Nderu, T. Agbenyega, F. Ntoumi, P.G. Kremsner:

    An alternative dogma on reduced artemisinin susceptibility: A new shadow from east to west.

    Proceedings of the National Academy of Sciences of the United States of America 116(26): 12611-12612 (2019)

  • J. Wang, C. Xu, F.L. Liao, T. Jiang, S. Krishna, Y.Tu:

    A Temporizing Solution to "Artemisinin Resistance".

    New England Journal of Medicine 380(22):2087-2089 (2019)

  • D.J. Ward, H. Van de Langemheen, E. Koehne, A. Kreidenweiss, R.M.J. Liskamp:

    Highly tunable thiosulfonates as a novel class of cysteine protease inhibitors with anti-parasitic activity against Schistosoma mansoni.

    Elsevier logo

    Bioorganic & Medicinal Chemistry 27(13): 2857-2870 (2019)

  • D.O. Willer, L. Oostvogels, A.L. Cunningham, P. Gervais, I. Gorfinkel, J. Hyung Kim, C. Talarico, V. Wascotte, T. Zahaf, R. Colindres, A. Schuind; ZOE 50/70 study groups:

    Efficacy of the adjuvanted recombinant zoster vaccine (RZV) by sex, geographic region, and geographic ancestry/ethnicity: A post-hoc analysis of the ZOE-50 and ZOE-70 randomized trials.

    Vaccine 37(43): 262-6267 (2019)

  • G. Woldearegai, A. Lalremruata, T.T. Nguyen, M. Gmeiner, L. Veletzky, G.B. Tazemda-Kuitsouc, P.B. Matsiegui, B. Mordmüller, J. Held:

    Characterization of Plasmodium infections among inhabitants of rural areas in Gabon.

    Scientific Reports 9(1):9784 (2019)

  • WorldWide Antimalarial Resistance Network Methodology Study Group:

    Competing risk events in antimalarial drug trials in uncomplicated Plasmodium falciparum malaria: a WorldWide Antimalarial Resistance Network individual participant data meta-analysis.

    Malaria Journal 18(1): 225 (2019)

  • R. Zoleko Manego, E. Koehne, A. Kreidenweiss, B. Nzigou Mombo, R.R. Adegbite, L.B. Dimessa Mbadinga, M. Akinosho, J. Matthewman, A.A. Adegnika, M. Ramharter, G. Mombo-Ngoma:

    Description of Plasmodium falciparum infections in central Gabon demonstrating high parasite densities among symptomatic adolescents and adults.

    Malaria Journal 18(1): 371 (2019)

Zertifikate und Verbände

Springe zum Hauptteil